0001477932-14-001262.txt : 20140326 0001477932-14-001262.hdr.sgml : 20140326 20140326171841 ACCESSION NUMBER: 0001477932-14-001262 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20140228 FILED AS OF DATE: 20140326 DATE AS OF CHANGE: 20140326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GOLF ROUNDS COM INC CENTRAL INDEX KEY: 0000319016 STANDARD INDUSTRIAL CLASSIFICATION: [9995] IRS NUMBER: 591224913 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-10093 FILM NUMBER: 14719420 BUSINESS ADDRESS: STREET 1: 111 VILLAGE PARKWAY STREET 2: BUILDING #2 CITY: MARIETTA STATE: GA ZIP: 30067 BUSINESS PHONE: 770-951-0984 MAIL ADDRESS: STREET 1: 111 VILLAGE PARKWAY STREET 2: BUILDING #2 CITY: MARIETTA STATE: GA ZIP: 30067 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN METALS SERVICE INC DATE OF NAME CHANGE: 19920703 10-Q 1 teee_10q.htm FORM 10-Q teee_10q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the quarterly period ended: February 28, 2014
   
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
 
For the transition period from_____________________ to_____________________.

Commission file number 0-10093

Golf Rounds.com, Inc.
(Exact name of registrant as specified in its charter)

Delaware
 
59-1224913
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

111 Village Parkway, Building #2, Marietta, Georgia 30067
(Address of principal executive offices) (Zip Code)

770-951-0984
(Registrant’s telephone number)

  N/A
(Former name, former address and former fiscal year, if changed since last report)

Check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x   No o

State the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date: As of March 25, 2014, the issuer had 5,848,185 shares of common stock, par value $.01 per share, outstanding.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
x
(Do not check if a smaller reporting company)
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes x   No o
 


 
 

 
 
TABLE OF CONTENTS
 
PART I — FINANCIAL INFORMATION        
           
Item 1.
Financial Statements
    1  
 
Condensed Consolidated Balance Sheets as of February 28, 2014 (Unaudited) and August 31, 2013
    1  
 
Condensed Consolidated Statements of Operations for the three and six months ended February 28, 2014 and 2013 (Unaudited)
    2  
  Condensed Consolidated Statement of Stockholders’ Deficit for the six months ended February 28, 2014 (Unaudited)     3  
 
Condensed Consolidated Statements of Cash Flows for the six months ended February 28, 2014 and 2013 (Unaudited)
    4  
 
Notes to Condensed Consolidated Financial Statements for the three and six months ended February 28, 2014 and 2013 (Unaudited)
    5  
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
    10  
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
    13  
Item 4.
Controls and Procedures
    13  
           
PART II — OTHER INFORMATION        
           
Item 1.
Legal Proceedings
    14  
Item 1A.
Risk Factors*
       
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds*
       
Item 3.
Defaults Upon Senior Securities*
       
Item 4.
Mine Safety Disclosures*
       
Item 5.
Other Information*
       
Item 6.
Exhibits
    14  
           
SIGNATURES     15  
____________
*
Omitted in accordance with the instruction to Part II of Form 10-Q because the item is inapplicable or the answer to the item is negative.
 
 
 

 
 
PART I

FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 
   
February 28,
2014
   
August 31,
2013
 
   
(Unaudited)
       
Assets
Current assets:
           
Cash and cash equivalents
  $ 6,551     $ 801  
Prepaid expenses
    18,673       10,700  
Total current assets
    25,224       11,501  
                 
Total assets
  $ 25,224     $ 11,501  
                 
Liabilities and Stockholders’ Deficit
                 
Current liabilities:
               
Accounts payable and accrued expenses
  $ 19,397     $ 33,096  
Notes payable, current portion
    95,000       -  
Total current liabilities
    114,397       33,096  
                 
Notes payable
    17,250       17,250  
Total liabilities
    131,647       50,346  
                 
Stockholders’ deficit:
               
Common stock, $0.01 par value; 12,000,000 shares authorized,
               
5,848,185 shares issued and outstanding
    58,481       58,481  
Additional paid-in capital
    3,270,942       3,270,942  
Accumulated deficit
    (3,435,846 )     (3,368,268 )
Total stockholders’ deficit
    (106,423 )     (38,845 )
                 
Total liabilities and stockholders’ deficit
  $ 25,224     $ 11,501  
 
See accompanying notes to condensed consolidated financial statements.
 
 
1

 
 
GOLF ROUNDS. COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
   
For the Three
   
For the Three
   
For the Six
   
For the Six
 
   
Months Ended
   
Months Ended
   
Months Ended
   
Months Ended
 
   
February 28, 2014
   
February 28, 2013
   
February 28, 2014
   
February 28, 2013
 
                         
Expenses:
                       
General, administrative and other
  $ 18,377     $ 24,372     $ 66,466     $ 56,544  
Total operating expenses
    18,377       24,372       66,466       56,544  
                                 
Loss from operations
    (18,377 )     (24,372 )     (66,466 )     (56,544 )
                                 
Other income (expense):
                               
Interest expense
    (777 )     (98 )     (1,112 )     (98 )
Total other income (expense)
    (777 )     (98 )     (1,112 )     (98 )
                                 
Net loss
  $ (19,154 )   $ (24,470 )   $ (67,578 )   $ (56,642 )
                                 
Net loss per common share - basic and diluted
  $ (0.00 )   $ (0.01 )   $ (0.01 )   $ (0.02 )
                                 
Weighted average number of common shares
                               
outstanding - basic and diluted
    5,848,185       3,567,377       5,848,185       3,567,377  
 
See accompanying notes to condensed consolidated financial statements.
 
 
2

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY
FOR THE SIX MONTHS ENDED FEBRUARY 28, 2014
(Unaudited)
 
               
Additional
         
Total
 
   
Common Stock
   
Paid-In
   
Accumulated
   
Stockholders'
 
   
Shares
   
Amount
   
Capital
   
Deficit
   
Deficit
 
Balance, August 31, 2013
    5,848,185     $ 58,481     $ 3,270,942     $ (3,368,268 )   $ (38,845 )
Net loss
    -       -       -       (67,578 )     (67,578 )
Balance, February 28, 2014
    5,848,185     $ 58,481     $ 3,270,942     $ (3,435,846 )   $ (106,423 )
 
See accompanying notes to condensed consolidated financial statements.
 
 
3

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
   
For the Six
   
For the Six
 
   
Months Ended
   
Months Ended
 
   
February 28, 2014
   
February 28, 2013
 
             
Cash flows from operating activities:
           
Net loss
  $ (67,578 )   $ (56,642 )
Adjustments to reconcile net loss to net cash used in operating activites:
               
Convertible notes issued for services rendered
    -       5,250  
Changes in operating assets and liabilities:
               
(Increase) decrease in prepaid expenses
    (7,973 )     3,750  
Increase (decrease) in accounts payable and accrued expenses
    (13,699 )     37,462  
Net cash used in operating activities
    (89,250 )     (10,180 )
                 
Cash flows from financing activities:
               
Proceeds from issuance of notes payable
    95,000       -  
Proceeds from related party for convertible notes
    -       10,000  
Net cash provided by financing activities
    95,000       10,000  
                 
Net increase (decrease) in cash and cash equivalents
    5,750       (180 )
                 
Cash and cash equivalents - beginning
    801       334  
                 
Cash and cash equivalents - ending
  $ 6,551     $ 154  
                 
Supplemental disclosure of cash flow information:
               
Interest paid
  $ 280     $ -  
Income taxes paid
  $ -     $ -  
 
See accompanying notes to condensed consolidated financial statements.
 
 
4

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2014 AND 2013
(Unaudited)
  
NOTE 1 — NATURE OF OPERATIONS AND BASIS OF PRESENTATION

(A)
Merger with Fuse Medical, LLC

On December 18, 2013, Golf Rounds.com, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Fuse Medical, LLC (“Fuse”), Project Fuse LLC, a wholly owned subsidiary of the Company (“Merger Sub”), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the “Representative”). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the “Merger”). The Merger is expected to be completed during the third fiscal quarter of 2014.

Fuse is a physician-partnered company and national distributor that provides diversified healthcare products and supplies, including biologics and bone substitute materials, while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners. Fuse has entered into partnership arrangements with physicians in order to distribute its products.

In accordance with the Merger Agreement, on December 18, 2013, the Company obtained approval by written consent from the holders of 3,220,330 shares of its common stock, representing a majority of its outstanding common stock, to amend its certificate of incorporation, effective immediately prior to the consummation of the Merger, (i) to change the name of the Company to “Fuse Medical, Inc.”, (ii) to increase the Company’s authorized capital stock from 12,000,000 shares of common stock to 500,000,000 shares of common stock and from zero shares of preferred stock to 20,000,000 shares of preferred stock, and to expressly authorize the board of directors of the Company to issue shares of the preferred stock, in one or more series, and to fix for each such series the voting powers, designations, preferences, or other special rights thereof and the qualifications, limitations or restrictions thereon, and (iii) to effect a 14.62 to 1 reverse stock split (the “Reverse Stock Split”). On March 4, 2014, the Company filed with the Securities and Exchange Commission (the “SEC”) a preliminary information statement on Schedule PRE 14C relating to the approval and adoption of the amendments (the “Preliminary Information Statement”). On March 13, 2014, the SEC notified the Company that the Preliminary Information Statement would be reviewed. Once the comments on the Preliminary Information Statement have been cleared by the SEC, the Company shall file a definitive information statement on Schedule DEF 14C relating to the adoption of the amendments (the “Definitive Information Statement”). The amendments will become effective no earlier than 20 days after the Definitive Information Statement is mailed to the Company’s stockholders.

All of the units reflecting membership interests in Fuse that are issued and outstanding immediately prior to the effective time of the Merger shall be cancelled and converted into the right to receive 3,600,000 shares of the Company’s common stock (on a post-Reverse Stock Split basis), representing 90% of the Company’s issued and outstanding common stock after giving effect to the Merger (the “Merger Consideration”). The Merger Consideration will be allocated among the members of Fuse immediately prior to the effective time of the Merger (the “Holders”) in accordance with Fuse’s limited liability company operating agreement.

 
5

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2014 AND 2013
(Unaudited)
 
In order to fund the indemnification obligations of the Holders after the closing of the Merger, of the shares of common stock constituting the Merger Consideration, 180,000 shares (on a post-Reverse Stock Split basis) will be deposited in escrow pursuant to the terms of the Merger Agreement and an escrow agreement, in the form attached to the Merger Agreement, to be executed at the closing.

(B)
Interim Financial Statements

The accompanying unaudited condensed consolidated balance sheet of Golf Rounds.com, Inc. and its wholly owned subsidiaries, DPE Acquisition Corp. and Project Fuse LLC, (collectively, the “Company”), as of February 28, 2014, and the unaudited condensed consolidated statements of operations for the three and six months ended February 28, 2014 and 2013, the unaudited condensed consolidated statement of stockholders’ deficit for the six months ended February 28, 2014, and the unaudited condensed consolidated statements of cash flows for the six months ended February 28, 2014 and 2013 reflect all material adjustments which, in the opinion of management, are ordinary and necessary for a fair presentation of results for the interim periods. Certain information and footnote disclosures required under generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company believes that the disclosures are adequate to make the information presented not misleading. The condensed consolidated balance sheet information as of August 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 15, 2013. These condensed consolidated financial statements should be read in conjunction with the year-end audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2013.

The results of operations for the three and six months ended February 28, 2014 and 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or for any other period.

(C)
Principles of Consolidation
 
The condensed consolidated financial statements include the accounts of Golf Rounds.com, Inc. and its wholly owned subsidiaries DPE Acquisition Corp. (formed on September 2, 2003) and Project Fuse LLC (formed on December 17, 2013).  Intercompany transactions and accounts have been eliminated in consolidation.

(D)
Loss Per Share

Diluted earnings per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. In computing diluted earnings per share, the treasury stock method assumes that our outstanding options are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options.

As of February 28, 2014 and 2013, common stock equivalents include options to purchase 330,000 and 360,000 common shares, respectively. These instruments are not considered in the diluted loss per share because the effect would be anti-dilutive.

 
6

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2014 AND 2013
(Unaudited)
 
(E)
Use of Estimates

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the valuation of equity instruments at the date of the condensed consolidated financial statements. Actual results could differ from those estimates.

(F)
Fair Value of Financial Instruments

The carrying amounts of certain financial instruments, including cash and cash equivalents, prepaid expenses, and accounts payable and accrued expenses approximate their fair values because of the short-term maturity of these instruments.

(G)
Recent Accounting Pronouncements
 
There are recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the "SEC"); such pronouncements are not believed by management to have a material impact on the Company's present or future financial statements.
 
NOTE 2 — GOING CONCERN

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated any revenues from operations since 2001 and has suffered recurring losses from its operations. During the six months ended February 28, 2014, the Company had a net loss of $67,578, used cash in operations of $89,250, and had no revenues from operations. As of February 28, 2014, the Company had an accumulated deficit of $3,435,846 and a working capital deficiency of $89,173. Currently, the Company’s working capital is not sufficient to last for more than 12 months. As a result, the Company’s independent registered public accounting firm, in its report on the Company’s August 31, 2013 consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. These factors among others indicate that the Company may be unable to continue as a going concern. The Company’s existence is dependent upon management’s ability to effect a business combination with a target business and/or obtain additional funding sources. Commencing in December 2012, the Company began financing its working capital requirements through sale of its promissory notes and convertible promissory notes. There can be no assurance that the Merger or the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 
7

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2014 AND 2013
(Unaudited)
 
In order to continue our operations and to make acquisitions, if any, under our current business model during the next twelve months, we will need to secure additional working capital, by way of debt or equity financing, or otherwise. We will need additional financing for working capital, and, in the case of acquisitions, for payment of seller notes and future earned cash to sellers of acquired companies. There can be no assurance that we will be able to secure sufficient financing or on terms acceptable to us. If adequate funds are not available on acceptable terms, we would need to delay, limit or eliminate some or all of our proposed operations, and we may be unable to successfully promote our products or develop new or enhanced products or prosecute acquisitions, any of which could lower our revenues and net income, if we achieve profitability in the future. If we raise additional funds through the issuance of convertible debt or equity securities, the percentage ownership of our current stockholders is likely to be diluted, unless some of our current stockholders were to invest in subsequent convertible debt or equity financings, and some of the newly issued securities may also have rights superior to those of our common stock. Additionally, if we issue or incur debt to raise funds, we may be subject to limitations on our operations.

NOTE 3 — NOTES PAYABLE

On October 18, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due April 15, 2014 in exchange for cash proceeds of $39,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

On November 4, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due May 5, 2014 in exchange for cash proceeds of $24,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

On December 26, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due June 26, 2014 in exchange for cash proceeds of $32,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

During the three and six months ended February 28, 2014, interest expense of $777 and $1,112, respectively, was recognized on outstanding notes payable. During the three and six months ended February 28, 2013, interest expense of $98 (of which $56 is for related parties) was recognized on outstanding notes payable. As of February 28, 2014, accrued interest payable was $852, which is included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.

Notes payable consisted of the following at February 28, 2014 and August 31, 2013, respectively:
 
   
February 28,
2014
   
August 31,
2013
 
Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014
  $ 39,000     $ -  
                 
Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014
    24,000       -  
                 
Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014
    32,000       -  
                 
Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015
    6,000       6,000  
                 
Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015
    11,250       11,250  
Total
    112,250       17,250  
Less: Current maturities
    (95,000 )     -  
Amount due after one year
  $ 17,250     $ 17,250  
 
 
8

 
 
GOLF ROUNDS.COM, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED FEBRUARY 28, 2014 AND 2013
(Unaudited)
 
NOTE 4 — STOCKHOLDERS’ DEFICIT

Stock Options

A summary of the Company’s stock option activity during the six months ended February 28, 2014 is presented below:

               
Weighted
       
         
Weighted
   
Average
       
         
Average
   
Remaining
   
Aggregate
 
   
No. of
   
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term
   
Value
 
Balance outstanding at August 31, 2013
    330,000     $ 0.68              
Granted
    -                      
Exercised
    -                      
Forfeited
    -                      
Expired
    -                      
Balance outstanding at February 28, 2014
    330,000     $ 0.68       1.7     $ -  
                                 
Exercisable at February 28, 2014
    330,000     $ 0.68       1.7     $ -  
 
NOTE 5 — RELATED PARTY TRANSACTIONS

On March 1, 2000, the Company executed a month-to-month agreement to sub-lease office space and share office equipment and a bookkeeper’s time for $900 a month from R. D. Garwood, Inc. (“Garwood”). The Company’s President/Treasurer/Secretary is the Chief Financial Officer of Garwood. Effective June 1, 2013, due to the financial status of the Company, R.D. Garwood, Inc. began providing the aforementioned services at no charge to the Company. The Company’s expense for these shared facilities and bookkeeping services was $2,700 and $5,400 for the three and six months ended February 28, 2013.

During the three and six months ended February 28, 2014, the Company’s President provided services at no charge to the Company. During the three and six months ended February 28, 2013, the Company accrued salary for its President in the amount of $7,500 and $15,000, respectively, which is included in general and administrative expenses in the accompanying consolidated statements of operations.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Legal Matters
 
On January 27, 2014, M. Richard Cutler and Cutler Law Group, P.C. (the “Plaintiffs”) filed a complaint in the District Court of Harris County, Texas, 2014-03355, against Fuse Medical, LLC, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc. (the “Defendants”).  Plaintiff Richard Cutler is the sole principal of Plaintiff Cutler Law Group, which provided legal representation to its client (“Cutler’s Client”) that was interested in merging into a publicly traded corporation and attracting doctors as investors.  Plaintiffs allege that a proposed transaction between Cutler’s Client and Fuse Medical, LLC (“Cutler’s Failed Transaction”), failed to materialize notwithstanding the alleged efforts of Mr. Cutler and his law firm to document the transaction.  Plaintiffs further allege that, subsequently, the Defendants continued to pursue a similar transaction without Cutler’s Client or the Plaintiffs.  The Plaintiffs are claiming that the Defendants are responsible for damages in the amount of: (i) $46,465 plus interest because Plaintiffs were not paid their legal fees by Cutler’s Client nor did they receive equity in the company that Plaintiffs hoped would be issued from Cutler’s Failed Transaction; (ii) $46,465 plus interest due to Defendant being unjustly enriched  from Plaintiffs’ legal services to Cutler’s Client; (iii) $1,186,000 plus interest, being the alleged value of shares that Plaintiffs claimed to be entitled from Cutler’s Failed Transaction, which amount should allegedly be tripled as exemplary damages as a result of intentional fraud and/or negligent representations that some or all of the Defendants allegedly committed and that such conduct allegedly constitutes conspiracy to commit fraud; (iv) $1,186,000, allegedly arising from a breach of a Non-Competition and Non-Disclosure Agreement to which Plaintiffs were not a party; (v) $1,000,000 for breach of fiduciary duty by the Defendants because they would have been directors and officers of the surviving corporation in Cutler’s Failed Transaction had it not failed and Defendants’ moving on to another transaction without Plaintiffs; and (vi) Plaintiffs’ attorneys fees and costs for bringing this action.  Defendants believe the lawsuit to be without merit and have retained counsel to vigorously defend the action.  In addition, Defendant Robert H. Donehew is covered by Directors and Officers Insurance policies.
 
 
9

 
 
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Forward-looking statements
 
When used in this Report, words or phrases such as “will likely result,” “management expects,” “we expect,” “will continue,” “is anticipated,” “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only at the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements. Forward-looking statements involve a number of risks and uncertainties including, but not limited to, general economic conditions, our ability to consummate a business combination with Fuse Medical, LLC, competitive factors and other risk factors as set forth in Exhibit 99.1 of our Annual Report on Form 10-KSB for the year ended August 31, 2008.
 
The following discussion should be read in conjunction with the condensed consolidated financial statements and related notes included in this Report.
 
Our Ability to Continue as a Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the six months ended February 28, 2014, the Company had a net loss of $67,578, used cash in operations of $89,250, and had no revenues from operations. These factors among others indicate that the Company may be unable to continue as a going concern. The Company’s existence is dependent upon management’s ability to effect a business combination with Fuse Medical, LLC and/or obtain additional funding sources. There can be no assurance that the Merger or the Company’s other financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern. If we are not able to continue as a going concern, it is likely that holders of our common stock will lose all of their investment.

Overview

General
 
Golf Rounds.com, Inc. (the “Company”) was incorporated in 1968 as a Delaware corporation, which is also authorized to conduct business in Georgia. Until the fourth quarter of fiscal 1992, the Company was engaged in the wholesale distribution of aluminum alloys, steel and other specialty metals under the name American Metals Service, Inc. In the fourth quarter of fiscal 1992, the Company liquidated its assets and did not conduct any business operations until May 1999. In May 1999, the Company acquired the assets of PKG Design, Inc., the developer of two sports - related Internet websites: golfrounds.com and skiingusa.com. In connection with the acquisition of these websites, the Company changed its name to Golf Rounds.com, Inc.
 
In August 2001, the Company ceased operations of its golfrounds.com and skiingusa.com websites since continued maintenance of these websites was not a productive use of the Company’s resources.

 
10

 
 
On September 19, 2003, the Company and its wholly owned subsidiary, DPE Acquisition Corp., (formed on September 2, 2003), entered into an agreement and plan of reorganization and merger with Direct Petroleum Exploration, Inc. (“DPE”), which was not consummated. The Company continues to maintain the subsidiary for use in any other potential future acquisition. This subsidiary is currently inactive and has no operations.

On September 17, 2010, the Company declared a special cash dividend of $0.50 per share of common stock issued and outstanding to be paid on October 21, 2010 to stockholders of record as of September 30, 2010 using cash from its general funds. On October 21, 2010, the aggregate dividend paid was $1,783,689.

On December 18, 2013, Golf Rounds.com, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Fuse Medical, LLC (“Fuse”), Project Fuse LLC, a wholly owned subsidiary of the Company (“Merger Sub”), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the “Representative”). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the “Merger”). The Merger is expected to be completed during the third fiscal quarter of 2014.
 
Our Business Plan

Upon completion of the foregoing Merger transaction, the Company will conduct its operations through Fuse.
 
Fuse is a physician partnered, national distributor and provider of select healthcare products and supplies that meet or exceed market standards while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners.
 
Critical Accounting Policies and Use of Estimates

The preparation of our condensed consolidated financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the reported amounts of revenue and expense, and the disclosure of contingent assets and liabilities. We evaluate our estimates and assumptions on an ongoing basis. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that it is important for investors to be aware that there is a particularly high degree of subjectivity involved in estimating the fair value of stock-based compensation, that the expenses recorded for stock-based compensation in the Company’s financial statements may differ significantly from the actual value realized by the recipients of the stock awards, and that the expenses recorded for stock-based compensation will not result in cash payments from Golf Rounds.com.
 
Results of Operations

We have had no revenues (other than interest and dividend income) since 1992 and will not generate any revenues (other than interest and dividend income) until, at the earliest, the completion of a business combination.

Three months ended February 28, 2014 compared to three months ended February 28, 2013

Other income (expense) for the three months ended February 28, 2014 decreased to ($777) from ($98) for the three months ended February 28, 2013. The increase in interest expense to ($777) from ($98) was due to the issuance of $112,250 of notes payable.

 
11

 

General, administrative and other expenses for the three months ended February 28, 2014 decreased to $18,377 from $24,372 for the three months ended February 28, 2013, a decrease of 24.6%. The decrease was due to lower payroll expenses of $7,391, legal expenses of $3,368, office sharing expenses of $2,700, and bank charges of $60, offset by higher directors and officers liability insurance expenses of $6,202, stockholder service expenses of $1,210 and taxes and license expenses of $112.

General, administrative and other expenses for the three months ended February 28, 2014 consisted of directors and officers liability insurance expenses of $8,077, legal expenses of $3,616, stockholder service expenses of $3,574, audit and accounting fee expenses of $2,750, taxes and license expenses of $221, payroll expenses of $109, and bank charges of $30.
 
Six months ended February 28, 2014 compared to six months ended February 28, 2013

Other income (expense) for the six months ended February 28, 2014 decreased to ($1,112) from ($98) for the six months ended February 28, 2013. The increase in interest expense to ($1,112) from ($98) was due to the issuance of $112,250 of notes payable.

General, administrative and other expenses for the six months ended February 28, 2014 increased to $66,466 from $56,544 for the six months ended February 28, 2013, an increase of 17.5%. The increase was due to higher legal expenses of $10,509, directors and officers liability insurance expenses of $9,333, stockholder service expenses of $862, audit and accounting fee expenses of $800, and taxes and license expenses of $122, offset by lower payroll expenses of $6,193, office sharing expenses of $5,400 and bank charges of $111.

General, administrative and other expenses for the six months ended February 28, 2014 consisted of legal expenses of $24,470, audit and accounting fee expenses of $13,550, directors and officers liability insurance expenses of $13,082, payroll expenses of $8,807, stockholder service expenses of $6,148, taxes and license expenses of $340, and bank charges of $69.

Liquidity and Capital Resources

General

As of February 28, 2014, cash and cash equivalents were $6,551, which includes $74 invested in a money market account with a yield of 0.02% and $6,477 in a non-interest bearing checking account. As of February 28, 2014, there was a working capital deficiency of $89,173.
 
The Company’s total current liabilities at February 28, 2014 were $114,397, which was comprised of notes payable of $95,000, accounts payable of $18,545 and accrued liabilities of $852.

Cash flows used in operating activities for the six months ended February 28, 2014 of $89,250 stems from a net loss of $67,578, an increase in prepaid expenses of $7,973 and a decrease in accounts payable and accrued expenses of $13,699.

Currently, our working capital is not sufficient to last for more than 12 months. If we acquire a business, our-post acquisition capital needs may be more substantial and our current capital resources may not be sufficient to meet our requirements. We currently believe that if we need capital in the future, we will be able to raise capital through sales of equity and institutional or investor borrowings, although we cannot assure you we will be able to obtain such capital. We anticipate that after any acquisition we may complete in accordance with our business plan, we will use substantially all our then existing working capital to fund the operations of the acquired business. In addition, we believe that any new business operations may require additional capital to fund its operations.
 
 
12

 
 
Commencing in December 2012, the Company began financing its working capital requirements through sale of its promissory notes and convertible promissory notes.  Commencing in October 2013, all funding has been from the issuance of promissory notes to Fuse Medical, LLC.  The Company’s existence is dependent upon management’s ability to effect a business combination with Fuse Medical, LLC and/or obtain additional funding sources.  There can be no assurance that the Merger or the Company’s other financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems.  The financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.  If we are not able to continue as a going concern, it is likely that holders of our common stock will lose all of their investment.
 
Contractual obligations

The Company has no material contractual obligations other than those relating to employment as described in our Annual Report on Form 10-K for the year ended August 31, 2013 and the Agreement and Plan of Merger with Fuse Medical, LLC as described in this Quarterly Report on Form 10-Q.
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.
 
Disclosures Controls and Procedures

Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, required by Rule 13a-15 of the Securities Exchange Act of 1934 (the “Exchange Act”) of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act. Based on their evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
 
Changes in Internal Controls Over Financial Reporting

There were no changes in our internal control over financial reporting as defined in  Rule 13a-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
13

 
 
PART II

OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
 
On January 27, 2014, M. Richard Cutler and Cutler Law Group, P.C. (the “Plaintiffs”) filed a complaint in the District Court of Harris County, Texas, 2014-03355, against Fuse Medical, LLC, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc. (the “Defendants”).  Plaintiff Richard Cutler is the sole principal of Plaintiff Cutler Law Group, which provided legal representation to its client (“Cutler’s Client”) that was interested in merging into a publicly traded corporation and attracting doctors as investors.  Plaintiffs allege that a proposed transaction between Cutler’s Client and Fuse Medical, LLC (“Cutler’s Failed Transaction”), failed to materialize notwithstanding the alleged efforts of Mr. Cutler and his law firm to document the transaction.  Plaintiffs further allege that, subsequently, the Defendants continued to pursue a similar transaction without Cutler’s Client or the Plaintiffs.  The Plaintiffs are claiming that the Defendants are responsible for damages in the amount of: (i) $46,465 plus interest because Plaintiffs were not paid their legal fees by Cutler’s Client nor did they receive equity in the company that Plaintiffs hoped would be issued from Cutler’s Failed Transaction; (ii) $46,465 plus interest due to Defendant being unjustly enriched  from Plaintiffs’ legal services to Cutler’s Client; (iii) $1,186,000 plus interest, being the alleged value of shares that Plaintiffs claimed to be entitled from Cutler’s Failed Transaction, which amount should allegedly be tripled as exemplary damages as a result of intentional fraud and/or negligent representations that some or all of the Defendants allegedly committed and that such conduct allegedly constitutes conspiracy to commit fraud; (iv) $1,186,000, allegedly arising from a breach of a Non-Competition and Non-Disclosure Agreement to which Plaintiffs were not a party; (v) $1,000,000 for breach of fiduciary duty by the Defendants because they would have been directors and officers of the surviving corporation in Cutler’s Failed Transaction had it not failed and Defendants’ moving on to another transaction without Plaintiffs; and (vi) Plaintiffs’ attorneys fees and costs for bringing this action.  Defendants believe the lawsuit to be without merit and have retained counsel to vigorously defend the action.  In addition, Defendant Robert H. Donehew is covered by Directors and Officers Insurance policies.
 
ITEM 6. EXHIBITS.
 
Exhibit 2.1    Agreement and Plan of Merger, dated as of December 18, 2013, by and among Fuse Medical, LLC, Golf Rounds.com, Inc., Project Fuse LLC and D. Alan Meeker (incorporated by reference to Exhibit 2.1 of the registrant’s Form 8-K filed on December 20, 2013).
     
Exhibit 2.2   First Amendment to Agreement and Plan of Merger, dated as of December 18, 2013, by and among Fuse Medical, LLC, Golf Rounds.com, Inc., Project Fuse LLC and D. Alan Meeker (incorporated by reference to Exhibit 2.1 of the registrant’s Form 8-K filed on March 4, 2014).
     
Exhibit 31.1
  Section 302 Certification of President and Treasurer
     
Exhibit 32.1   Section 906 Certification
 
101.INS **
 
XBRL Instance Document
     
101.SCH **
 
XBRL Taxonomy Extension Schema Document
     
101.CAL **
 
XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF **
 
XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB **
 
XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE **
 
XBRL Taxonomy Extension Presentation Linkbase Document

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
 
14

 
 
SIGNATURE

In accordance with the requirements of the Exchange Act, the registrant caused this Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  GOLF ROUNDS.COM, INC.  
       
Date: March 26, 2014
By:
/s/ Robert H. Donehew  
    Robert H. Donehew  
    President (Principal Executive Officer) and  
    Treasurer (Principal Financial Officer)  
 
 
 
 
 
 
15 
 
EX-31.1 2 teee_ex311.htm CERTIFICATION teee_ex311.htm
EXHIBIT 31.1

CERTIFICATION
PURSUANT TO SECTION 302(A) OF THE
SARBANES-OXLEY ACT OF 2002

I, Robert H. Donehew, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Golf Rounds.com, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: March 26, 2014
By:
/s/ Robert H. Donehew  
  Name: Robert H. Donehew  
  Title: President (Principal Executive Officer) and  
    Treasurer (Principal Financial Officer)  
EX-32.1 3 teee_ex321.htm CERTIFICATION teee_ex321.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Golf Rounds.com, Inc. (the “Company”) on Form 10-Q for the period ended February 28, 2014 as filed with the Securities and Exchange Commission (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
 
 
Date: March 26, 2014
By:
/s/ Robert H. Donehew  
    Robert H. Donehew  
    President (Principal Executive Officer) and  
    Treasurer (Principal Financial Officer)  
 
 
EX-101.INS 4 teee-20140228.xml XBRL INSTANCE DOCUMENT 0000319016 2013-08-31 0000319016 2012-08-31 0000319016 2013-09-01 2014-02-28 0000319016 2014-02-28 0000319016 2013-02-28 0000319016 2014-03-25 0000319016 2013-12-01 2014-02-28 0000319016 2012-12-01 2013-02-28 0000319016 2012-09-01 2013-02-28 0000319016 us-gaap:CommonStockMember 2013-09-01 2014-02-28 0000319016 us-gaap:CommonStockMember 2013-08-31 0000319016 us-gaap:CommonStockMember 2014-02-28 0000319016 us-gaap:AdditionalPaidInCapitalMember 2013-09-01 2014-02-28 0000319016 us-gaap:AdditionalPaidInCapitalMember 2013-08-31 0000319016 us-gaap:AdditionalPaidInCapitalMember 2014-02-28 0000319016 us-gaap:RetainedEarningsMember 2013-09-01 2014-02-28 0000319016 us-gaap:RetainedEarningsMember 2013-08-31 0000319016 us-gaap:RetainedEarningsMember 2014-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares 89173 852 330000 330000 330000 0.68 0.68 0.68 0.68 P1Y8M12D P1Y8M12D 2700 5400 17250 17250 17250 112250 <p style="margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On March&#160;1, 2000, the Company executed a month-to-month agreement to sub-lease office space and share office equipment and a bookkeeper&#146;s time for $900 a month from R. D. Garwood, Inc. (&#147;Garwood&#148;). The Company&#146;s President/Treasurer/Secretary is the Chief Financial Officer of Garwood. Effective June 1, 2013, due to the financial status of the Company, R.D. Garwood, Inc. began providing the aforementioned services at no charge to the Company. The Company&#146;s expense for these shared facilities and bookkeeping services was $2,700 and $5,400 for the three and six months ended February 28, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the three and six months ended February 28, 2014, the Company&#146;s President provided services at no charge to the Company. During the three and six months ended February 28, 2013, the Company accrued salary for its President in the amount of $7,500 and $15,000, respectively, which is included in general and administrative expenses in the accompanying consolidated statements of operations.</font></p> <p style="margin: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The condensed consolidated financial statements include the accounts of Golf Rounds.com, Inc. and its wholly owned subsidiaries DPE Acquisition Corp. (formed on September 2, 2003) and Project Fuse LLC (formed on December 17, 2013). Intercompany transactions and accounts have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated balance sheet of Golf Rounds.com, Inc. and its wholly owned subsidiaries, DPE Acquisition Corp. and Project Fuse LLC, (collectively, the &#147;Company&#148;), as of February 28, 2014, and the unaudited condensed consolidated statements of operations for the three and six months ended February 28, 2014 and 2013, the unaudited condensed consolidated statement of stockholders&#146; deficit for the six months ended February 28, 2014, and the unaudited condensed consolidated statements of cash flows for the six months ended February 28, 2014 and 2013 reflect all material adjustments which, in the opinion of management, are ordinary and necessary for a fair presentation of results for the interim periods. Certain information and footnote disclosures required under generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company believes that the disclosures are adequate to make the information presented not misleading. The condensed consolidated balance sheet information as of August 31, 2013 was derived from the audited consolidated financial statements included in the Company&#146;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 15, 2013. These condensed consolidated financial statements should be read in conjunction with the year-end audited consolidated financial statements and notes thereto included in the Company&#146;s Annual Report on Form 10-K for the year ended August 31, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The results of operations for the three and six months ended February 28, 2014 and 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or for any other period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Diluted earnings per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. &#160;In computing diluted earnings per share, the treasury stock method assumes that our outstanding options are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As of February 28, 2014 and 2013, common stock equivalents include options to purchase 330,000 and 360,000 common shares, respectively. These instruments are not considered in the diluted loss per share because the effect would be anti-dilutive.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the valuation of equity instruments at the date of the condensed consolidated financial statements. Actual results could differ from those estimates.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of certain financial instruments, including cash and cash equivalents, prepaid expenses, and accounts payable and accrued expenses approximate their fair values because of the short-term maturity of these instruments.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">There are recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the &#34;SEC&#34;); such pronouncements are not believed by management to have a material impact on the Company's present or future financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 18, 2013, Golf Rounds.com, Inc. (the &#147;Company&#148;) entered into an Agreement and Plan of Merger (the &#147;Merger Agreement&#148;) with Fuse Medical, LLC (&#147;Fuse&#148;), Project Fuse LLC, a wholly owned subsidiary of the Company (&#147;Merger Sub&#148;), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the &#147;Representative&#148;). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the &#147;Merger&#148;). The Merger is expected to be completed during the third fiscal quarter of 2014.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fuse is a physician-partnered company and national distributor that provides diversified healthcare products and supplies, including biologics and bone substitute materials, while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners. Fuse has entered into partnership arrangements with physicians in order to distribute its products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In accordance with the Merger Agreement, on December 18, 2013, the Company obtained approval by written consent from the holders of 3,220,330 shares of its common stock, representing a majority of its outstanding common stock, to amend its certificate of incorporation, effective immediately prior to the consummation of the Merger, (i) to change the name of the Company to &#147;Fuse Medical, Inc.&#148;, (ii) to increase the Company&#146;s authorized capital stock from 12,000,000 shares of common stock to 500,000,000 shares of common stock and from zero shares of preferred stock to 20,000,000 shares of preferred stock, and to expressly authorize the board of directors of the Company to issue shares of the preferred stock, in one or more series, and to fix for each such series the voting powers, designations, preferences, or other special rights thereof and the qualifications, limitations or restrictions thereon, and (iii) to effect a 14.62 to 1 reverse stock split (the &#147;Reverse Stock Split&#148;). On March 4, 2014, the Company filed with the Securities and Exchange Commission (the &#147;SEC&#148;) a preliminary information statement on Schedule PRE 14C relating to the approval and adoption of the amendments (the &#147;Preliminary Information Statement&#148;). On March 13, 2014, the SEC notified the Company that the Preliminary Information Statement would be reviewed. Once the comments on the Preliminary Information Statement have been cleared by the SEC, the Company shall file a definitive information statement on Schedule DEF 14C relating to the adoption of the amendments (the &#147;Definitive Information Statement&#148;). The amendments will become effective no earlier than 20 days after the Definitive Information Statement is mailed to the Company&#146;s stockholders.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">All of the units reflecting membership interests in Fuse that are issued and outstanding immediately prior to the effective time of the Merger shall be cancelled and converted into the right to receive 3,600,000 shares of the Company&#146;s common stock (on a post-Reverse Stock Split basis), representing 90% of the Company&#146;s issued and outstanding common stock after giving effect to the Merger (the &#147;Merger Consideration&#148;). The Merger Consideration will be allocated among the members of Fuse immediately prior to the effective time of the Merger (the &#147;Holders&#148;) in accordance with Fuse&#146;s limited liability company operating agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In order to fund the indemnification obligations of the Holders after the closing of the Merger, of the shares of common stock constituting the Merger Consideration, 180,000 shares (on a post-Reverse Stock Split basis) will be deposited in escrow pursuant to the terms of the Merger Agreement and an escrow agreement, in the form attached to the Merger Agreement, to be executed at the closing.</font></p> 39000 24000 32000 6000 6000 11250 11250 GOLF ROUNDS COM INC 0000319016 10-Q 2014-02-28 false --08-31 No No Yes Smaller Reporting Company 5848185 Q2 2014 801 334 6551 154 10700 18673 11501 25224 11501 25224 33096 19397 95000 33096 114397 17250 17250 50346 131647 58481 58481 3270942 3270942 -3368268 -3435846 -38845 -106423 58481 58481 3270942 3270942 -3368268 -3435846 11501 25224 0.01 0.01 12000000 12000000 5848185 5848185 5848185 5848185 66466 18377 24372 56544 66466 18377 24372 56544 -66466 -18377 -24372 -56544 1112 777 98 98 -1112 -777 -98 -98 -67578 -19154 -24470 -56642 -67578 -0.01 0.00 -0.01 -0.02 5848185 5848185 3567377 3567377 5848185 5848185 -5250 -7973 3750 -13699 37462 -89250 -10180 95000 10000 95000 10000 5750 -180 280 56 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Legal Matters</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 27, 2014, M. Richard Cutler and Cutler Law Group, P.C. (the &#147;Plaintiffs&#148;) filed a complaint in the District Court of Harris County, Texas, 2014-03355, against Fuse Medical, LLC, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc. (the &#147;Defendants&#148;). Plaintiff Richard Cutler is the sole principal of Plaintiff Cutler Law Group, which provided legal representation to its client (&#147;Cutler&#146;s Client&#148;) that was interested in merging into a publicly traded corporation and attracting doctors as investors. Plaintiffs allege that a proposed transaction between Cutler&#146;s Client and Fuse Medical, LLC (&#147;Cutler&#146;s Failed Transaction&#148;), failed to materialize notwithstanding the alleged efforts of Mr. Cutler and his law firm to document the transaction. Plaintiffs further allege that, subsequently, the Defendants continued to pursue a similar transaction without Cutler&#146;s Client or the Plaintiffs. The Plaintiffs are claiming that the Defendants are responsible for damages in the amount of: (i) $46,465 plus interest because Plaintiffs were not paid their legal fees by Cutler&#146;s Client nor did they receive equity in the company that Plaintiffs hoped would be issued from Cutler&#146;s Failed Transaction; (ii) $46,465 plus interest due to Defendant being unjustly enriched from Plaintiffs&#146; legal services to Cutler&#146;s Client; (iii) $1,186,000 plus interest, being the alleged value of shares that Plaintiffs claimed to be entitled from Cutler&#146;s Failed Transaction, which amount should allegedly be tripled as exemplary damages as a result of intentional fraud and/or negligent representations that some or all of the Defendants allegedly committed and that such conduct allegedly constitutes conspiracy to commit fraud; (iv) $1,186,000, allegedly arising from a breach of a Non-Competition and Non-Disclosure Agreement to which Plaintiffs were not a party; (v) $1,000,000 for breach of fiduciary duty by the Defendants because they would have been directors and officers of the surviving corporation in Cutler&#146;s Failed Transaction had it not failed and Defendants&#146; moving on to another transaction without Plaintiffs; and (vi) Plaintiffs&#146; attorneys fees and costs for bringing this action. Defendants believe the lawsuit to be without merit and have retained counsel to vigorously defend the action. In addition, Defendant Robert H. Donehew is covered by Directors and Officers Insurance policies.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Stock Options</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A summary of the Company&#146;s stock option activity during the six months ended February 28, 2014 is presented below:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>No. of</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Term</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Balance outstanding at August 31, 2013</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 52%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Balance outstanding at February 28, 2014</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.7</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at February 28, 2014</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.7</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On October 18, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due April 15, 2014 in exchange for cash proceeds of $39,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On November 4, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due May 5, 2014 in exchange for cash proceeds of $24,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 26, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due June 26, 2014 in exchange for cash proceeds of $32,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the three and six months ended February 28, 2014, interest expense of $777 and $1,112, respectively, was recognized on outstanding notes payable. During the three and six months ended February 28, 2013, interest expense of $98 (of which $56 is for related parties) was recognized on outstanding notes payable. As of February 28, 2014, accrued interest payable was $852, which is included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Notes payable consisted of the following at February 28, 2014 and August 31, 2013, respectively:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>February 28,</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2014</b></font></p></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>August 31, </b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2013</b></font></p></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014</font></td> <td style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39,000</font></td> <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,250</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,250</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112,250</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Current maturities</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(95,000</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Amount due after one year</font></td> <td style="padding-bottom: 3pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="margin: 0pt; text-align: justify"></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(A)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Merger with Fuse Medical, LLC</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On December 18, 2013, Golf Rounds.com, Inc. (the &#147;Company&#148;) entered into an Agreement and Plan of Merger (the &#147;Merger Agreement&#148;) with Fuse Medical, LLC (&#147;Fuse&#148;), Project Fuse LLC, a wholly owned subsidiary of the Company (&#147;Merger Sub&#148;), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the &#147;Representative&#148;). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the &#147;Merger&#148;). The Merger is expected to be completed during the third fiscal quarter of 2014.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fuse is a physician-partnered company and national distributor that provides diversified healthcare products and supplies, including biologics and bone substitute materials, while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners. Fuse has entered into partnership arrangements with physicians in order to distribute its products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In accordance with the Merger Agreement, on December 18, 2013, the Company obtained approval by written consent from the holders of 3,220,330 shares of its common stock, representing a majority of its outstanding common stock, to amend its certificate of incorporation, effective immediately prior to the consummation of the Merger, (i) to change the name of the Company to &#147;Fuse Medical, Inc.&#148;, (ii) to increase the Company&#146;s authorized capital stock from 12,000,000 shares of common stock to 500,000,000 shares of common stock and from zero shares of preferred stock to 20,000,000 shares of preferred stock, and to expressly authorize the board of directors of the Company to issue shares of the preferred stock, in one or more series, and to fix for each such series the voting powers, designations, preferences, or other special rights thereof and the qualifications, limitations or restrictions thereon, and (iii) to effect a 14.62 to 1 reverse stock split (the &#147;Reverse Stock Split&#148;). On March 4, 2014, the Company filed with the Securities and Exchange Commission (the &#147;SEC&#148;) a preliminary information statement on Schedule PRE 14C relating to the approval and adoption of the amendments (the &#147;Preliminary Information Statement&#148;). On March 13, 2014, the SEC notified the Company that the Preliminary Information Statement would be reviewed. Once the comments on the Preliminary Information Statement have been cleared by the SEC, the Company shall file a definitive information statement on Schedule DEF 14C relating to the adoption of the amendments (the &#147;Definitive Information Statement&#148;). The amendments will become effective no earlier than 20 days after the Definitive Information Statement is mailed to the Company&#146;s stockholders.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">All of the units reflecting membership interests in Fuse that are issued and outstanding immediately prior to the effective time of the Merger shall be cancelled and converted into the right to receive 3,600,000 shares of the Company&#146;s common stock (on a post-Reverse Stock Split basis), representing 90% of the Company&#146;s issued and outstanding common stock after giving effect to the Merger (the &#147;Merger Consideration&#148;). The Merger Consideration will be allocated among the members of Fuse immediately prior to the effective time of the Merger (the &#147;Holders&#148;) in accordance with Fuse&#146;s limited liability company operating agreement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In order to fund the indemnification obligations of the Holders after the closing of the Merger, of the shares of common stock constituting the Merger Consideration, 180,000 shares (on a post-Reverse Stock Split basis) will be deposited in escrow pursuant to the terms of the Merger Agreement and an escrow agreement, in the form attached to the Merger Agreement, to be executed at the closing.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(B)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Interim Financial Statements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated balance sheet of Golf Rounds.com, Inc. and its wholly owned subsidiaries, DPE Acquisition Corp. and Project Fuse LLC, (collectively, the &#147;Company&#148;), as of February 28, 2014, and the unaudited condensed consolidated statements of operations for the three and six months ended February 28, 2014 and 2013, the unaudited condensed consolidated statement of stockholders&#146; deficit for the six months ended February 28, 2014, and the unaudited condensed consolidated statements of cash flows for the six months ended February 28, 2014 and 2013 reflect all material adjustments which, in the opinion of management, are ordinary and necessary for a fair presentation of results for the interim periods. Certain information and footnote disclosures required under generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company believes that the disclosures are adequate to make the information presented not misleading. The condensed consolidated balance sheet information as of August 31, 2013 was derived from the audited consolidated financial statements included in the Company&#146;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 15, 2013. These condensed consolidated financial statements should be read in conjunction with the year-end audited consolidated financial statements and notes thereto included in the Company&#146;s Annual Report on Form 10-K for the year ended August 31, 2013.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The results of operations for the three and six months ended February 28, 2014 and 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or for any other period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(C)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Principles of Consolidation</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The condensed consolidated financial statements include the accounts of Golf Rounds.com, Inc. and its wholly owned subsidiaries DPE Acquisition Corp. (formed on September 2, 2003) and Project Fuse LLC (formed on December 17, 2013). Intercompany transactions and accounts have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(D)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Loss Per Share</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Diluted earnings per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. In computing diluted earnings per share, the treasury stock method assumes that our outstanding options are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As of February 28, 2014 and 2013, common stock equivalents include options to purchase 330,000 and 360,000 common shares, respectively. These instruments are not considered in the diluted loss per share because the effect would be anti-dilutive.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(E)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the valuation of equity instruments at the date of the condensed consolidated financial statements. Actual results could differ from those estimates.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(F)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The carrying amounts of certain financial instruments, including cash and cash equivalents, prepaid expenses, and accounts payable and accrued expenses approximate their fair values because of the short-term maturity of these instruments.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>(G)</b></font></td> <td style="width: 95%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Recent Accounting Pronouncements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">There are recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the &#34;SEC&#34;); such pronouncements are not believed by management to have a material impact on the Company's present or future financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p> <p style="margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated any revenues from operations since 2001 and has suffered recurring losses from its operations. During the six months ended February 28, 2014, the Company had a net loss of $67,578, used cash in operations of $89,250, and had no revenues from operations. As of February 28, 2014, the Company had an accumulated deficit of $3,435,846 and a working capital deficiency of $89,173. Currently, the Company&#146;s working capital is not sufficient to last for more than 12 months. As a result, the Company&#146;s independent registered public accounting firm, in its report on the Company&#146;s August 31, 2013 consolidated financial statements, has raised substantial doubt about the Company&#146;s ability to continue as a going concern. These factors among others indicate that the Company may be unable to continue as a going concern. The Company&#146;s existence is dependent upon management&#146;s ability to effect a business combination with a target business and/or obtain additional funding sources. Commencing in December 2012, the Company began financing its working capital requirements through sale of its promissory notes and convertible promissory notes. There can be no assurance that the Merger or the Company&#146;s financing efforts will result in profitable operations or the resolution of the Company&#146;s liquidity problems. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In order to continue our operations and to make acquisitions, if any, under our current business model during the next twelve months, we will need to secure additional working capital, by way of debt or equity financing, or otherwise. We will need additional financing for working capital, and, in the case of acquisitions, for payment of seller notes and future earned cash to sellers of acquired companies. There can be no assurance that we will be able to secure sufficient financing or on terms acceptable to us. If adequate funds are not available on acceptable terms, we would need to delay, limit or eliminate some or all of our proposed operations, and we may be unable to successfully promote our products or develop new or enhanced products or prosecute acquisitions, any of which could lower our revenues and net income, if we achieve profitability in the future. If we raise additional funds through the issuance of convertible debt or equity securities, the percentage ownership of our current stockholders is likely to be diluted, unless some of our current stockholders were to invest in subsequent convertible debt or equity financings, and some of the newly issued securities may also have rights superior to those of our common stock. Additionally, if we issue or incur debt to raise funds, we may be subject to limitations on our operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">A summary of the Company&#146;s stock option activity during the six months ended February 28, 2014 is presented below:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Remaining</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>No. of</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Price</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Term</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Balance outstanding at August 31, 2013</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 9pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 52%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Balance outstanding at February 28, 2014</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.7</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 9%; border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at February 28, 2014</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">330,000</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.68</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.7</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Notes payable consisted of the following at February 28, 2014 and August 31, 2013, respectively:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>February 28,</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2014</b></font></p></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>August 31, </b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2013</b></font></p></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014</font></td> <td style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">39,000</font></td> <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">24,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,000</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,250</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,250</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112,250</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Current maturities</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(95,000</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td nowrap="nowrap" style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">Amount due after one year</font></td> <td style="padding-bottom: 3pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="padding-bottom: 3pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,250</font></td> <td nowrap="nowrap" style="padding-bottom: 3pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> 330000 360000 7500 15000 EX-101.SCH 5 teee-20140228.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCKHOLDER'S DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCKHOLDER'S DEFICIT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - STOCKHOLDER'S DEFICIT (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 teee-20140228_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 teee-20140228_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 teee-20140228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Prepaid expenses Total current assets Total assets Liabilities and Stockholders' Deficiency Current liabilities: Accounts payable and accrued expenses Notes payable, current portion Total current liabilities Notes payable Total liabilities Stockholders' deficiency: Common stock, $0.01 par value; 12,000,000 shares authorized, 5,848,185 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficiency Total liabilities and stockholders' deficiency Common Stock Par Value Common Stock Shares Authorized Common Stock Shares Issued Common Stock Shares Outstanding Income Statement [Abstract] Expenses: General, administrative and other Total operating expenses Loss from operations Other income (expense): Interest expense Total other income (expense) Net loss Net loss per common share - basic and diluted Weighted average number of common shares outstanding - basic and diluted Statement [Table] Statement [Line Items] Beginning Balance, Amount Beginning Balance, Shares Net loss Ending Balance, Amount Ending Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activites: Convertible notes issued for services rendered Changes in operating assets and liabilities: (Increase) decrease in prepaid expenses Increase in accounts payable and accrued expenses Net cash used in operating activities Cash flows from financing activities: Proceeds from issuance of notes payable Proceeds from related party for convertible notes Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents - beginning Cash and cash equivalents - ending Supplemental disclosure of cash flow information: Interest paid Income taxes paid Notes to Financial Statements NOTE 1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION NOTE 2. GOING CONCERN NOTE 3. NOTES PAYABLE NOTE 4. STOCKHOLDERS' DEFICIENCY NOTE 5. RELATED PARTY TRANSACTIONS NOTE 6 - COMMITMENTS AND CONTINGENCIES Nature Of Operations And Basis Of Presentation Policies Merger with Fuse Medical, LLC Interim Financial Statements Principles of Consolidation Loss Per Share Use of Estimates Fair Value of Financial Instruments Recent Accounting Pronouncements Notes Payable Tables Schedule of notes payable Stockholders Deficit Tables Summary of the Company stock option activity Nature Of Operations And Basis Of Presentation Details Narrative Common stock including options to purchase Going Concern Details Narrative Net loss Net cash used in operating activities Working capital deficiency Notes Payable Details Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014 Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014 Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014 Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015 Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015 Total Less: Current maturities Amount due after one year Notes Payable Details Narrative Interest expense Interest expense for related parties Accrued interest payable Stockholders Deficit Details Balance outstanding at August 31, 2013, No. Of Shares Granted, No. Of Shares Exercised, No. Of Shares Forfeited, No. Of Shares Expired, No. Of Shares Balance outstanding at February 28, 2014, No. Of Shares Exercisable at February 28, 2014, No. Of Shares Balance outstanding at August 31, 2013, Weighted Average Exercise Price Granted, Weighted Average Exercise Price Exercised, Weighted Average Exercise Price Forfeited, Weighted Average Exercise Price Expired, Weighted Average Exercise Price Balance outstanding at February 28, 2014, Weighted Average Exercise Price Exercisable at February 28, 2014, Weighted Average Exercise Price Balance outstanding at February 28, 2014, Weighted Average Remaining Contractual Term Exercisable at February 28, 2014, Weighted Average Remaining Contractual Term Exercisable at February 28, 2014, Aggregate Intrinsic Value Exercisable at February 28, 2014, Aggregate Intrinsic Value Related Party Transactions Details Narrative Expense for shared facilities and bookkeeping services Accrued Salary Custom element. Interim Financial Statements Custom element. Custom element. Note Payable1 Note Payable2 Notes payable. Amount due after one year. Note payable 5. Common stock including options to purchase. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Shares, Issued Stock Issued During Period, Value, Issued for Services Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value EX-101.PRE 9 teee-20140228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"GC=:&K@$``#P/```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,EUU/@S`4AN]-_`^DMP9* M4>*0DI68$EH^'EQ6"RTF`#7RUM M2@KG]`.E-BN@YC92&J3?R96IN?.W9DHUSV9\"C2)XQ[-E'0@7>B:'F0X>(*< MSRL7/"_]XS6)@Z*C/N/"E=2+&G$FX4(E_9GK%%J>V5QR"T M4Z'9^5U@4_?F1V-*`<&8&_?*:X]!EQ7]4F;VJ=0L.MRD@U+E>9F!4-F\]A.( MK#;`A2T`7%U%[1K5O)1;[@/Z[6%+VX6=&:1YO[;QB1P)$HYK)!PW2#AND7#T MD'#<(>'H(^&X1\+!8BP@6!R58;%4AL53&19395A4"VY`O#OC4]S9`7[V/L3A M,\[8*&U]VC-P^A2V<:ZI#K5O!,:5L`MT7<%HI^B3XNF">\D,FBPJ0'1HTS;[ M#K\!``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@"7W)E;',O M+G)E;',@H@0"**```@`````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````C)+/3L,P#,;O2+Q#Y/OJ M;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B]. MP[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4 M_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\U<%J"`=[!ZH^^CSY MLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P`` M`/__`P!02P,$%``&``@````A`#B30&6&`0``V0T``!H`"`%X;"]?'0Y=S0:;78_;9-\H?.U-9F`22H2-+DM:E-FXN/P^K02 MB0_:%+JQ!C-Q1B]VV\>'S1LV.L2??%5W/HE1C,]$%4+W+*7/*VRUG]@.35PY M6M?J$(>NE)W.3[I$J=)T(=W?&&)[$S/9%YEP^R+N?SAW<>?_8]OCL<[QQ>:? M+9IP9POY;=W)5X@A!M6NQ)")8\'UG*L4DH.]QDG MCSBW4Z11P(Z&9*-F8^:-K[3#XCVXV*7X&/ARE=],4VDS'U/,T$!HR%-K_X,4Y?, MG5%BN-&09(`;#9!LU*A=1(CO*;RZU`]E_QVJKKQYD&U_`0``__\#`%!+`P04 M``8`"````"$`^AXP1ZT"``!X!P``#P```'AL+W=OB]QX8Y7B4@Q-Y\`V#29F,N/B96C>IY>_3DQ#:2HRFDO!AN8' M4^;%Z.>/\Y6L7I^E?#5`0*BAN="Z/+,L-5NP@JH#63(!.W-9%53#LGJQ5%DQ MFJD%8[K(+=>VCZV">Z07LV[;=7KMF_&6A-Q=!WD+Z#4%X3G,T1-/>A@B!-T4"H;G^(*%8T^<2 M7F%-/83.'-.HSCB<5&'FU,:QBB]%QH1B&8$S)7.>48!%QC2G8L:0BHM4W.^I M@('6S`#)-+SW,)-H\%1@,X=(Y7!/,Y\JV`S`;\D=G,5A]$5\>/(#Z81KL)`3[:K MHC@-$G+G/7GCFP!788"GVU5)&OM_KN.;23!-R"2X#/TPQ<48FV-O5T^#&R\- M)O#4:?I$TJD7)9[?M(TU,#.GG\KX]C9,;X,H7;."OE/H/XC\,.@P^XW0.[U8 M[F:/D^#"S&NCX/2"V>%(4OJ''?W@N/H M=-CV`ME)$IDP37FN2$2K"D;J&^K*Z<#M);++Y%,'EW>0[H[F3AL=N'N%=2.' MW-2CN*4+BZTQ^/_0UEI8!T]3MPFNU7SN,)UG-)_!;Z,^U'.W>8BU^6F._@(` M`/__`P!02P,$%``&``@````A`-0U,T+E`P``U`T``!@```!X;"]W;W)K M$W`2U(`1=CK=;[]E'!)LD:KC.2 M%_5VJ?_^]3J9ZAIE:9VG):GQ4O_$5/^R^ONOQ8&T;W2',=/`H:9+?<=8,S=- MFNUPE5*#-+B&G@UIJY3!8[LU:=/B-.\&5:5I6Y9O5FE1Z\)AWC[B03:;(L,Q MR?85KIDP:7&9,I@_W14-[=VJ[!&[*FW?]LTD(U4#%NNB+-AG9ZIK53;_OJU) MFZY+X/Y`;IKUWMW#R+XJLI90LF$&V)EBHF/FF3DSP6FUR`L@X,NNM7BSU%_0 M/$&V;JX6W0+]*?"!#GYK=$<.7]LB_U'4&%8;XL0CL";DC4N_Y[P)!INCT:]= M!/YMM1QOTGW)?I+#-UQL=PS"[0$1!YOGGS&F&:PHV!BVQYTR4L($X%.K"IX: ML"+I1_=]*'*V6^J.;WB!Y2"0:VM,V6O!+74MVU-&JO^$"!VMA(E]-($11Q-D M&_;40YY_W\44,^H`XY2EJT5+#AID#;R3-BG/030'YYY,S./$>@T5&+G)"W=9 MZH&N`06%^+RO/'=AOL.29D=)>$'BR9*HE_`%Y+9QWW"V1?*0I%?PZ`'1"0L6 M:XAU.5#][+F8S[Y_;R@:P/N$8\OOC<8*SYP>%BR+#! M[+U`GELH).Y0(BNBNXKXKB*YI9#P8"*/1XN+ESJLW2DXWE2>?"@DTRX1T=0) M%/QHV&^[3J`$)A[V^[[K*Z%-AOV>[[GG7)>P8#\]CL7%"M9,P1(2_RK6L/\2 MUK#_$M:P_P:6_PP6%\M8OJ5@"8G`FEP*ER2X!"8)+I%)@AMH<((]'C$NEO>9 MKQQ/H9!`NIQS58:/[BKBNXKDED)*2%Z/#`[[VZZ-EHB0E"= M/!ZD3JTPG4^C[A8-CQIQ'$[0#*EWY"%O.1P`/IV-B)QTP^/?5^I'\*C1H`J!-&Q)X?C"Z_6))"#NPS*?64Y'^TM7H2GN(YE#Y0>VEM,>\J.?M MYJD#:NHFW>)_TG9;U%0K\09>91D!7%RMJ,K%`R--5]FN"8-JNONY@W]/&&I* MRP#QAA#6/_`7G/Z/K?X'``#__P,`4$L#!!0`!@`(````(0!'?Z<[:@,``&L, M```9````>&PO=V]R:W-H965TTK3.J.EJ-G&J73A$'G.4W8OTG7%:HTDDI54@W]5\$;MV*K4A:ZB\FG=7*6B:H!B MR4NN7UM2WZO2Z>.J%I(N2XC[A0QHNN-N+X[H*YY*H42N`Z`+T>AQS)-P$@+3 M8I9QB,"DW9,LG_NW9'I'KOUP,6L3])>SC>I]]U0A-E\ES[[SFD&V89_,#BR% M>#+0Q\S<@L7AT>J'=@=^2B]C.5V7^I?8?&-\56C8[B%$9`*;9J_W3*604:`) MXJ%A2D4)!N#=J[@I#<@(?6D_-SS3Q=Q/1L%P'"4$X-Z2*?W`#:7OI6NE1?4/ M061+A23QE@0^MR1Q[$H2HJ$VOGNJZ6(FQ<:#H@%)U5!3@F0*Q+O`T$87ZEN1 M0HB&Y-:PS/VQ[T$0"K;G>0$%.@N?(:7I%G.'&'CO,*1#A."FLP0V^I9.YWBG M;,!&V>3<6+G#&WV9^+1,\AX9`X9-ZYF/H[U]5$;,H(<9GE8&2#]`D_,$2O)\ MH&;1W(?HNO3%T3XR=("84;L!21+!Z[0!J+F^@?/"!FP+)QTO"B.F'WHRZ2`' MFSMZC[0!V]*#CA>E$>,B#>7I'K4!V]+[[41IQ+A(F^=`[Y2=3[@!V](C*VK$ MN$A/#J7=BLTLLBV,+0N(N5QL!$J['[R;@W:5;>':LK`%.7@PS:>W`8X>L&4= MGKE]76,1$`1-VD,7!:.]QX.Z)Z8OO=\!=K,#!V1_J+<.$'31@=7P''.`7>W0 M@=WY"((N.H!Z_4`.S"JK$HC=^0B"+CJP.I_)P0#NG3^0YDE_Y,!N@5M0_TC& M9-^L#HO!ZH*.-DZT0V+W)'+<#]^V875$QXHXT1J)W9^(>V^$N>TC57&B2QZ[ M<&B3.//A3%0QN6)?6%DJ+Q5K,\\1.-;=W6[6O(W;:;'[`4:]AJ[8#RI7O%9> MR7)8&@5CJ!N)PR)>:-&T$]=2:!CRVJ\%#/4,YI8H`'`NA-Y=F'&T^YNP^`\` M`/__`P!02P,$%``&``@````A`,>>TVOU`@``FP@``!D```!X;"]W;W)K&ULE%;;;J,P$'U?:?_!\GLA3DIN"JE*2'=7VI56J[T\ M.V#`*F!D.TW[]SO&`7%IT_0E@?&9XSDSXS&;N^ED,G<+RDML&=;R&@Z1)#QBH8B.!2NU M)9$LIQKB5QFO5,-61-?0%50^'JN;2!054!QXSO5+38I1$:V_I:60])"#[F=R M2Z.&NWX9T1<\DD*)1#M`Y]I`QYI7[LH%INTFYJ#`I!U)EOCXGJSW<^QN-W5^ M_G)V4IUGI#)Q^B)Y_)V7#)(-93(%.`CQ:*#?8F,"9W?D_5`7X*=$,4OH,=>_ MQ.DKXVFFH=H>"#*ZUO%+R%0$"04:9^H9IDCD$`#\HH*;SH"$T.?Z_\1CG?EX M-G>\Q61&`(X.3.D';B@QBHY*B^*?!9$SE269GDG`XTQ"ILYTZ1%O_CZ+:R.J M!894T^U&BA."IH$]545-"Y(U,#?*;!RMUK>D@D9#QG)NPN M$D(&S/ONWIP8.TO5J#+BOAG1XZW,06`QLW2H>5JM!F+/7:2)[C)K%-]WW MEQ`]:?./2#/@H;15/]V!Q=A*+;U!MG=V]8+P\*(_7`HF@M?]K2X[].U,+)A, MV8[EN4*1.)J!/H,.:JWM77,_-:-B8`_(&@;8V!["W53;W=8![H:*INP'E2DO M%$X-.#1J24JMVWD0 MJ*QD-56^:%D#(X60-=5P*W>!:B6CN9U45T$#.QKGDFA1*%]L`L0=%CS+)@%X+1:Y!PJ,+%[DA5+ZI4NP_29Y_Y0V#M*%/I@-;(1Z-]$MN?H+)P6#V@^W`=^GE MK*!/E?XA]I\9WY4:VIU"1::P>?YZSU0&B8*-'Z?&*1,5`,"G5W.S-"`1^F*O M>Y[KHL<&?W3*9A;6Y.S".@9H)BT)_,<;8S)Q&%$SM?$FLS!\ MR\;6L,'QTQJ266?10P3-]8AFDH,XQ#[S\I9I*+Z#P':]0@XGA(>':XU^/) M_]"922Y=X@2(&J2+8(=Q`SP_WN,S!^G%^XL1][DF;E]1TF$-N7J"R>EXCVMV M#9<1][FBD;OOH0;!;F;IL)\HN&3%P8%X16A6[=*YF\I!A+M*U(L%=Y5W!)@; M'K%X=K1TQ[Y1N>.-\BI6P%,>^F;SDWC`XHT6K3TKMD+#P6B_EO`BQ.`@"7T0 M%T+HXXTYPKM7J]5?````__\#`%!+`P04``8`"````"$`YE>>"%T#``"N"@`` M&0```'AL+W=OW'_4N3& M,^&"LG)IHLG4-$B9L)26^Z7Y^U=\%YB&D+A,<U+0QU0- MP61K-#NN"_"#&RG)\#&7/]GI*Z'[@X1J>R!(Z0K3UXB(!`P%FHGM*::$Y9`` M7(V"JLX`0_!+?3_15!Z6IN-/O-G400`W=D3(F"I*TTB.0K+BKP:A,Y4FL<\D M,.-,@NR)'7C(\S_`XI]9X'YA<6UO%MR0BZ5UU39%6.+5@K.3`:T'F8L*JT9& M(3`W_F@UK6/_,PR<4B0/BF5ISDP#O!!0Y.<5FJ.%]0R527W(IH&H M.BC>J!GH\/:G;!M$,R76`W4!+-#8"H4B=(6^W0"-'@56>AK6M1X`[E:@W4]D M,T9X?A\2C2$#DNT8,22)QQ!GVJ[34^Q\1+$"0W-W!*+Y(+NUQK@=S+"`5Q'1 M5<3V*B)^#]%S`%*]O>8*O#3!WK;$OML:6[?C6D."IL&]07S3C=NN.[L41K=S M-^[/X,OM\V^[<<_WW4$!8AV':YOBI0`]X?"GN5VX`O>%!TX_L;6&O+UP+6US M%1%IA%^;%\QM;V#.MAM'4Q0,XO%[*_3$PV_L=O$*W!?O#C[;M8;HQ.\_X$UTGV5XEB?LDCA_8_J6%>A[`K_AV#Q2X[P&:#SM`8W3K!W,T&\0W M.OZ>`U<8ME<9X)R@\GQ[#:U>GP/T!E<0OB<;DN?"2-A1[?$.]%X[VAX_'FSU MFQ^,KU$(N]%X/$(A;#DP;K43X+A0X3WYCOF>EL+(209+32N#QSZ1;*J MWFYW3,)!H7X\P+F0P#XWG0`X8TPV+VJ!]J2Y^@<``/__`P!02P,$%``&``@` M```A`+IYQ&*<`@``?08``!D```!X;"]W;W)K&UL ME)5=;YLP%(;O)^T_6+XO!A)*&H542:INE59IFO9Q[1@#5C!&MM.T_W['.&&0 M;%%W0S#G]>OGG&,[B_M76:,7KHU038:C(,2(-TSEHBDS_./[X\T,(V-ID]-: M-3S#;]S@^^7'#XN#TCM3<6X1.#0FPY6U[9P0PRHNJ0E4RQN(%$I+:F&H2V): MS6G>39(UB_7:$K9R;L;7-A+P;0RJK`!V!$/ M>IGS';DCX+1AV`@FYO.;YVP,W M#`H*-D'<83!5`P`\D11N9T!!Z&OW>Q"YK3(\N0V2-)Q$($=;;NRC<)88L;VQ M2O[RHLA!]2;QT60"],=X$DSC))V]PX5XHB[!!VKI2X10CR,)`>UZ6<90NR`O4E!TU:Z^!9Z])DK%D@4!X)X::C&D_GL?3G!.[.!<,1WMVG\8D=SVZW22S57)"`6*-D1Q!9S`!KN. MY":!;E"+.)J-$=9>,QUHSLMU33%B!)/_9W23,@R%Z/L51W=GC%XS\QU/PW`< MW@S#R700'M'!$1C27:^<$Y]1Q6?+KKW&4Z7)8%G?VV$X@O"?Z1[+7P/^E$BN M2[[A=6T04WMWQ"-(MO_:WSZKN+M`^@"<_I:6_)GJ4C0&U;R`J6&0PMK:WQ]^ M8%7;G<&MLG#NN]<*KGD.VS0,0%PH94\#=T/U?QS+WP```/__`P!02P,$%``& M``@````A`/MBI6V4!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/ M;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z M89UC1"SF67"72( M6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3! M*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`& M9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L) MC]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z M%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ M@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509* MNE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y" MOZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=! MO-29#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B& M2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1! MM]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP; M<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;' M*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T- M,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4M MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U- M9O]2!=( M.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNU ML&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]6QE<'6" MG(,6:(J"HBB;,5\4DKJS4_2_=V;Y-BN)Y%*BM/W0"#F+%'?FF6=F9U^Y-]^] M^I[RV8EB-PRFZN"RKRI.8(=+-WB:JC\]FA=C58D3*UA:7A@X4_7-B=7O;K_Z MW4V]7FP_.[X57X9K)X!?5F'D6PE<1D^]>!TY MUC+&0K[7T_K]JYYON8&:2KCV;1$AOA6];-87=NBOK<1=N)Z;O#%9JN+;UQ^> M@C"R%AY`?1T8EIW+9A<[XGW7CL(X7"67(*X7KE:N[>RBG/0F/9!T>Q-L?--/ M8L4.-T$R5;7BEI+^\F$Y5:]4)35Y'BX!Q!]_W83)M[]/_[S[YMV[_K^^_O8? M/SK+?_[\I]W??OY:[>5JB$SP0;W,RWZM6/@YE=S+++B]684!,02\S@BZ?@G" M+X&)OT$P@'GXV.U-_)ORV?+@S@#AV:$71DH"7@;[V)W`\IWTB;GEN8O(Q<=6 MEN]Z;^EM#6^PP,B>\UUP$][LI1K.JV>!:'*;Q@B#LTG'.]0F'TRR\&:]3=8O M>VSB=`V;=1W#'Z>+65%O5V>Z=N-BA\-C=!6^(GJBI\54-4W((8-^'VFE#CN1 MLLF\#_K.INQJ>#;+=%,W1YU:QL7BKM]0H6YV266#0O/]Z.YL=':OK,JZ+`V? MJP9@A>N611>J;DW]'IGX.4>0.\N<:+`A`LE^_[XMH8N M1P`=4<3=2Y]K>/HILMX&&FMXQ0K$H>/=#Z9="U4,^'3L=#W0_QT+-2$_^:=<9JE&J,KD(4\)7%Q M8-*_'$TFD_'@:CP>3PQ]8!B,Y$46T6ZP=%X='*MT1M,N@B$@F.CCR94&0/K& MF*DZ*P(=`(R&P_%P,-$,^)_EMM,CZ)K3H2K;JP2!)*\2!)*\ROK&O0XR?U93 M8)I`=SRP#3Z1[E2"0Y%6"X-Q>S8=5\_M[DXWO=WMFG?6/,UW8B6^OBXT: M89RZ"*,EK)/DD_\#'<:(Z;W;&\]9)3`BC=RG9_R;A&OX=Q$F":PJW-XL7>LI M#"P/OO;R$OG?FI*P[@)++%,U>7;M%U#&#>M3;E(5I])09#T#1Q/&R.B/C*%V ME0[8.E+M.TMWX^]:5^C>&Y=`(W+;;#CA,"B49.%03BWUT`N9^P1+,%9^P^?O[JFAQ81+K]N9U1=;%8=D: M%XYQV1V_PDQQ]C5M7=,+T%552*LLI%CKM??VL/$73F2R'0Q,!;N+,]+EU8QU M"\KK]Y[[%/@.FX934S$_1&'BV`G;8<%FT*OPZ!5X!ID@$3S'Z#?8Z$7B1JA^"2UA_E_&`>TFRH`87T*"NP],E`AC,YPC`"3(0X-Z7C`,( M3QD(8)"4(X``+1$`G)JH.*8>#$@V@Q@H58+^4ZF$')-;R:D\H955Z1?TUUAI MX%I(21@`CY1:4?83!ER+<48:"`19&9)$@R8K15(, MLG)DZ0I-5HHD$&1E2.H)62F28I"5(XDK9*5(`@$8D9(AJ2=DI4B*05:.+%VA MRTJ1!(*L#$D\H9\X1?;HM&DZB4KG3W%O;=74(S@H'_YO^^IUU3B1.J@:-(&L MO'@Z>DI'CN`+-I8B0VE\V\C*YTZ5YS!R?X-!)KYU9,-DJA.I^)9:XMKTSI?( M6C\ZKS`435=Y7E='&=B`J=0/,]FJTD9YY_P<@47`TPU$-%K.!O6-$_-;D<%/ M;C=&2",(G-R1C0&YSC!T'@(=51&LN;)I@D92.@;J*F@PFY+AP=GLETVF!!F9A;6-U/3O_;1`A."&^*QNT M\VH[HGGX?S@T]R4ZYZA-='2NG-;7O*]U*"!]>P2^/QUEV9/-F1_?TM/409+9 M*;!0KM@V%X%^(.F(4-\UP-O?'3*AJ<;>;BL"#P'=):>"C8^^/7,B,W9.@*5+ M-QP"3]0-7!7&]1]Q/\RR1:@\0`]O#H4JS2ZX]K5&&/(A[JNRHMY][8VHY/D0 MT$)5?Y?ZNM1T4I*K\'(DP]$E_U-QW`"N?0C(H!B87[`:GVV[JTL4E2':JJMQ MRI'907V?*D!-]>,@=QV$D/2(.O$732D9(&A9>G5S;[3;;C6I,BVGAR M]1ILK:L2IEC_EQ*.F['Y+J>";W.GG<(V;FCH?=8E\\J:?!J@'*,G2N,4N6BW M'IR;3UK1^#X%L:U2)`EM'@ON81$/1^$$=3`XSK'=5)5]6-BB""R#D$WE_);R M8M%$P6-2X%BW_A^4"^6]CR<`FZ MQ&7`-'-;7%`DD\5S/Q3DWMCG1[99H\2%)HO@HK)*/V($$UE@$XSX5$KI._A&.,(63X2C5$KI-3[*=<$H3Z64_N+CVQ",[U1*Z2F0 M1RPRX`=QBPH?Z3R[AB"[,VN99UT^8+"=$8$!!X#:&P\.9@WQ6%>V(V8HJZP-.#6X?;B('2*1H^_K!OVT8, ME$[%\$D5^T\B8CX$ZTWA(3Z78M,M(N*C&[PX2SYR>(8U`"DBZ<'9))%5Q!]? MI31!8A[P]<%"!I\BTO/T\G<=L_[G`[PMF).(.RE(W<%9!1'@WV\20B.6(D(T MP;STZ";P3G5>B3D1"$L$QV,(.W@*$5L915#&WZPHP-K"5=VM&*VPJ-P/!;W_ MY6OY*BGC/<%CHME+IL5X`(A:.BMKXR6/Q8]3M?S^5W9:`013]M0/[N3(:S MNXNA,9_=W9F3OM:?_P MFZKD(H7/WOT&V#"UDQO1BXLSOV__"P``__\#`%!+`P04``8`"````"$`1Z91 M[JLA``!=9P``%````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`T>PJJ)L>MP&EUW9WEV%4V+WIC1(L\YC#M, MBC$'^CF.\K7S/]O>_[0Y[=IQU?VK/],=LNDC+*+]C;],5P^MWGQ7N+)YG>8GFN/,R*A>%"\?J MK_ES7'07#7NW5=P(NEYG>9^AY[-HRC9:2XVRV3Q*>V^&Z7@ZRR!"F8T_#MSY M393'A3M9E*;2[+2[BUHL`B<"KP_1P-Z.G_UA]Z'AQLC5@U>IWRA#DM,"9O%7 MD4V3"728N!^B:92.8[8/?A1NXZT:;W-YDTPD& MZIF;Q%?).,$\W?69YN6\\'+^='MK>X<#Y@[6+>)OW<[N`"34?UWA=2!:E#=9 MGOPUG@S50\30<7$:)DUNC)P*,\\'I?)IWC:4[CA!)'$&L%R M2<5FDKIQ-$\0@>ZIX=EBMIB::/LCE=U7/&'L-"M.O_KM%AEMYX\=_0N4[A08 MP<+&90):KU7"-O8XAK@_BAG=S2^]%0!J6#/G,6\;L/?L_*IY[P&^-500D,DG#)M'$LTSI,>)\5A;O*LYD+[W+([EPG6L`EN(>SV&V$F9[W]GB4EC&: M4E9K=:<)6UHY6??=X[AT4[:V[G?'P7`BS5K0Y>8[MB9%#R MAT;B7ZY9\%X7OCNL6>W>80_QSO1_)(_@<)K=/DK_[>TK>[NM6!`QD@U98]`G M?UX4I4><,L/BC+-TC.?ITJ`)CE_UMWDG"_E*6)I&O\/4*UP%3HBXEXF\A-0\ M@&#F"*1<$>>?DC%>`<".L>WKS.@F2J]YOKR8>5"F:BWKTP.$C:-T3/Q7Q,\Q MX?XOS3-_P'^J1NE=7!J)6^VUV)H/^CD/D@F7JBOJ7:Y=)2G.IR3Q'JZ=YMDX MCBEL?>)\!O`1/$%7B_S++N!()'$X1YGGU*)@C# M)2-7['C50(#S`G1RZD].#L^'%T[[L?AN='Y_K]].S@_.#XPAYUIS\V14-E M#SU3.$+C4O1>/KDX<#M;[M];MO_X-UFA.$ M_NMO__N<])',OV")8T>I&U[GL;'/=/:44$ZL"UNJ)@C_K-^UF5;OUVVPH$ZA M=P8.'?HS/KD_%\?!-7*W.,W3.T?XSSZ*Q6613!*%\*RK#8?=VD1AX?/%I9]. M\KR_Y8;:YH$ M79H-JE\X#+R>3MU,?/=LU[F,(]K8H"4*Z-(GC)'PK?@"TH43^3WXDUPT>X), M<@_'YY+TRY@:VN7!I%F3AR M\YL[/+PD2C<%E3C$S*KYD4"3L=3HZ-&BS)/+10F6EC[GF7FM=@Q1ON!.$;#(4VQY[;B!PTO:63V_ M2>8NRI&WZQ#KF.8URTGTLQR_0!L#@CU18]MC1;(>OXZ\UE&7L=8=3^>!%HT+$+#W:&^SN;@_V]NJP MG]]$6*BLM%A(%]0:;%H`U?],9@#RA9?;4<#R0*@1*=OIYY1S18("&;"1&):< ME(K)XL#%5U<^<^"2F?C$6T#*G$RJ$57[7@4"7K\&;B-Y+MJ/S0LSW4E9N8** MBDZ\$;`1*`@(+YQ&/S6%GP-A]F:_1>%__>WOB%`==0OCE+GP!/*4[:=0($^; M'-K?*Y]D:2=:NF])L\P=_FN<9U7"A9=`QJN8+#!ZIR2.9H-UG:Q-_SW@G@EY M&;P!6PN(6I_#Z'2916`,`R<)SC1(8)Y\Z^P:;)YP:S-ZW-F04,!)WV'8+`,K M<)D-',+Z5\EG\]GB:'P#)NA_[`7;Q*?,@N]Y=FN*/(F+Y-JCE-3:3DY:2U## M[!FKXY$#GT")RQ6KFJ7)8TYAJ[$[T'+JI4WV8>"FR0R.>6/!'(J_\R08#\T7 M9ZDG%6+@Y%15V&"98%&Z)!07P5[:,EW]V;L_.]B*KG,4E#"WWL*`>?@TCS^@PNR/Y5UO+\8*0%!/BX MQIPOE0UO>7IL,V1G8(P[I_PT60"Z^&.<:<1A,)=F:C+;40T>HF$TR>9M:VMZ M[,.N:OW3UJJM;+::X]#%' M^93$M_%DRYTH$:[14CU@#VE.[=\/SW9#NH/)!)E3"BQL*S@2;'699\4-50;L M,L2,+.N:PC$&/TS[_8/#U;1_F-S*1X1U[J'V!4=O\9_10@<9/H#H2[DH,AZCVT&(B`'3#113$T(K#/D-+4(YB9GMT;0CH456.H M:,(@U'LJ[,=]"`ZA["W.&%I9\!Q<,=_&!$->2(C+):9MV[/6<#0'+Y/&*`3W MT/,2&1K+#E,\0O:9.(26_,N\0NW6D$8X`$[&8O?>X/5RTCPU][`"G`5NA<-7 MJAS^.0(JB9*]3?;:>\'!5SWU#C1D0Q,RV73(QD&]WUKY]=##>Z7K3/J]G*DV M]Z.O;QC6(0M*=;2=)JU@4F<0SSZJ5,N=,&`NI[>5_JF"K9Y8XH[5+MP589P) M:$*R9Y;6=L1EE]/DNK(B7H;#[EJZHP!0_2!VWFS5*5YE$#5K)I0?RU4%Y1*Q<4X)S$P7^1*QI22:PDY2C>K/8#` M^#KJ-,T@\`MCHXJ89OLU6DD&4IXE-IY5EF6MG@4LM9`G_HRM,\%A=08'NO4X ML_%#+V`_$C@DLT=E#23!DAD3!5%W495'I>2AGBKRU_74RU!/M7X,<6IU<"^8 M$'ZMCJ;-]]D_/7##,4ELR"[3/<+EW3(JGO;"\HTQ0;GW@:=WWMXL9P[P3XPS MY&ES8L&[NDLC^'B<\\&CU1Z!S=24,LPU,_[?D(VP'18X;&BT&D5PX6%G;UU[ MC5@4NZZACU]<-&W;"-0W%"\)4^3P,]O#R__B8UOB+B2>'[U:?=C*7@GYZH@6 M?ZG)2Q/;CF]JG(?AO_;%,X4(XW$\-]7T>66I#;$8>5Z2%(5K>4JU!K'G#!=;@[J8 MDN-U^@@\CZ]5V)5++GJ(SP\[O%ON@O=&`S""E@@M]"A0:$_GM9(J#X6)NJG"W?(S M1,5/"/&X=;@>BF5:VNE3*HR%EQH9CF^&;IBF1#>.;!GM-/)O M#P6[]"3]WGS2+XLF&'Z$(,Q90XJ5&RYN&F<\LFTS^L^+U&*L M)KZYP_'<5$K@\:0PY?!Y8@5J M33UM])N3CFH)15G?=CH(194OD8W`+Q-DF>)%Z!?XA7;5K3:K&T(\-`:)/A=Z M689^5S'G]AY1,C+7-;JN-:1)L7WEVZ+(/9N;$3P'MY1OUFSU21HX#&&X0!"] MA41!RZ%AGP7[/198D\$I7#N7D]BE^KZOUBMT4ZF96A]OFCN)B%H(Y1/NSNB_H8T!$]WD(H3N M)D^<"4(H!2P]5!\0QVR%."1PB#0_Q_DX4>V5<8P@,>))PIBEMWGL9;P!.LUI M&5&$<.G="N\)ID2=&AEK<@2#,O*&0MS3!/.%19:AU6$%\;SSLI(L.%R4'2I; MDT&5=KSI$R3>YC0GEF2(SB1B?TLJHU4-"*I,EXTWH!;;F^R1A)!L*"8-89XWZ&OYC8X`.+-#;#:SVI]0T%1'"UL,$@4P]^1^N=F9K/XO&N[9@M0JM%?X#QYX2B%5-69+9 MEEX5'_9>^[^KB2ST6FY3JTP=A8(RA]=")G%,X"S]53CL<:!F4=6)6*+JR*8 ME1;:(Y)`4LE[*S@$".NX=RO\0,:*PS^1L($:5J(U]@UGV)=Q-&BYMDH-U8XE MG#$7C$2./XVQU]2JXIW5W M8G*+IN,0*#2BTCI\NZ1GT9*(9G^TU-`R\TL=OCXBJ^WB?3VWOE3UV81"?.=< M%O"(*P!NI5&!\#B7>;E)S#]#G"CWA>H3XZ!@:]]]&K[KT?",.`OQ&#:1#6Y! MBJQ1TY?ZKR`@>"!,4-Y/@M6,!.1;(ZO$9$@;'P[/?Z"J5-=&E2LX0%]H%;OV MW?:%NXB*CW+?QS%Y/XGS\&AT.FPBVU9TM+84\(3\])/GW_JB2F='%92%J,E2 MVDT4*AL>#$A5FJ7\-L>\5UGSD3>F-.^#.8I$9=&O%JJXXG?VXY8>`]Z='!V_ MXY[&\>C@[+A+VF,U=.QNN7M?D@"+Y(_/WZS:6"MFY22@)PB#HQBYZTSL0+-1 MB-2G8*TZ3;U&8!*:"KQGA>LT3?Y:@T8+8<2Z@@>%RM%X7%+/%NK(&]0KJ6)R M>MYQ)3S*7\HQ(^Q?CG%5B)8!\D!L8$@64\6G5,K1[I;#1)$J4=$#-W?'T$ZC MBX5PAC,BLS38ZXBR6=5@B6(3RVRY?52*5^P4#Z9]O*`&R8"N0'73?<>YG[[^ M:O#J*SIC,(D!-3A^LYQH\_3-UX/=5]M>T#4%)8EUYP-*5[L**S9BZ>%N][@M MN#=XN:=&]M?>`E$[RC\:YT,IUW>:JWF^VM_.5P3"(W\]H+.+=R.DN'L?F5?)XK]8;6D3BA MK<`X.E^0A!ZW4>@JR6DX@L:^FE)E!<3-]GX[L:[$^_XD!%T4B%(>F2>O-B'N MN?FX(EM<@H.7>,,F,^U5_%T,.G#DZLL8$R$P2T?1*K=+ZJ*2LZ\=6(BA@H\% MPO*G@FM<"=LLNE.YCTRCNC0?L<02`>+/HJ%T!58UM%W,T=<&%(WVK5,$ARYR ME:YRKMDEV&=Z[MTH^N/H)"J;5["7+V"Z;\P@(U7??5!I06)7``'D^Q`PJU.. M]1L1V8]:XHS(N=;83P,_$:U\LJ/.W./>4Z)(UKZN/)*:J:^@VFA(;K5V\'@Q?-M)GARU"DVUAEAL28!G M0N6Y@G2;ZQPU]8,"+5>+`^4!'^!IF/!=$%&+YRR;Q,3^#:2G\6?T]#:>$A_Z MC#X63GUO<"*E+5>*9+$^FMI(:D>V!M93A/XA29,8]8?;P6NNF=RT9]R"&5M< M,VPMTIJZ'F#(V%L(F:RSYSB=)KS+5!"@XEU*SK6?0G7;O"71P4-1:J`R079& MO6:VQ*:3?427YU%*-/&@H%<40PLJ]`E$:R%^3Y9EF:BG'P.D(>K/AI//&=(`0MA8K^ M;$-U"H@D64%1*`%R[$;7O`GF<#ULI4E'%8FKA7I%A0LJ'X19?!<@DT]P2J;9 M'#FZM=53+-R8!7B_?H>_12E&+W/1LI17:@4T9TNY)WJ58:06J;T!(90:^M%6 M#F0:P&ZI,*H,H'4,/WQ#'X`B'?7L-RKSJAFPMF1[@E?PJ`'+2:>FJ;PCZ,9O M:\[QT(S"*B+0%1GUTN:%&A<"J2NU;->Y9'>FR4=UMB&."%+()TB=*9'@MAG+ M/*]63F#I-<8F[!''@O/*+J.'T@301)DVN\'0V7DMEXB0"%HMI,/#.F6?EY.AS\/?WA_T`5?BSCV M:"&_[Z63U)W@ENC*4]/@W<;^0*M(1 M>;VIVPEWZ,5!4FB^;5&H9D$V0NVS:M#VZ=[7RF=YTP9`F/.RX#XM--3ES$M` M3BZ3G$,D`H=I;VO[-\;DX`U@]1NH#%4\@A")07M8%5CW"`HYZ@K12Y\;7_9, M_AUR?$#('D^+W9?_>5HT+MKK7YL8OUO0/[GKIWWY&-&P:[O_0=%HQ8W`:0PL M"UL>$4'6@A=N20HUGW[UU5 MFF&"+M.Y%-!^P<;VY'8$16IO[.LW;H,->D/U]-5KX;B4U3HH9>SH(\>%>/YE M>UP;U>(NV/WT>B]5(DTD>/KF%:3Q6V$;P8>5*E.VR27\2D47L$97]B_HITENU5<`R:M[AWI1*3+'._=4VK/ MT<%U?6GEFV(>C?D"RQRQX;9>_.3[UO2=][_7W@6+E4_6Q^I-+%5"J@Z[PQ&Z M]N!;14*^($,LWF:4C[VJ!/BWAL\^N%M&Z&]#)M/39]DJ='?[M/O#9O>'+SU/ M%]!_[?.T8/W?W6H/;W_MO2ZA[KV[79:)WRUPFZ@VD7G;V?M6'>>ZGR-7JL*0 M8'>;>L@Z<=A]]9ME>;"Y=[^VN5]]P9Z"R(>1O_:NJMG]K;?>OM[CPGY39`L7N_O?^/J5S'CWYUZF?NBO4,MK\JVLNEZ@-H?NR/.+D]'O?SQYOW]P]NS< MT6-]-#JZZ+YDKM_++==Z^?Q9>/G@>/1S]_USZ^,/Q=;NPR%^-_?12*,$M!OY M_+0E/.DJ[4WXCC;XGC=>0Y"<;_[^RCSG0$4O;J/CGA"E289 M=Q^<6T6V^RN=*./>9BZ(?[LO6B6L^V.X@;_D'6"!6L9`^MH=]4X?G.I?ZZX. MV[L7>YCE5[&*H=V)#C[/U5+7_7G-KMHV33CRLCLN;,#LU"H[VGW_[.#]\.)@ MG_CG[.)G=W$V/#X?CNQ2;O=-TX=76^[Q(P@$["++/_]A7PZB][V=[U/Y/_3S M^BS39IF%X*AN%+9,T^)RDX8[2^N0*"=/(;OM/4>)`R)G/RNY-+<,CYQ*TJ]9 M]O%C3$8\-R6S5GXY84^_YJLUD5_2ET;.\/\H*D7Y;:;6EB.[B4LO;?BE:6QO M*^TI;@/%_K1\<>$[9.+\Q;ENX]O'K5!'"P!).K3KKB>V5<)1>H3]>WHB45)V!" M;H]]I`!!P3TAJM3UUK!F.*L/%MH'KQQ=T9))X4LA-M"UZ*])`N#&G(K^6KQ> MR3S2W<%78@%<>OIJ\)(_PU1,]^B88*_G7O[BV*)%29.4FK,*TOU7`.K]WTNI M7[8#@HC6#N24FS-/%K[J[54BOME4R%GYTKPDZ2GELXJ>Y`ETQ<]U0B'+F'6\ M_]"UX9W^Y:_?U+Y_M5:[G"K'O6Y];W6@LI-[LBQ\>>_#T<4'[O7[V_Y4>"^H M]&)(CP[.5T+-:SY[\$6CWF.4IB`./<5YSX<`BW['[5]K@_<->Z0F/H!FY!)U MH7&T*)42EE"&/]]'M^X=%9$Y=^*W1LW=?&[*M$9TS=QD97KA M!=^':=^@/UL4>`A\OVU:JEOO=WPFRTJ%/W!%@W^?*1=5NA_!-13]AE2KSK6Z M>[*Z-<,-+FJ'[UI:KC]DE48`V9$#95.+)9`[9X7XSHD]!'W_6^C0U5E%7 M5^QE-_T599*F1-*YO:WDI+Y*X.R!YE6G!+]2=*+! M2V5/94YS,N=*W->WA[W(E]:7*'2:9&3O5%34E,J3\H\6`7A`'4#(:*U'0@6? M%&]U>.)R43"A/:ZW95NLQ\_N\6C4T4VRB^8;!3KJ0#TN^IT350T7)#.4]U<= M4?75!MMMCWRD+M3-8,@'/KX96"'^ZV,+4X1:Y5_-R+&M@T)@Y899PUK[,3PD>6:4*;`8S0FMI4PEX3[-O&EI M)`IV7*!2M83Y\L<8?>,6JVP;N&PZ5PMQ:,`IJ-46EN"6C9E$,QQ=<=G>KB'T M&[L/_O3EZ\'+UZ_O=;:EE2'!R0$^%PAZ]*,Y"7Z*F9VVGGZ M)Z*3@^R]O:W.#'\A,-3#PG;&/B3PIVDM=P.LTJ-?MW#*ZJMS;UH MI>;>O)9-6B:K\M">PE2<57OT_B:ZWX"KV5D"T^+%IS8KL#/U8K2%6JNWL1FG&5^6XAJGC$CB MIYLC9)+/$OK(E-WH-PQ;]UO08WV)8K2>@,;F..S;B]R$712(AG6Q6 MO$HXGGU79K+`NJ%&'1)5JLC/]*.:/C2M],WG"$0U'Q/XVJUF*>JOLK3M`(IW MK^!8LQ)7]J7K`8DU>:TTF,J_$TA\DB1[`Q;QJN!R%7ZKGR2@.2^[XQ+'P#>:%IS\@&T!>TJ(HOB+>L MA9!6W;<($-,:X12LV'=`:#"C0C35VY^2ZPRO1Q]^F-C4-EVUVA%9XU"J&S1+ MKW`XV.&8:T**"V#D?OVM"*T=HJ""2`N^6&O('(^23Y$6/:_^R[[=Y#9.PT2] MY-"Q^D!CUFY_=7+(;G[@\X9\PQ?_I>V,5/.\[71C[/__I0H)Q*,O5?SS'X@, M:/3_URI67*,!-%"S_^RU"J5UZO*WV[A0YJCH:X_5;DY#`<2_U%6-^H,A6`]@ M$/P*!9/>BZO2KVN7MKQJ]0TBT`Z<*.F#UC9[$Z_,L8:;2YW\:G?LEP+-OK!S M6O#->3[TI*LT?9I]&>+T)NSN$%M,[T`XC:_CF>&I+D8TEUJZ(Y?ZI=U&;Z6U MGQQ^9\W.H]#LW!O77>=/:WMDNV]VI"[,O'8?QTOB%]Y^W)PM!JW[NOG*V9MQ MW76.JG)-.Q/6*>UVQPS7E&B[[[6*#4UEHN;86OJLU)$U9%J36>[DNP>X>GP= MAP_L*KG7T[20_G[@K3H;_L![AU5R_('W0J[\@;?6'+"7.G]@FHAP55-]OJD45O2VVXRJ$DMOJK[^N+,C5X M-("V%D;.PA=S3Q6MM9-1!;Y^Q]SU*<7=`XH!BND>7Q#HSE+AY+EEOYNG+_B_ MQ_G^_P0```#__P,`4$L#!!0`!@`(````(0`4VJ<]B@(``!4'```8````>&PO M=V]R:W-H965T&ULE)5;;]HP&(;O)^T_6+YOG`1"`1&JTHJM MTB9-TP[7QG&(11Q'MH'VW^^SS3&LB'(1Q^3UF^<[V)D\O,H:;;@V0C4Y3J(8 M(]XP58AFF>/?O^9W0XR,I4U!:]7P'+]Q@Q^FGS]-MDJO3,6Y1>#0F!Q7UK9C M0@RKN*0F4BUOX$FIM*06IGI)3*LY+?PB69,TC@=$4M'@X##6MWBHLA2,/RNV MEKRQP43SFEK@-Y5HS=Y-LEOL)-6K=7O'E&S!8B%J8=^\*4:2C5^6C=)T44/< MKTF?LKVWGUS82\&T,JJT$=B1`'H9\XB,"#A-)X6`"%S:D>9ECA^3\=,`D^G$ MY^>/X%MSL,2`A]]>-6%+;* M<6\09?=Q+P$Y6G!CY\)98L36QBKY-XB2G54P27D)N6ND9.QN#L\M-_-S^0&+?FT2WR M2T%MH*:;:7\T(1NH`]M)9I>2]%SQ=*GHQ0<)`;P#(^3ME/'_M=NS.3%4":,C M6^]@Z_%G0=(_D63GBJ=KBC,T>,_M:$Z<8_`^H&7'B`-:D(Q\3N,H3CI<[SX^ M@X+(;H=RX@Y4YZVS(!EXJ`3.+_?K@%V5G,%!<]T.Y\0=N$X;S8(DP&7#_C`9 M=HMY37&&-O@(FA-WT+I]%B37T*XI`EHXV<*6;>F2?Z=Z*1J#:EY"%\71/42G MP[D6)E:U?FLNE(7SR-]6\/GAL&_C",2E4G8_<2?GX8,V_0<``/__`P!02P,$ M%``&``@````A`&M&;:ST`P``<0X``!@```!X;"]W;W)K7_J&D;0\6N[JI^;LT=9VV7/XX='0H=@VL^PV% M1?GA+6\N[-NZ'"BC>[X`.T^!7JXY\S(/G#:KJH85B+`[`]FOW>]HF:/4]38K M&:!_:G)BD]\..]+3+T-=_59W!*(-^R1V8$?ILY#^J,2_8+)W,?M)[L`?@U.1 M??'2\#_IZ5=2'XXZXL>UB^-%E/@8@=S9$<:?:F'I.N4+X[3]5XF0ME(F@3:!JS9!P2)((Q3% M=[A@[0+7T24,HB2]@<53ZY)A>BQXL5D-].1`[@$YZPN1R6@)SB(^&*)\/3X0 M&#'GNY@DIX*:P::^;H)LY;W"/I1:LKTB,17YI0+[9XD'>&=&B-N4<9Y-B&$- MKG-FP^AL*_&W2A).))&IR.<4!AH\YW8T(5Z[X#VB!>:#MTJ2RIC&4621Y]/A MU!]'#298V.U,0FPQ88M)26+)A-(XL<9S8]Q/_$]V$<[+[5A";&&%%I:2**P@ M"@)K/)^.(Q1]%JWX'BPAMK"LU-DJR>=8T_$9K.0>+"&V?+408@LKM;"4 M1&%ED3]);UE-BZ%!AJ"P3B,WCR;5)ELX'BU5R;1&QPR%ET$S%#-1 M0U8C^()-%>]I*0O':J39E$:S)4%DP>?RD6OWFL`,FZC&DX3[`DW5;@/-KK)( M:?23,8I#.]<,1>3C\)-D0W7?T!73:(2>;H6- MTV'E_E9K],.1'X>!E:2Y*<%I&HZ;8-+]KV8!7P07NSPN7X=1:=2KTK7^KTV4 MX%JG51\-ZFVX+P[D]V(XU!US&K*'8^(O$LBU07TRJ!M.>_G6NZ,<7O7ESR-\ MVA%X)?87(-Y3RC]NQ$?)^6-Q\Q\```#__P,`4$L#!!0`!@`(````(0!0D'TY MMP,``)D-```8````>&PO=V]R:W-H965T&ULE)==C^HV$(;O M*_4_1+X_!(>/!40X6K+:]DBM5/7SVB0&HDWBU#;+[K_O3!R"[R))IN)2'4-62LZQY MJ2S":#R>AR7+*V(<5G*(A]CO\Y2_B/14\DH;$\D+IH%?'?-:7=S*=(A=R>3; MJ?Z2BK(&BUU>Y/JS,25!F:Z^'2HAV:Z`<7_0*4LOWLU%S[[,4RF4V.L1V(4& MM#_F9;@,P6FSSG(8`:8]D'P?DV>Z2NBG0K]NSC_S//#44.D&:0!L['*/E^X2F$:(-8HFJ%K*@JP@,^@ MS'$]01K9AZ'+,WV,R60^FCV-)Q3DP8XK_9JC)0G2D]*B_,>(:&ME3*+6!+[/ MYGGTN,FD-8'OUH1&0TE",ZHF82],L\U:BG,`RQ6X5;[ M?,;'UMSCP\UZ.)_9VFV^R"];:C1V[,BOVQN:>WRX90_G,QN\P^>7+NT?`I%7 M1&5H"BII)?-F&YHMI@NZN$K<[&IMB;C4V7N17\PW-U<;E>^CP@,ZWQ]\4D'!]_#J>/0$69:F M2S876M1-E[@3&KK;YN<1_@)QZ+K&(Q#OA="7"^SINC]5F_\```#__P,`4$L# M!!0`!@`(````(0#-=FE3/`(``!,%```9````>&PO=V]R:W-H965TV MN>R_[]@&2D35[O(`"9SY?,[,D.+Q*%NTY]H(U94XB6*,>,=4);I-B7]\7]V- M,3*6=A5M5<=+_,H-?IQ]_%`_@EUII M22W:T\D6R):,XSHFDHL.!,-5O8:BZ%HPO%=M)WMD`T;RE%OR;1O3F M3)/L+3A)]7;7WS$E>T"L12OLJX=B)-GT>=,I3=8)F1`@S8I*0`+7=J1Y7>*G9+I(,9D5OC\_!3^8JVMD&G7XI$7U M170N2&P8-!4PTRAR)J18,P#N2PFT&-(0>_>=!5+8I<9I'V4.<)B!':V[L2C@D M1FQGK)*_@B@YH0)D=(*DX/[T^R@:C;,DR_]/(<&1#[BDELX*K0X(E@;.-#UU M*YA,@>R2I="?OR>#2*[FR17Y4E`;F,9^EHS'!=E#"]E),[_5C(:*Q:TBRR\2 M`OXN)B'Z^TVZ(@B#T97)R87O@\R#YOY*DPT5BW\I!A[AH/=[=$4EAC/^>)S$ M0P?SH,E]F],TAM=0`(OO("=!/A`$AV&OP]A[NN$O5&]$9U#+:S@WCAY@"778 MZG!C5>_'NU86MM%?-O#PX3#[.`)QK90]W[C_S>5Q-OL-``#__P,`4$L#!!0` M!@`(````(0"T]N6H%P<``(@<```9````>&PO=V]R:W-H965T5I M8_WS-?ZTMB9MEU_V^:F^E!OK9]E:GQ]^_^W^I6Z^M<>R[":@<&DWUK'KKOYL MUA;'\IRWT_I:7N"70]V<\PZ^-D^S]MJ4^;YO=#[-G/E\-3OGU<7B"GYSBT9] M.%1%&=;%\[F\=%RD*4]Y!]??'JMKBVKGXA:Y<]Y\>[Y^*NKS%20>JU/5_>Q% MKHW7\A\N>J:.JV/G13D)OQ"Z5COIO=S4#IX7Y? MP0A8VB=->=A87VP_<^;6[.&^3]"_5?G2*O]/VF/]LFNJ_1_5I81LPSRQ&7BL MZV\L--TS!(UGI'7PHC8P/S]S[!L"\@H MR$R=)5,JZA-<`/R=G"MF#VLL5$WFC=_BU M'P)\BH;KZ<)9>NN^]S<:KD1#^!0-[0]?-:RCOG/X_-A5WXF&\"D:>F]>]8Q/ M7.^#,._RA_NF?IG`XH*I::\Y6ZJV;X-_T`%\X(,G7K,$>(&I?&$R&\NS)C#; M+?CX^X.]=NYGW\%[A8C9CL3H$0%&,*,QV=`$D0EB$^Q,D)@@-4&F@!FD9<@- M&/)7Y(;)L-S@J+8(9+*,5`48@4U"$T0FB$VP,T%B@M0$F0*T1+B_)A%,9F/! M7\4DKFZ!+8^Q81D/04L])!A"ANP0$A$2$[(C)"$D)213B98DN.1?X18F`XL1 MMJ,A`?9ZH:=@*X+>RM(0,F2)D(B0F)`=(0DA*2&92K0LP;BT+(W?:7!;8=%] M,G`06T%@TY7I<8WT!$,0-@L)B0B)"=D1DA"2$I*I1!L[7/0'QLZB];%SXKK# M3A(0$A(2$1(3LB,D(20E)%.)-E"X#WQ@H"Q:'R@GZD`)"04!HRE&,+:*:`A" M(\2"K(8<[@21^W,RM%*E5_H23(<@E,X$63-I+1VL6J;WV"DKD;IC57S;UC`$ MN`F-K`47[J7\#LM$]"QQHF:)D%"097]+=N:VL5*BX7<<12R(DB!!E`0-K=B- M'E2-33P=?D?53!":&RA@2&Z6SA13\[6^OI8:J.LP-TQ$SPTG4#JK4^CI4QB( M(%Z-]O7&:+.UWBP204Z?4_=N/I_K`;$(D.MT1WI*;NDI'9JIH[C3>\O4WC3; ML7).R^V(OY0D]N%Z%@5R%L-J"2@**8H0\3,#2VV,2#$6(BF?4)0BDEH9HEY+ M'S.KY-.W6YDAWT<*8[0"C%!LAZ@]?_?*-$''7.`OJ M&HQ0;(-(2B>(I'2*"*Y6V0I-FV!4+Z_GC)5]:L[>212O$K5$<:3YA*#0)BA" M)),>(U)]0AHF&"6MDR*26AFB$9^P,DX=,SOWW.8340#*;K8V1X9/;'V=!A@E M)S-$)"8O@MQ@C5)^("I'2"45(Z1?2.3X36B$]84:?F[!V?B!I0 M311'FD\("EGQ#]NY$A4ADEHQ(M4GI&&"4:I/1)34RC!JQ">LF%/'S'SBPI;[ MSMA%#2C[V+**GHU*NR4MS(,?1LF9#!')F8P0<9.L1CPB.E,](I!43E!&*J>( M7E/.,&#$'JP<5%/U3HIX]0AZ>&H98(CPRQ&F16(AA"%*0P1R6(M0K3NZQ4; M'FN1'47TIKIEN`"43E!'2J>(7I7.,&+$+JPD-%-G+V55?%OI9_/*4DL>1V`C M>3_TR&XL@N0TAT)*L5^$Z`YS-Y(\(:0:C6@G**0:340);8](9]AHQ'>LZ'LK M>;<9CY>.6NY$-:GO4L:I(;!%E-Q+0D32'9%`KJYE'-%B;`BW'5F]+(S3U@ZC M9(\)(MEC.MJC2RHA?FKK%?6B6B#-GO;"/)M@ ME.)/@5S]_FV>3C"*[^`VM56,THIC$$M1YL[<4HU[MC;V^Z.][BHGYZPC^ M&/I<-D]E4)Y.[:2HG]FK!M@R'NX'S-^#;%<^/&V`K?#07R$KWTXA%*> M>3X<12F']RQ?G!&^A?6,?K<.O)<9BW=]>$`XHK\`_7Z;-H46/CPKHPVV M2Q^>(XUPS]^.#2#P_&",AYX/#T&H3KCVX>Q/>>SY\`2`\IWG[WH^&P8`[X&N M^5/Y9]X\59=VENI5UIM=K#M0,F6`6,;*=IWW['=D*`9)/T!H?PS<_\,P-F?O=65\8K M9IS09F&ZEF,:N,EH3IK-POS]ZVF2F`87J,E111N\,-\Q-^^6GS_-=Y2]\!)C M88!"PQ=F*40[LVV>E;A&W*(M;N!*05F-!)RRC-)2A=06^W]P`90=M=7(B7Y.,44X+88&R M[`;#Q<*\=V>KR+27.^WP4NZ^\)(_HTT&(H-;9(-6%/Z(M'G7/X% MP?9)])-JP`]FY+A`VTK\I+NOF&Q*`=T.P9#T-F'UEA[/@NX,8:<_%$I*1I9%LN:/U70^Y>2HMX>Q%8 M]R)N8'E)Z(;1!U3\O0JL>Q4ON#D%()4/6`\I3"TW<#Z2`!A6&K`>-*`?EVM@ MZWJJ]J1(H.6QFD0H'F,$NORRB> MVZ_0_VR//)Q!DB'R>`:9#I'T%(F=(;(Z@[@=8H/+SBJT?6S5A\)=MBJ#%B8< M.ZNQU\FK:CQH)%%U"),@.=Y>77_L7_>]V)D&(X6T3TQ\/TJ\:%2LU1!)DB#L MLAB8A*G\N$D9-#+I=_+:I$:BH\GDF("VJ0D8[*Y2(R*]2JPN$0.;<)N^ST3$S_P8>"C82U7`\1UHL`[#M/`931T>;F)$AZY&\W7@T8N MS:@F^FT>::17"=@E92+G-;0]O0OJUVR+-O@[8AO2<*/"!332L6*H$--[H#X1 MM%6OTS45L'>IGR5\JF!XUSH6P`6EXG`B=]GNXV?Y#P``__\#`%!+`P04``8` M"````"$`W,3O6E$$``#A#P``&````'AL+W=O)K\]@TIZ5E\>Q(RY3/V8E6\&;/ MZC)MX+$^6/Q4TW37'BH+R[%MWRK3O#+1PK*^QP;;[_.,/K/L7-*J02,U+=(& M^/-C?N*]M3*[QUR9UJ_GTRQCY0E,;/,B;SY:HZ919LOOAXK5Z;8`O]_)(LUZ MV^W#E?DRSVK&V;Z9@SD+B5[['%F1!98VJUT.'@C9C9KNU^8362:.;5J;52O0 MOSF]<.FSP8_L\GN=[W[D%06U(4XB`EO&7@7T^TY\!8>MJ],O;03^K(T=W:?G MHOF+7;[1_'!L(-P>>"0<6^X^GBG/0%$P,W<\82EC!1"`OT:9B]0`1=+W]O\E MWS7'M>GZ(2`"[@2(X+E/\?]%[)@(LF(@@"&HQ?@&V M!VJ.=N\UPAO)*TQ`H/N9"#`$6KHX"-2;8X0L)(BG(I(IA$(-C-Q/38#7)O@] M:.(OU(MCA(1M+&=^X`6A"D@4@.?[BU%6A1@DN$Q,))@+!3@=17%(TTZ[/T8( ML!A\T+6;0B@4_4L:BD.J MAN%H'FL#(3)!7<,IA$)1C#JMC]P.LSBD:AAJ32%&"`HT"Z+`'11J74CD]V[P MF8#1(^S$(8W=F.,H($(Z=L3U(SV^,L`-%OYH0%&/0$7(\DU71XO6F&FZQ!VF MHQ9&;:MU4_2`60_I`I768I._NLLL?\K+,?9A#E(KF>$1**+ M-6+0$P*.C)ZH+,&5!UB*4UH^ZJ..(&9"2QDP1?&A@2)^K>D4]8G289"B)_>2 M3L1^H(C?-[//RT4;)S?*Y7J.A%H3B4D_2,3%H:VUR$1Y[;ICL:FAU8;(#5K8 M^.7$B\:#TT.@GT?TGH8_Y%V?]QA(*\&C%;A MR21$E4\;(3?DNYX=T=CZ._D0LVAGOR,UWR[;^MZFL%6ZP^BA5.\VM1:O5 M&NG3H\/(TDF7(\%I#!+$C0H7CI+6!YK0HN!&QLYB6W+`]>';89-[P8)W2`_TCK0]YQ8V"[L&D/0^@2FML:9_$*O'L)QO?@(``/__`P!02P,$%``&``@````A`%8^0+J+ M!@``6!X``!@```!X;"]W;W)K&AY2X^OJ].'G/657GY7GML]'8][)S6N[R\V'M__W7_9>Y[]5-U_W?S\T^JEK![K8Y8U'C*W*4^WV>9G=E^E1DYZ9-4F6GI`'^ M^IA?:I6M2-^3KDBJQZ?+E[0L+DCQD)_RYH=(ZGM%NOQV.)=5\G#"UR/`&GW:NR_=J_84K?2Y_JIBS^;8.83-4F"642_)5)XE?C M(QF/OVK2R2@.)[.YF-6>*6A1"Q+NDB;9K*KRQ4-G`5=]27B?LB6RJ:=O,W1\ M7*,#//`D-SS+VI_Y'IZT1@V?-XMX%3R#]E2&W-HAS(S8J@A>+:#K((*43X#( MLW"(O((<\ZTR])A#`DA%4$#@Z1,`\2QH%IVSB0G@M@UAZ(6.5Q*R[4(H2`SZ M!)`\"UH#G=PA6$P)2AGS&LHNA*)$8AVE>]&I+N/!`DQ70VG!HN_AS4QX6U?, MO(LQ.FTZ!`T/-M%(R[3KL:UN,6;"4M&?6RR[V7P$K`-7'D]DHI`63-USLNB> M5_3^MHNA]>"[FB8'K]>#!YMS2XO&@&XQ&%B8,PD&6#R:#:>`9S)A2(M.`1N/ M"0==$.6`H9W>3X*(-J=7)HT&PV3PP!P*'(\7(X`?V`HB$T'2:BHSF;"$MXNR MJ"#:^WH_L%8PH1;=`E4FG0H9)4PF%5S,M.[[^*I@4A9U)-)D4D$E7PUT@.,: MIH%[@PJI>#H`:=*IT$TF%5RUM-G^Q_+@XDW6AS*97$1D@?115EM@H([N#2YX M-.E+:=*YT$TF%T0LWYC-5D0F3?HVP<;D@+)U1_7[K8EID%`R6RF526?@JE8R MAUA^4"-LL13)41[PWVT8;$PV^6T?19LA'"27(MIL!F72J#!,!O&A0RXGL`W4 M2I&&P.A44.>!GB;40`'61#9(*T-;*Y5)Y^&J5H9$*U]?%"*:/*[40W-1]`>C M]J"@!II1_7'"9&"01(:V1"J3SL!5B>2O5[H(<8F<+_A+VN!FL!52)*>+@M$C M1!]E+0JN9II^OU$>J7W:;A'JK,FE<&":# M^<@AD=/H(R=KD8D@<:DDHWNI&BCPFN`&J61DJZ0RZ51<5-$4FPHX43@A3?W1@ M=,M4`QW-P!7MW2H92?W35%*9="JNJF0T2"5%-'E$)W2.B>") MG)Y877O0;!$N1+"_.A!$F`?;H\N#;-@V7)X)/$)1K7FF\(C26)XY/'-7MA#S MX!#OF"?$/#@NNSR8!Z==EP?SX!3H\J`*.&XY/!&J@*.1P\,P#UYR71[,@_=Q MEP?SX,W7X0DQ#]Y271[4!V^)+@_J@Y<\AX#=5U%A>U%:4-NHEQKW=)#MGO277(S[5WRO:0@;$X.5?M MS6#[HRDOT#O<[I4-;O3$?X^XPF0D```$K```9````>&PO=V]R:W-H965T,99L* M(!?":5L],*ZR]E3S$]D_=_[GT]-RDVS]_'`^M[]FYV.>GN[;5Z;5; MV6F7/^Y/SW?MO[XN_IBT6\5E>WK<'O)3=M?^F17M/^__^Y_;]_S\K7C)LDL+ M%$[%7?OE"E2B9RSP_8"]2]>]J\%JAUW'Y$[;L_? MWE[_V.7'5Y!XV!_VEY^E:+MUW#G^\RD_;Q\.T.X?UF"[0^WR#R9_W._.>9$_ M73H@UZTJRMM\T[WI@M+][>,>6B"ZO77.GN[:7RPG[??:W?O;LH/^M\_>"^7W M5O&2OR_/^\=P?\J@MR%.(@(/>?Y-F/J/`H%SEWDOR@C$Y]9C]K1].US2_-W+ M]L\O%PCW$%HD&N8\_G2S8@<]"C*=_E`H[?(#5`#^;QWW8FA`CVQ_E#_?]X^7 ME[NV/>H,QSW;`O/60U9<%GLAV6[MWHI+?OQ_961)J4JD+T7@)XK8'W:&8LH: MP$_I_/D*P&@N->"GU.AW!OWA>%*VXDK-;Z0C_)2.P\YD.!R,)F.HSQ5'"QI8 M=1S\@HW^=,=9(U2!7Z3*X(,5&*,K_%*[6H/>2`2.U[Q;!;X<1^[VLKV_/>?O M+4A."&WQNA6I;CD6="".H$JB'E._&E(PEH3*%R%SUX:ZP&@I(`^^WUN3X6WW M.XS=G;29-MCH%C.T$`-5R+HFF)M@88*E"3P3^"98F2`P06B"M0DV)HA,$)L@ M,4&J@"Z$IXX1)-;OB)&0$3'"WITBH*#UC8"@!;JX)IB;8&&"I0D\$_@F6)D@ M,$%H@K4)-B:(3!";(#%!J@`M()#TOR,@0@9F7"UI1GH$II6--5",C+R:U29U ME!B9,[)@9,F(QXC/R(J1@)&0D34C&T8B1F)&$D92E6A!@R[\'4$3,C!9PBRK M3'5C(VK2Z%K4:I,Z:HS,&5DPLF3$8\1G9,5(P$C(R)J1#2,1(S$C"2.I2K2H M03]K46O>V>`R)*S+X&"G3B6!!9;"-;3T<,UJ(W1S&9DSLF!DR8C'B,_(BI&` MD9"1-2,;1B)&8D821E*5:+&`3OQ$+(2U'HN*V':]`LT8<1F9,[)@9,F(QXC/ MR(J1@)&0D34C&T8B1F)&$D92E6@=#_NJ3W2\L-8[7I()=3PC;D64X,P964BO M:OLO-FA+26YJ94]ZT3;#9V3%=`*F$THOF!B4Q#7V)^O:"!-WPZ0C)AU++ZIB MPDBJZFBQ$$=G=<-\?4(2UGHL)*$>FS'B5L2F"LX964@O)19,QY->5_O0KXVP M#U=,.F#28>VEAL?6Y]5U;832&R8=,>E8>E'K$T9254<+#QSE/A$>8:V'1Q(E M/(RX%5'#P\A">BGA83J>]-+#8_2A7QMA'ZZ8=,"DP]I+#<_`"$]MA-(;)ATQ MZ;CV4J6-/6E2&Z%TJDIK$;/@UN,3(2O-]9@A4H+&D2N1K7>WL=^>DQ76?(%: M2BP148D>.:K]8FP,?;)"^15JD7R`B.1#43LD+Y%+5*>3VNXCBKSI35U4)'7*U<7O:[;],<9G8P:IA!;;A"D!<+U:$8 M]MM8Y-22B*H_X\B5R!:EU7<2HY[>HCE9H?P"M:C#EHBH1(\<57EC8^F3%2CCU9665RO,S(,5FA`A06(J+!0H@%9K3G:H"-918A( M*^:."4EJ+`[8:YX;T5>,IS^-J_E;(AA5!R4QC!9F)*U98F_N#.O%= MCN:(M"RWC7EK@5:C6FN)B.0]CGQ$5/L5(M(*$)%6*-&`T)JC#3J25H2('&/N MF'"4HF.II4<,5KS/1$R8&PMLA09Z!AI+YTQ<4HF(T6!S.9HC@DF0]CGQ$-/^M$)%6@(BT0HD&_7J,K#G:H"-I18A(*^:."4"ND3LS'2?&DU^/6.AA46 M\,)"*@S;MM:5K8XQ66U0A5H1(5(3N2H>>DCI6G-?EE!9JI41@!3E&])=W#^P M43*DLPT.DW_8',EK#'5H5$C)Y)EX+6NNJPS-T8J&Q@(19S\*>\MU!!52,_> ML7&,F%FU%8YP5R(M>RLK^UKV2B$:]TNN[9&V.J)9]E9:5[*7%1;PPD(J#-NV MED@J-V0O$XZX<$S"5UJ14%FJ%M41M0RQ.DE='QL>RMY31MUT2J=G+D=/X,.L+^7>PO"8P@=;9?U,WH@7W:'*31PX&4G M=Y@.'7CQUL!'#KP7XAQ.F-#HIJ+AO`B-;GH"9QSP:2H=3BS@T_0$=MG@TU0S MV#.#3],3N'MSQ,T:KS5%'FX(8:V-SV!RUUH1],3 MN)>%=C0]<<<.O*#C]?7&#KQPXSP<._"VC/-X["1-W)TX\-*)VWL3!]X8<1Y. M''C=PWD\<9*2=^L.AP\07[?/V7I[?MZ?BM8A>X+$[I5[IW/U"6/UQT5>&#[D M%_CTL+P[?(%/33-X[]@3^_&G/+_@'U!PM_YX]?YO````__\#`%!+`P04``8` M"````"$`HUOI6I`"``"+!@``&````'AL+W=O8TB6)*H!6ZD&V5TU\_K\\^46(=;PO> MZ!9R^@B67FP^?E@?M+FS-8`CR-#:G-;.=1EC5M2@N(UT!RU^*;51W.'25,QV M!GC1!ZF&I7&\8(K+E@:&S)S"H>A-X;"3*.DG`PO"'_KW01:NSFF*D[$#ZZZEIZ)$[*W3ZD_XF`P4 M(3@=@O$]!)\OHODR/D]0ZQT2%A+I?5UQQS=KHP\$9P4E;*R8&S&7`X/,9,R(8BH[*J':ZL@=[95]2G\IE MV)C*I&_+G/^/C`?G%)]C\JOY2!N$`V0V@3PCCOPAY'1_'HPMP#Z.RMC5%](! M=((TTDRE_93.XE6T>*^_/J[/8BSSL(/5GN2U&/,Z,HST4]5_CY(''TL-.VE_ M`*>#@O,VY3W9C8\[EAAVCMTL7[@)AS\<$@6F@L_0-)8(O?<'.\6Q'W?'.V?; M9_UR?Y9M^XEEXP>\"SI>P2TWE6PM::!$RCA:8IE-N$W"PND.,\=#K1W>!OW/ M&B]]P,F/(P276KNGA;^OQK^1S5\```#__P,`4$L#!!0`!@`(````(0`@B:_. M*0H``&PN```9````>&PO=V]R:W-H965T-SN3_U:P3Q_1*-X?M[O\G6Q M^W;,3Y=:Y)P?MA>H?_FZ?RM1[;C[B-QQ>_[Z[>V/77%\`XG'_6%_^5F)]GO' MG>F]G(KS]O$`[?XQGFYWJ%W]P>2/^]VY*(OGRP#DAG5%>9L7P\40E![NGO;0 M`M'MO7/^?-__,C:SR:0_?+BK.N@_^_R]5'[OE:_%NW/>/X7[4PZ]#7$2$7@L MBJ_"U'L2")R'S-NN(I"<>T_Y\_;;X9(5[VZ^?WF]0+AGT"+1,//IYSHO=]"C M(#.8S(32KCA`!>#_WG$OA@;TR/9']?-]_W1YO>\;QN!V-IO.;V]`YC$O+_9> M:/9[NV_EI3C^M[8:2ZU:92)5X&>C\F%G**:J`OR4SO/![&9DC*'"'ZT`#.=* M`WY*CA+C!:2DB$[P_CZ>W=\#L,WIVT67;8M"U6:"%&JI!= MZ\#2@:T#1P>N#CP=^#H(=!#J8*.#2`>Q#A(=I#K(%#"$\#0Q@L3Z'3$2,B)& MV+M+!!2TB180M$"7M0XL'=@Z<'3@ZL#3@:^#0`>A#C8ZB'00ZR#10:J#3`&M M@$#2_XZ`"!F8BUI@T46/$8L1F MQ&'$9<1CQ&O>V>`J)*RKX&"G+B5I M+4RS43M(S$C`2,K)A)&(D M9B1A)&4D4TDK%N+HK.Z7KT](PKH=BYH8!B4!(VM&+$9L1AQ&7$8\1GQ&`D9" M1C:,1(S$C"2,I(QD*FEU/)S1/M'QPKK=\9+<4L"49FWHX&(.FW%T5HB@VII<62CHQ(21"3OHN/5SO3("GO31RV2#Q"1 M?$B.:JR,]B2[(2N4CU"+Y&-$))^@(_5$RE&&CI56.V+B;/GQ>6M<'T5AFXOU M7"*B2JTX6DO4BEBMI2`;':G-#B*2=U&K'3&M2SVRPJKZJ$7R`2*2#\E1C=A4 MCYBL_;3IB0BU2#Y&1/))M[QV>$O)"FN?H59'$,5Y]!-!K(^OK2!*1/5[AF+K+#J-FI1SSB(J$27'-6.OVG+>V2%\CYJD7R`B.1#9<<57EM^^F1%0T5;5&DU@>58BJ4UI*W&;!(Y@A95= M<\5)6DWKCO15XRD/WFK^ULB`C9@2 M3VT-68G+*!%/6J+6'%F(P)BT#&W>LM&*#ND.(I)W.?(04>U]1*05("*M4*(I MH0U'$3J25HR('!/NF'*4H6.EU8Z8.()_(F+RQ$YM7HI7.A"+:3L#M:5S):U: M&5@[*LA"*YCXKT5,.M)8=M"1QK++D8>(YC\?$6D%B$@KE&A:O=BLUIX-1Q$Z MDE:,B+02[IARE*%C1XZ)@_HG(B;/]6K$:J3EF+8;68UKJU:.,62AU?_),>E( M8]E!1QK++D<>(JJ]CXBT`D2D%4K4RK&Z$@J*T)&T8D2DE7"ME*,,'3MR3)SP MU8C]L\U.?4\`J8QKV%*\O>2IIRTC*VFEY-D:$9VM+(F,5AKSR;(N<4)#W$$M M&N(N1QXB-?685H!6I!5*U$H]V6S*Q@@=J5XQ(M)*N%;*48:.':DGK@=8(.'M M/4Q78M.*NYA/[&#EA8,:U!I!WBESX%Q;M5:PFV4K8(T,ZF)+6AG7=C12B%+` MX=HN"K4G9FVD>=)J^NL=#2LLX(6%5!B.]$U;>3S0)JL(5:@5,2(UD9L>4KI6 MWY>E5)9JI04@0WF>[I!H':-D1F<;'";7-T>53'NS*Y&2R2N.UAQ9B&AHV(@H M8QQ$E#$N1QXBTO(1D5:`B+1"CC:(2"M"1%HQ(M)*.$H1D5:&B&?R1-QQL$Q6 M8O2A\V>EHH5("%<[4V7PW&C'B)5T5-=6B=3L170E>U&(QKV#B,:]BT+7LU=: M_3I[49D*"Q!182$5UF1O6YEG+ZJ0<(R(A!,25KJ692^5I5KIV8OR'=FKWSCI MB_4'LY??1,%G<=70H&&\XFC-D86(1K:-B++$043R+D<>(M+R$9%6@(BT0HXV MB$@K0D1:,2+22CA*$9&6^(RPZB\E>^O/`NNON8[Y^25?Y8=#V=L5W\0G?W`$ M>;AK@W^DP-;,J0?0"9B:\T^9"R[D)KUPYAQ,I M-+K+`\Z7T.BN)W`F`I\N-3CA@$_7$]B5@T]7.&"/#3Y=3^"NSA0W<;S6<,UF MBDLT_@1NR*"Q3PZ>I-N!4!GZXGL*,=SD0]VZGL`E M/)33]03NSZ&P*4PE-/U!.YSH9RN)^N%":__>'^Z M"Q->YW$>+DQX%\=YLC#3+@YOMZ`=U42@C5AX5P7MZ'H"KYF@'5U/X`T1M*-Z M,FSDX%O?M^U+OMF>7_:GLG?(GV%B&%5[KW/]M7#]QT5>.#X6%_C(M[I[?(6O MNG-XNSD2^_GGHKC@']#`8?.=^,/_````__\#`%!+`P04``8`"````"$`AH\: MHTP$``#W$```&0```'AL+W=O^Q(N9)6AQW_C]_OWY;^9Z049%$&2_8SO]B MPO^^__FG[967[^+$F/0@0B%V_DG*\R8(1'QB>20F_,P*>'+@91Y)^%@>`W$N M690HISP+:!@N@CQ*"U]'V)0N,?CAD,;LA<>7G!52!RE9%DFH7YS2LZBCY;%+ MN#PJWR_G;S'/SQ#B+;WX<"UY&;QGP_B2S**YCJP^#\'D:EUSP M@YQ`N$`7.N2\#M8!1-IODQ088-N]DAUV_A/9/-.U'^RWJD'_INPJ.N\]<>+7 M7\LT^3TM&'0;YH03>./\':$_$C2!=KYT\5DO@RG M!.#>&Q/R-<60OA=?A.3Y?QI$5%$ZEBKM)9+1?EORJP?S!K0X1[@]9`.!ZYIT MA*;*L2*A.@SRA%%V_M+W(+^`SG[LR7*]#3Z@&W&%>=88>&TQ#2*`:IJ2H(QN M2?;VU)D1C)FQ75C*LS9TTU![FJF9!IE/8::WTZ$3X+HD5F$37U>@,;,.9MX@ M#*(`<2>*8!@23+KIWWK5Q-69-<8A,T3I9D;N-)Q-EJ/;6+<;'5453;\K"[2] MK:L=O<%W86:]W6D$FYDJ"U7[W%T8V+L^&T)7>(CN3!,=S1R5I',PO4$Z-].@7YFBLIBLB'-TAAL".R^.QV%-I/5 MIB$A@D>_TRDE,FNHZC8?Y=;+48F(R6CD@!-`==/>R8;H7K;*9&%D$0^WE2-: M'>`<-R>H-IFDIB-C>D@TB$4U2-C*D9:-"N6@&R@_W98Z[Z9R['77HAPD7(S0 M?D@[R%`\:I-EEA;Y6,PF=\6##-6C-IF37(Y0>D@_2",@K7_YEPP!@&FXPM:C1UDJ?3(XD9E]A2G* M2T?8[W!"M,K6'65[X*M1:I3+*"UB1.93AQ7&7P8]K:]-)N^1HTL?4B.%'O#N M']T*Y<+;(EANXQXJ%JU,!FTZ=G(?4BQJ4RPZ.+G.B@57,V/9U*\()\52GKTU MM_TTHOWO7'V5T_>EG)5']@O+,N'%_(+7M!5<=!IK=86DB\T3]!2^VP=/5O!$ MW2[[3P@\L'G,-D_PT\`2BN`3:Q("24",+3XTA"S6:!2BP?:#3]!4!M?.N!';,!:Q@C&RG:?_]KG%*25M-Z0N"R_$Y]]P/KZX>54,>P%BIVYPF M44P)M$(7LJUR^OO7[<4E)=;QMN"-;B&G3V#IU?KSI]5!FYVM`1Q!AM;FM':N MRQBSH@;%;:0[:/%/J8WB#C]-Q6QG@!?](=6P21POF.*RI8$A,^=PZ+*4`FZT MV"MH72`QT'"'^=M:=O:938ESZ!0WNWUW(;3JD&(K&^F>>E)*E,CNJE8;OFW0 M]V,RX^*9N_]X0Z^D,-KJTD5(QT*B;STOV9(ATWI52'3@RTX,E#G=)-EU2MEZ MU=?GCX2#';T36^O#5R.+[[(%+#:VR3=@J_7.0^\*'\+#[,WIV[X!/PPIH.3[ MQOW4AV\@J]IAM^=HR/O*BJ<;L`(+BC319.Z9A&XP`7P2)?UD8$'X8TXG*"P+ M5^=TNHCF:3Q-$$ZV8-VM])24B+UU6OT-H*1/*G#UJ=UPQ]P3M+YBCV@:7'$7`<,/E\P`X*AZ*",:N[!7]E7QJ5R'P%AF\K[,]",R'HQE'26_?.TO0&8CR`OBQ!]"SO?GP=@"[.-+ MV=+%X"AX#J`SI)'F?&D/[J6'VAXCXS(D:3HD<^)R\1$I#SZ5.D8F_8R.IP.' M;&S![\HL7D:(__^(^G.G$L<(#LRHM)>OW(2E#9NAP%3P!9K&$J'W?B$G..M# M=+@K-GW6K^.S;-./*1M^X`YWO()[;BK96M)`B91QE&*93;@%PH?3'6:.FZP= M;F__6N-E#3CN<83@4FOW_.'OF>'Z7_\#``#__P,`4$L#!!0`!@`(````(0`0 M?5R>H0@``$PF```8````>&PO=V]R:W-H965T&ULK)K;;N)( M$(;O5]IW0-P/8',**&04\%F[TFHUNWOM@`G6`$:V,YEY^ZT^E/M0'4)& M?*ZN=OU=W:YN?/_Y^^G8^U;435F=5WUO,.KWBO.VVI7GYU7_GR_1I[M^KVGS M\RX_5N=BU?]1-/W/#[__=O]:U5^;0U&T/?!P;E;]0]M>EL-ALST4I[P95)?B M#'?V57W*6_BS?AXVE[K(=[S1Z3CT1Z/9\)27Y[[PL*QO\5'M]^6V"*KMRZDX MM\))71SS%IZ_.927!KV=MK>X.^7UUY?+IVUUNH"+I_)8MC^XTW[OM%VFS^>J MSI^.$/=W;Y)OT3?_@[@_E=NZ:JI].P!W0_&@-.;%<#$$3P_WNQ(B8++WZF*_ MZC]ZR\R_ZP\?[KE`_Y;%:Z/]O]<X+G=_E.<"U(9Q8B/P5%5?F6FZ8P@: M#TGKB(_`7W5O5^SSEV/[=_6:%.7SH87AGD)$++#E[D=0-%M0%-P,_"GSM*V. M\`#P;^]4LM0`1?+O_/I:[MK#J@]/VWLJFC8JF:M^;_O2M-7I/W'3DRY$8U\V MAJML/)X-IO/1V(.^;G4RED[@BD\P'\R]T6(\!R=7>I_(AG"5#:>J\ROMP"L/ M&:[8(?.!?S?U MIC,V(%="]$`!D0VTF;ML#$M-FC!$I^Y M#6P0VB"R06R#Q`:I#3(-#$&63AN8*+]"&^:&:8-1K1$HL7Q+"+3`)H$-0AM$ M-HAMD-@@M4&F`4,(F.R_0@CF9M6'?[LD64S-P-?"Q(-%HK.Q3#:=22<.(2$A M$2$Q(0DA*2&93@R-X)%_A4;,#!'@-/2$A(1$A,2$)(2DBF$T,65M_K M;^'KX\^LS=@ET<:?D("0D)"(D)B0A)"4D$PG1J!0ZQB!_O3X,T>F!I*8XV^_ M6#NC;OP)"0F)"(D)20A)"5`66'#@**0 MHHBBF**$HI2BS$"F1*P@TR5Z)RU$_6;(()&>%@0%'D$A11%%,44)12E%F8', MF%F%]8&894&F#[U$YM!/[*'OK-30$Q1Z!$44Q10E%*44908R96`EU`=DD!67 M+H-`XW$W*3:LKH954T,!12%%$44Q10E%*469@4ME>"M MT\DDRS35Y=H3R(?7M)8Q\P,K7B/9C*RZDY7V9%TNIRR&-3E%,A74VOC M$110%")2OB)$>IX17PE:J1Y31,I7AHC[,F-FI9L>,\\LCT_`=\*719_J9NT) M9&;3Q!KR#5JI\0T0\4-F/J=#1")U_(DC=61O>NI(I%PGZ$>Y3A&]DR>Z>T,S M%I^AV76AN+FY.DFDYPE%`44A(B5ZA$C+$T0J*1**4D3*5X:(YHG/*M&?RA/> MT@J?.8/]L3&=)_:65C:$"ZZ]`2(UF"$BN<3`[SY6OD5HH>4)(N4Z0:12*+534>:^X!A%(#N:$HH"A$I'Q%B/0\$3UJ[A.T4CVF MB)2O#)$C3UA=JQ)9R6+57!ME MA1(&B%3I%B*ZXT6+!S\BDA5%/``,+?J)L9%*C021M-UAA:.=&$5I2V= M-U6E\FU%H"\*4R.-!&*CUM5-<[(:2R,US(%T!>U0AA#1`K5SB"<=Z8E&?"?H M2/E.$4G?<^(Z0PM'WKD*:%V\VQ*/%M"^JPZ>6-N(#5JIM21`I+(CE&ALOA:M M[5N$#6%YZD;+FUB[L!BM5(\)(M5CZNQQ;%?,V-"1DZP@)3D)/[[#L['=&Z;D M[5LY]K._/;>[JEEMJQ?V206$_'#?8?&] MQ]KSE^PL"K0@=\9PAP\EN3.!.WS"V7=F2_CEP^%KOH2C?P>_6\))N8,OEG!4 M[.#>"'KF2Z?=LPQ'5I^S@!_TY)0'.GY/"DKN#6$,+:&0(<""TWSCL!W&&G/E0J.`"! M.RY!X$AHR8XZ:!LX&5K&XLZP&RWXEN>2/Q=_YO5S>6YZQV(/B3GB[Z9:?`TD M_FCE0<53U<+7//S,X@!?;17P3<2(K1K[JFKQ#^AZV'T']O`_````__\#`%!+ M`P04``8`"````"$`U@K-GH,"``!-!@``&0```'AL+W=OF)ISBX"A-1FNK>U20@RKN:0F4AUOX4NI MM*06EKHBIM.<%GZ3;$@R&MT2246+`T.JK^%092D8?U1L*WEK`XGF#;60OZE% M9XYLDEU#)ZG>;+L;IF0'%&O1"/OB23&2+'VJ6J7IN@'?S_&$LB.W7US02\&T M,JJT$="1D.BEYSF9$V#*%X4`!Z[L2/,RP\LX?9AADB]\?7X+OC>#=V1JM?^L M1?%5M!R*#6UR#5@KM7'0I\*%8#.YV+WR#?BN4<%+NFWL#[7_PD556^CV%`PY M7VGQ\L@-@X("391,'1-3#20`3R2%FPPH"'W.<`+"HK!UAL>WT70V&L<`1VMN M[$HX2HS8UE@E_P10[),*7#ZU1VIIOM!JCZ#=@#8==<,3IT#\=BZ0A,,N'3C# M,XQ`QD#]=GD\BQ=D!Z;9`?,0,/`\87H$`=%>&=2N5W9@I^RJXE)Y"(&A3/*V MS/A_9!P8RCI(?C[M:8-P@$P&D!/BS!]`KO?GP-`"Z..I;+.3HR`=0%=(`\U0 MV@_:_-WNNET^A[[(APCL'&0U[@MR9O?V7//?@^3`YU*'2.*'=3@F,&T77I([ M=T+>&5:W\5SC$#FW,WEE)QS?<$8DUQ7_Q)O&(*:V[F@F,/5]M+\UEC[MU_%) MNO0#2_H/<)H[6O%O5%>B-:CA)5".HAEXT>$^"`NK.L@F23[!HVYM38HL)PE8V2IMMS5Y M7BW2&4DP"*M$TUJHR0&0S/GU524=DZV'1]\Z\$$#)I%DD4E7DUT(CE&*<@=& M8!8;-H:;UAL1XM%OJ1/R76R!EGD^I0:"4"((>@2F;B22`:GDB'0?OND!2E)H MP(`-2(NLH-_=`-[@GQ?ZY*)I=#BX.-.@>\E6\A2.[3WJL=AU7=9->HWH7]#7 MY<-3/VJJ[7%7$@@_[J<1&)9QE1L-ZO;`]V^^21!W%?V=54KV=DQZ$`%4$M]C M)[MS\C*YNU\M""_SXB;-)VDY794%*W-6SM85/;>&^WP$FD'@W\0S@/?>/_^< M?P$``/__`P!02P,$%``&``@````A`']!A8!W`@``T`8``!``"`%D;V-0&UL(*($`2B@``$````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````G)513]LP$,??)^T[5'F'M!V:)N0&A<1`M#:I$L/$DV42EUJD=F2;"OCT MNS04DLWK-MYLW]]WO[M+SNCL:5./MEP;H>3,FQR/O1&7I:J$O)]YU^3BZ)LW M,I;)BM5*\IGWS(UW%GS^A)9:-5Q;P^;\HUWS!S#&8)EI72 M&V9AJ^]]M5J)DL>J?-QP:?WI>/S5YT^6RXI71\V;0Z_S>+JU'W5:J;+E,S?D MN0'@`(5-4XN26<@R6(A2*Z-6=H2?2EXCOV]$0%?P\E$+^QR,D=_?HJ)D-8_` M<;!BM>'(?S]`5YRU15LRH4V`MO9TRTNK],B(%RC;U!O=,<-;G)FW95HP:0&K ME76;W;INC-7!#Z4?S)IS:Y`/@NYPM^QK^VMQ$DPG.P6LALK60T<"AB$C$;;F M)ELMF;8NY$F?>4?1$7=`^RY2^#8HEA;J11/9=5NH/OE;#I&"1DO#*PHKHVI1 M,0N;FD(;G.,4B2+"UHF,;T/"R2PGGE,DO22QIE:83SU*E(,X(+N@QOP_,Y=BH*DD7? MK[)YC/."QO@BB1+B%.9X'A(<@[.(B*-=.\@CFQ MM[\?H"L8A+ING41K)N]YM=?\;FAG]TWW0`63D^/QES&,Y=X9\M^?HN`G```` M__\#`%!+`0(M`!0`!@`(````(0"GC=:&K@$``#P/```3```````````````` M``````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U M````3`(```L`````````````````YP,``%]R96QS+RYR96QS4$L!`BT`%``& M``@````A`#B30&6&`0``V0T``!H`````````````````#0<``'AL+U]R96QS M+W=O,$>M`@``>`<` M``\`````````````````TPD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$Q?Y]K_`@`` MGPD``!D`````````````````E1<``'AL+W=O>"%T#``"N"@``&0````````````````#+ M&@``>&PO=V]R:W-H965T<1BG`(``'T&```9`````````````````%\>``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,````````` M````````,B$``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$` M:(AM8_0*```Y7```#0````````````````#W)P``>&PO&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%"0?3FW M`P``F0T``!@`````````````````W5L``'AL+W=O&UL4$L!`BT`%``&``@````A M`+3VY:@7!P``B!P``!D`````````````````/6(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`-S$[UI1!```X0\``!@`````````````````QVP``'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`-8*S9Z#`@``308``!D` M````````````````$Y\``'AL+W=O``0( (``#CIP`````` ` end ZIP 11 0001477932-14-001262-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-14-001262-xbrl.zip M4$L#!!0````(`%R*>D0-'54_S#X``%BR`@`1`!P`=&5E92TR,#$T,#(R."YX M;6Q55`D``S]$,U,_1#-3=7@+``$$)0X```0Y`0``[#UKMK=H/7RZV)8BVY)`<4I0E996J M]5(P9>M1K/SC]9QHPW_M':^M)H'SM`'N"_##@>FH,[(]]NY-9TV]Y4NK_5 M:C2:6__Z]/'*&X@AK\O01#STQ$8R*Y#AM[)YS?W]_2UZF@R=&HG($QSM+7Q\ MS4T&&0F<,WZ*$GCJ1^F$_.#M+?NP,%26#MVQ0V4RU!<3XXSP-OOJ9@L>P/AF MN]YHUMO-9+@6O9DD[VS!TV2@-*K3:N[.6Y\=D4R(3;W/^2B=T./FF@:[!R7$ MP!.M`F%*Y]"3DDFA"L-X6$Z7'^FM:#P26S"H#J.$EEXZ;_&DX@2@`;\NIXZ> ME%#WY>3D))V`AP8.W!#'=1JMUMY&REZ#$2PX,!;0Y.JB<3-N^, MO^$>(\JW&T8.1P'(U%8"RIX33X61N(N8]-]N=,UYSU*VAY2Y@>E0$48R&J?? MIM]+'Y_TI-",*!,%=B5B=73VT\8[/*;MYGZCN?-F:W)RAFZK%)_#-@)6*[^$ M"CHUT;ML`2D*]V02?@%2\J7CQT(FM9X[DUH/R:13K89V(_9!S".%8EEOM.J9 M)#\3A@%3=(1&ZUVVG`12]FQJ&IC49));=X;>+TQ9BS`^3][FA'&"20]R8MO/ MG4GM[\`DV(AVO;7]?)GD%O#`:@VUYU](K=%RGI!:3)VRJG[Z_LX;F0YD5<'EMD@2LW9#$H;3;__7J>&I3 MAX*;6(MWKN)_`&,28,FC(@J$-@/^U8!K86:BYGK/]C.\ZT,"W!@TD:RZ#FD!Z+4`UEN`CM8KY,XBT#G#PO<*&,H=C&]DF?O!]G0R[X&+_JWG+MGX]PH#F/(SRQV#0&\H'* MJ60920-'M@PGU+F5G'T^W7C7IKZI;#EKI^Y1EC^]BW^5Y7^`@9$Y"R](/7_0 MRI@"`^:T74PSX\[(@U`&;S4`=]8SDKB+5!<^;`%XOQGF]M*Q?BB%$LNAY`Y,T]Z*8 M!U^$'K:KRMV[B^9O>Y^:K6/GR#\"J:5R=0\29N_0+!*:*W#K$:E]0`,``1+X ME$9Z]!K'$L%8)8=F/6PJTMA<(Y&7(N`1HM?1^`M09H#I@!ST)!`L#`I&[FOS MJXP&^2EE4E36+#Q+T7=8WW:0V;WW;G0=8'VFN[E#%870,4X?)K,YFYKN^%48BG@U5!7R6141ITP\:,*^Z@7/JM(&#@Z>$;N MN>YYH%=%7VGMS=;2^&?(D#F6Q@L49M2^`"7O`XB,*ZOY'X/H<,1,-`[$VXTA MUWT9'K#&*#ID.+W.`]F'+_Z(321[XXT?^]$ASM@:T:>_-]ONGSR4'J`^8$T` MPK[(H3#LL[AEEVK(PYK]HL:NP`7K';(4WWQL"'!9X#3Y/"3J/G'M#7[DP]'A MWYL[C<-FC;4@R*NQ:"`8ZF@>CIFX$UX,S&6<#0'%H!ZI.GU@O*\%Z6T6*6;B MZWH@0',SU>NARV9&'/X%D\(HQ9E\+?Z,Y8@FX2-.9%PK]>V;$".A'2V=G4/# M(B":]91F/^PW&@EVUH,M8Y>;['B3?>#Z5BF_QLY";Y.]2N;N'KH'R1=[AZ\W MV9=L27DD%^`M4BUBZXNVN5>]=24\+2*NQT2<-)8=`REZ[%2&//0D#]@Y+4?# MLA(Z-ME)KR=`\&X$^[\X%(S8V6S7F`]F%%B$8'HI`$,O2^+\'+=KL+3)E5D6 MB3X/V4BK&XDVFN9P8`[Q'T0=]L<(?0,D&<8C%BKF`=?[*5X'?R8?A%6WQ&\8 M#Y]HUWS6XY[+GQ(=N&G)=B$=*=);;M@/K=HN;A6,^6&[!EH^`0?_`U&QPB#O M[$X"SM`'!*?B6L?`;-;:L_S:I'.$XOS,#E5VD)[K"FPVD2A<L*< M]%:55*+"$K2T"!4U&+>)?V9X@(-0)F64)TR&]CR1I<43^<-N;;O12`7^A^9V MC?0BS!C9$Q[`4;T=2&_`0#_(T`MB)`0`]>D%\,!J-W\(SKN),,`&I>#.F$GQ M>9ZE$)<(9LFH0/IHQT@WV/"=:`"*U$BX,'W6\5CH4959PTE#>I12`1,NX),W M_EZ64>-:KB8[EFY#C%^B*E=!#Q#%H8^OU0^=:<&] M1(FY':@@&#-U2^HVO@;QD5R#:F3'%R>LZX%I,]2D!**G1V"20-2&C@SX\DJ, M(ENV;I&A;;\FR!=:_0%"Q4YCT+H?/QXETQA,.1:>G='>0`J M4U4HYYE_-*&EP3^J,4[R7Z+6$7[D5K]PP;DC5E!:JS@"'1J6JO,E"4#\!DMA MP%-?:).9)`@WL#0=I315,6[WX(+'#;BM@;HU2V!,UPXVIX<;R7@0$/8AQS.& M%L9'Z;9HR!35$L.BP#5#`0'D(,W<)E=@#>B%:W`?$1'"#T&[&)/81`Z^GM1@ MI<'["R/:-X0`?\9!1+2GCH&TYYS99A2SR8Z$QG8:>("ZR\Y%##VEHA`"-^:G MML<`1)!A]"WA&(!J'(4./\STVH9[X%V-9013AS% MVL3<1B1(J(X#8?6B%OTX<,+H?&[P\\&]0->61IS<@2,2]LEO&$J#747D+A/> MQ)>X!F4J;@3&!."\()3\RI##W(?EP1XA"4/^S=J8/%\<@X%:X`P#3!`VH4]O M??-T681VCC8IL)K6U(W[(!"L[>(.#7&8CG:W(/)L9 M_ETW#&.8>"E&2D=HLTZ!+%"K]9\`;`!3;R6$;=7XC=,_JQMG\K9K1`/%!,@; M,\O.E](/;%)Q`%P#*0`&,VOV_HA#,I8956/!=5V@Y;29[*70Z/YB20"`0 M+BIV3UXYU8#D$`E6,4SLZ4ML].@>0*(/UVC?2&^@,D@4L@1E*$-?>C9PX8?+!$\*WCV-\`NP`=P%LD)G@HC/LW);@4,*^"8/K2SQ(2[APQ5YTB M&FYE$-C(BSL9P+B?TH+.VYF]0!7"J;]%%L_$[AA%'$8B]WEY;K<;F+$B,.T=^SD!1!T2 MM<26I?FLQ,7"QG,=.R?'V25TAR1(;Z8HDC,<8*-CI@ZOA<>\$=@=CI&>??7>KL8 M(#SC!JZF&:AH/QPOG80=;`74OCSRSFLH:*5D4UI?*)J16`LQ.G MD:V@%T2*`N]B.HS?4F6[5&IQDW6I2R.-FZUI]R6L6"=AF#(Y#BT^!D6YGI3Z M4XC:J0WBO)>Z:V?9FNR9>>Z'(?&^/:XUY=YRTN*YY$.V';DMK3D]20<(,S$H M"O0AITMKC$Z9]-,X&FB M%IU(062JHSHXV$/@6X2>WM@]*NK?Q9)1:>\G!0;XW$UUP856(7ST1&["7\R% M_X(!NMTZ\M@]TA1Y;9AG@?6KP6*-::].NU?OV:M,AC!/>P)*L(]_4`^^85^X M^8:AO"=>6P^V>W9TT>2P6[SD'73?@RJ M"02#E,_PH9TN3H<2>IP%-BLK=4C M;AM29M>2;V"5C,)&5"K"N6JAVU4DM99M!M$`;L^-O"$;:)9@<>G^3W;(.)JD MR5)+-M.$T7L@\&]_LD=`:C])./T)04QDFV+P1+[$EH^V@E1:),K(:#`V$I1Y M6(=0(@I):R059$ID1`,/31`\ M]V//N=PF'HT"\K=3>VF;EZ0*5%]Z=M2U"@4):B0CB"%3`V6HHR*`9T`"R3>( MGJ\\4,"(?+I`A*B;,`\%:!`7`:)V!(7$/6Z4U$%S+UN[B!TL\ MNEDT@&`-K8Y+FIW&S+$)O'E2%A!3%[5M\GP@1V")L[@/:I]RGVEI:%IG%UHR2IN-U+6]5\!&!.#_HP&XU5B> MM)8#A3FMQB7%:9<':M=:K4:MW6ZX+`TJ4DDQ9)8#JF56C6P`,.@/E800.#B7 M%YV8B&["4+AF`XR:X#A[-M1-JGU*0S3.;>I:I.V,,Q M1-E:_AL5G7TAW670B/7-%O5S858L8W0QWZV(CFT[:MY(*G,CT'\+K7*#8(\@ MXM?4#F`A@K24`)L8YZ(&A0881IC`=J&FZZ$%7RL.1A4^0D(9^U@_GR$7;OZ7'A9I_&I:E[67>0/@Q MV,^+RQ-8]Q$L&!L>K!VEDD*BD6QOHLT;)Y)!BL':L`F*+G($G.4(2$N"4UYR MPB:&RC'C$2P-0U;K0Q2$->FE6(@JS2;C;DIQ*[#^@CH[*8MD/9-A18BYCI)` M4,NS\]B!W.+>PE$"-QUW&*L[`B)D:;5CI5TY/CDMWY7*&W&WKQ"SO=B MO7@[CU=SED!-[:JLZF+K7(DF1H1[)>QLS MW81,VNBE#N=NY%PL>[0PSD0/+`@<\(GJ-87T:#80+N;Q$&*[MC-E4V?(8,%N MOU+.\0/K9:)ZB>IGU]Q(\WK"X=IO_&,.BAF<*7H,=++Z-L:QK$EJ^CF6E`;L M[,A5XN@(S@K?"X.8._;80*@\[BHMKH:=9$&P!HD[G-M!5WR:MXMSR/W?8M5K=3G:98S3%YU3H9/%JO*YW/LZ#2U5O1LC(>11P] M!E94!KD0-.G\2M[*B_+\6YRAGY-A+[3RX^N6[FW+TM>K9[Q).NOUZDHPJ[P> MVMZG:VBFX,U"U'H`XDMA5B&^U2DEOC4+4?L!B"^%68GSK5+BVU.(DK=T.ZN^ M@;Q31)3"6PY3E355QN0>;*_\4G4S>Z,[#V\I1!5?GYZ+R!?RX(3NJ+P4?7HW M+8SPUSLKE]<^G'\\99?G7S\?7[&C\T_L[//1FZU94*>Q'@EL8PS.P$C<_22J M5_7R5XC.A)9'=^PRQU_&H^J+:S;J/UOX^>EE8.U=.2?VIM[*\//W?,Z$ED?7 M34*XTX#W*Z/I@30(BZ$`(`_Y*-8:OZ;*#=XIL.Q:ZLF5M?.@30O`K^#>_Q2J MV_!*<(,O+E,175=&^UGE!6`&M&FTOZ@@#O&E[E,(5'7UYK`BN@DH)>)M^6`[ M_,&ZVI_$K8SM-[P*=!&T::Q$S1&PNZ]T]2-U!4H#YK$4?!+0Y$DH@"Y9;_;K M'_;JI?-"U%.FPNA7[!;>-[>]U]EK[FT7N#$'5]D1M<)HC]8I?%=]&WYN%8_G M%*39Z%#VET.&G\O0I9"F7M+E9M`-??R_DZR'J1L=N=ZHF??V5#%4>WAW^5*8 MUD9>JP)Y[7;GLQRFHE;VB1N&JHU+8 M*Q-0R5O:V\'[BY7,[?]`*,)=&6"GTV&ZU.DLA7.O2JJ-8>3%3 M*%SSIO.`0=+=#="Y.Z'ON8OM=F-_)T='=8QK)K:2K.^W]W?70FP^5%J>@XMN M8*L(OJA9&,Q5]>XT\U.8:N7V]$UW1LV[[ZNM=P35AU= M;OVK+FZ[T>Z4[^:2R"HMK=WQW\G]?L!B5.LAKEKF[=[$3?[<">CZ>!A3A^JQNPYC1<[5 MV^V=O5;^>MW%N-9#7176U=N=-@C9SGVHN\J5KNV/RJS.J[V]SG;NXM@IR*OA MKL2)9F.GTVJO'_GB'\!=0@.LF2-/BZCE?N=Q*8WP4'Q[@B16_"&SY7360_%O M)>(F5=9BXO(_U"4MJY8=YF:Q=SH[.?-3!>WZ2,WNRJ^6P&WO[CX.J4M?Z]]I[[8>B]0E M;^C?V>YT[DEJTJR77.3_$((YB6-%(NXG-* M/Y)7XC#/$HO_;^]9F]O&D?PKJ&Q2EU3)&MN*7\G-5CE^S'HN#]5PR'Q+;HK-"DW9T=)3#1FF"9\V_&F>E798>+ M\VIG7XT%5IC]:QB$10:ID`D.BEPP=ZXU@5I19Q188S,PK:P]\A3;%$@KJI'G M@23BJFW-V*1]""^,"57GR6N\W:Z#HI;74], M70FD3XCV@CVYPY<$]$DM4!N4/JDQ%D%Z_&Q(2RT9=;?B;WUZ-;=9LS;W+KMC M]#QX-KFJ19S>U%4M%HMY3;)/3L\*`6#]5K5(A%YV54MN@R]EEI?ELD4[T4MN MA;\H[^^#=5WVTKK>;[MDRU;UX5A=2^OD-6UTOS3D:RN M$7,M]'_O@F)^;R7QP-E%/H'XJ2FK`'%5E';.\AA='\)E$D>KB=8[IQ<7BR!? M!I+-K6=U.KP_/:YZ.>!@8_[^O6FM]^GQSTA`T)!NLEWBA?WJ2')^44RZ7'KV M:N%>6:L<'1Z=5P+WO6DC@(#,S6)])G9+V"/9X*M.7($NTWM3/_A/5)K/ M7EX%LU2REL+!2EYQ5;'Y>W(Z3;494\U*I)&Z22$R8&@Z-7@@W)4U9Z]/31Q\ MN8M_?!8#[IL6ZW&,A9"P%$LW+AP+"N9+CZ4X**-1ZBJA6*3=]IS!@LW]W!L9E@D4@VG=6CMM&.ZC M.!6JN6-Y1UWNV?,E7I7+E9#70^;KBEW1,WD"42D[;)!IJ]SIXDZVL0.6F[/5 MX9*N+SV?6BWW:&+\RXLSC^-@EM=H#'7#[Q06[^?UF^TY;BQ MUFP0QEBG+1'$F?JP)N<2UA$D_C MUC`(,UT4,Y!T6;T\!3'K&CZ.-#IT]2W3V,%"Q72;D6B,)<@P$,/^BST^XH-< M[W?;:_X#U4E^_?ZT]?[TA(W])&/)M&U,;G[J\(=]/ZA;C>XTXZ?&IB^PV,CZ:.JWYF\6N)SBO1O@L,>-4ZO\1@-&PV/K=*-+9K'T)RZ2N&[T$),D4 M$,ZA*M<7[U'+4*F;=5;(FTJ']OO`P5E5[ZSE1][ZR!E68@8_L2%V/XYI.4;- M4R>5*5M^JKVW44@S:0O+`UVU>Y8:S?#U45???@!IFBF88"-#%8A'4/'"E,+& M?@Z102-,IP4-FU5HLU!6J:;-$6$#[$H$&LL(F84&&]-IRTA8529Y@>&>:B1\ M?/I!#D+P+R)@H!X-K67;&*([X!63>]'*L$.`3+E-Z-EXX8,PY:*O"]3[9JEW MASTFJ-KI&`LLRF5ZO:T6,#U]20UW!'NTLTT99I]S*41>&'DP\;1]N+TSC6&_K"]R/L+,\,'OV()PH/O[UE?[O-B`PL^2UAD>=D;8!3(X8 M]0+,T6DK=+(^@N%QUH!X[C-T-T/FG&7> M-?[[&K:Q5V<3F,^1+2/;S4^A/!DU0VLXPF6$P]-^S"5,N.]HUS#:W0'I9!!) MKQ&4J]A6FT/H`_TD`-H^&^/^&882>8X8=0(\<+CA?P#ZK$L0/,\`R' MZ"/K`JX'"N],'0!E0O6!_>/JZN;F]G:6K[3V*CYQGW*)PUPI(7(N)3-L)*`>2[6TR=[^>?]L M>)Y*IJ@Q:,4\CRW[!G6E;UW@J1D&-L([:ZOBNA&M=O#,R`:K#6R.EHZ6=7>@ MGMS<,.7Q3H[?9#Z376VGBK7.3NE+H9DJ=K@B=]OR?IL"_]EBEP-LIE]SW#Y& MQZ87)EU?;!_.BZ7@W(@572_1L$F,4%O`7H)#5TUVW#YCKI$;V23BUQ8PIS<7 M@G[4/G/YV2@TH7Y'KOC-9QHVL%C=-M&TM+B&^],W^EO`2'KFQ=C2W!VI/?J.JU\ MAV,FHRC!+NO8OOB`VA>S,2P5O@[5(_9A%]B-_!8;PG\1/73Z6NSSYRO62P2[ M'"OILZ,3V]TX8.*G-^3!0%"S=(]'0X(`!O2$Z%&+^->="]Q8:K,?0Z&'EQ'# MKN<>T*?78EW!501#Q4*)*,;-QD[[\`WU*E<"2`K?LC%_Q*;C.!Q`$'ARS'UZ M(O_:B,>)`@Z8U\9<,Y+EIAJ2;Y%8-&,%A@&_A@]BA!SXOFH&_,(?V2+N8Y;S M"`[DON/WCOOVB_NNA:>Y[_BT:O;[/0F$'79I]7?L&'!/&/`:"!`,"$+DN'BH MA"`Z`:LQ8K6(B:`'W#=UGM;*:"E^C@7P!S'/V=D9#?#ZJ'5T=-P"EHC&PHOE M@_`?6VS"(_C&"P>!_`\,&@;Y7'T"`QF.^`==IS;3`+(5@>O,`>[BG+V%_TZ& MTANRUR>GR-DH!TKX/(9QQES%4D3O")*%L+(2G))T&EJ\'="L*T+`$#WX,.D+A`[@:>9]3A3\&L3KHK+^9OI39=[E+_`Q$G5'53I,V1 M`?M"S;&0YMXL7-#26SD+F;?&P` M.U7<9W.,\P*,4]GUN"9I^+FYYR_/8/LPX[X?^FX;_X[B-3CFKUO2X8IN)RL? M?F8`5>MVYHY"&\AL.R5J^HRYQF+F^.!%5E_G:M7.(VSBC'42U>TKKGV8<=\I MOH,>X51"TJ9D3>=]U5C2'!\XI]`YA0VGSWPE7X,7!=U,>7PK44Y[?\_[ M(XRYWT`'8:?<([QS_7PNWRE4[#DCG-6<#QKO(W\64?2!725*8:4+4\Q"BJ@* MMZ%>5R2<)U&$]NW%R08JCU?$EN\<_]4(M%K>[-E=)W;>"BLI27PYPFHL5%:) M]V.A6!@(]BBX6E/B.HV0M_VLC;V6&[51;JRR#KMC/\=^+Z+L9U5$G5G8M%S] M]%,2R0`<[FL1>4J.8QD&ET'O$X]D]*U_KT0$/CC';]8L4+12/]JH:5RYI?>ZU<Q^^"OM,LTYY MN!Q#I:_EQY[-8>QM-@+^F'NCQ>Y5^&_AQ?HM>+C%.#C,H>\_LG`2`)Q1THUD M3V(].5-LSE8:?3L3L.])MS`!KNJZS2YQ85^$^$NH%@8[@D[^V%!&S..H_^)' MQB,:7XEQJJ(?A)V5`!P1%:(R7OXHO)&;ODT@_3D.`ZJ9EXQ&I/;MF+'B0<0] M_"K2%F`TUK4=NX_T@"%#BNR6_096"=CV?8`(/FO$FXJE^L)$*R,&P1`EZD$^ MT'EEM`**9](_MSXJNVI@`E1BF4)0 M`65YC`5_'V0/)NN!.*A(]B6\.A35P)_[R5>'.GZJ,EX[$L$1%<4M7S2 ME1`^#Z2GG^IB^(J,&LLXB07N8`+8W(^H(BDX,@@"\3>P7B_T$E)I7A@!)CA^ MKX?Q?!F@8L+JJ+`6`!$>EP`)("3I@R@F"@!N96N/6@2,!AX@C.@!&FND=1R# MUZ2/^L.@*6IK93'D45';VM^'UF*1:RB#!58- M^IRD;&T%=UG-6]6C*K5$P]DZ&Q3^#`.>U[-A-^8253$?H^P`4X$!F"@9QT); M#F3F/H0%])9IR$`0@-+LM(Z/#UN=SB&+AASK6<-WR";`WR.8.L(>#JW,JI$- M``3].\1RUO;A?+7@XHOH)L`Z>GI,=/+[P/8Q&D;-D0'@8!PJT@8M)OI]7=65 MR1%*"#P)AF:L9$CLC/#/,H4::RWV5K[#QTS9;_PE@-G+=@F>*/D4"$GJ=*`K ME%DI'%2/"J`JP2.1'\L^=_H1I#J)AX`5+*`,3H&,@0Z$!(WZ([IQAO_/(3J/ M*YB"X#C13RUZ$O4'#?H?H<+<0T"COE"H,>R(P"TS!BL]I]T<>!@,,#P1^;J, M9[H>6G`WY(HJ]O:D`A*%*IJ!5BK?GIL(?YZ:#/43J&.@Z"@$=1Z!6*!X&!CZ M\B?6J28(!/>&H+;Q7_00C?<0$A..PPGI6C`4()S$#:AY:3(!(@4?8(80WH`8 M$_P*T/9ZIX)&40*@HQEA1'`A?,V6>A!?CJ2.L(V48-5LU*/&U]+O!QIDX`[- M'IIU03C`"3D]QF^.X#6T8,*0(P)+%4][?_H1:I;"ON,C!1?I&SB>7'FZ=OU[ M6VH[C_<^&+!>ID&^8_%Z.ITC^&YL$7QX'.OHH]240/A^O7"PI`V4NV:&*H'#,,(HHU%V-\14)W]ZQ"$'!=<5J)U]P57FL0.X1=J"*(&;CA0& MLO1$'_P/K1V7HLKUS>ULJBQ-B.MLRB?I0-Y\-A1!0U%&5Z"SE-/M`4@+5^"V MD<<7`+U8CS]&YJ@!(7AJ7@P71IP8WZQIAD*.SM15<^KYU-I!022`I M2[;O(S<`4YJP&/U:FRE+3BRYP22GZ/7;SB"@1_+>QEPW(>.V6(Y2=R/G8FG1 MPC@3/3#?-X.#>X%[D=;KII`>S0:."X9/X(B=UNF439W#@P6[_38TCA]8KR@^ MF*'Z61>W>=^5'*Z+PS<+IIB#F:+'0)(UT#&.1HW&1YCW.F<&[#!E``&^T"[: MO/"]\!`S8L\`PZ%'6Q(<8-&]+>PN"/:00`KG*$@@+:;B`G#_91S;G"D#+BH[ MV?D]),0>&7L`T)>\JP,Q$Z5JGAW3DM#IM1ZYTR3;CIO2Z+:?&`\.&S.,@M2' M@X@(9M8>G.49PQTY&X-=Z)"RI1C"?)SC>F/T09L(^0VI63+0@F"MH"-`^-F3 M@I]*3D_`DU*K(88'0>&$C1,5)3R(K7#`0D917K66@T?M=:7O\RRHE('IO*%& MC,&46['AA&"],R;=K6P`(UJ.S[ MX21:8<9T[3:>08^79K;G7KL?I8:WW`,(:X.PH&;^<`86PQVP,/1 M^P=T4@)11Q3A)P2,LSZ7BHUS>2`X`GQ,_#A*M\ZT5T3ZS!0QB]KL"DP.A]GS MNP>TEQB&,74_[*6]>;-[C"`_Z&X-1`!L@HP/PB7&Y`?HGFVT&Z<['_JFU5=N M@R/%/>[&C7!/NC?ER*C$-[M52@P2O^BX/;V?18$(S6NW3;K"E^!C1=DV3WYE MB&'>@^5QW4YRQ/\2QHW,\&(0+##5*&8PDR\X6GD=]:3+HFD7:),"JFE-I59F MU!P/$`PJH)=MTN=8-QNYG]JCC'7M)KIMIC_`/<2A7CF<(MNGY' MAP?_\XS]0_@G+:1\=*+/N'`MA)M(S!.X6?`#FK+M-4XK@'?^G02>"20-5)A[ M>H#G"`8STWB?.3K)#[4OI$U;O8N_#JZ,:J!46-JB)L50HNF^N,0U7('5!%8? M5FC?2&^@,K`*65(62(^"SBS5P\QLMUYX&HJN+K:K>#JON@A(-`@,%>I!L>]11=;U7@%5K.N8MR-L4V; M]B;&V5X^P#+I9UF0A3$6FXZOWJ*;I5L7?T?O5)?T10U^V'DW,_K*OY(E6)QI M"VY.%6E'P&8M%?+M3'MBO:+,W34G?V;?SLMSMU/E>ZO*KW=+E7\.HTR)WV,^ M*>YP.^U=YQ5<2S^Q81/XFP'E-([U,:@2=OM"9]B,(6`"#Y5R,^$M.LQ(HK0W M/29!)>`@ZP.1D8B'8:^E(VV/8KG0@PB2R3Z+LE`RS<7!1&4%6C1UD'7.4.&0 M90*A&AXW*$^:G8/2J6SA:9V>`SYW%M3AF!2$3^58F?V`0*^[9\)G[95;M!2/ M6MM@G.A,D,Y\-$JP)_T4$EOST0.A?Y2,['Y$"-C)G=2:@T9C5PHKMQE*8Q5Z M0O3TSTFDSVK&B8+0/"KASNQW@$52?("9KNHO@3FU$K"A\ZCUB#J\8-_&69X3 MG3V1+>.&\@_V!-9L`LU?8!B`Q9X@8N?.;M!:@#:#2)_]$E2``+U:HHI!1G$0 M@ZY]L:DU7,%E>O*X:$>X0&S<4'S@?L$SM'R?Y^=.1Q^.9;-U(.581\,64X)=H7'$Y/?:=@^S?WB MH!`/K%!LB>W,EWC8C0,>MD]DX-R[K;M#;V]VR[W[TR1$FQ#]!L;'TPQW]%GK M%9C!@3H/1]L%F'.[-.@8Q._3-(M^7IM%R?=8P`/H^W M<@=4S'U>@L6;M`^7]:&9OK=:$R"65V-P&>%V:OWV9QX6EL M>@Z6G?UH?Y!61>DQLU],W2XP5DEZPH8PQX]%"V/.EO1]!GL[80;6"919F&^S M2R_&PP:[7ZT]Z)Z$%2M['!1&.0SMB\OC[,R4G;G=+3MSRV5VO?Q_0=1(B+*D MF[M,TISIJ?,*TIUAKA1EW.1TLV=2#C+EEU.@N4N;.O^"$K#QCURH0)=ZQESV MZ!P-5*M1T.GNJZG=K!-_]`\*$Z+MX_H2RD]2GZBCI=(I%*C=X5?K]:=YGV!? M#C"UTM:YL_>:B^&%T\-[JX=_VRT]_(?P[.4A!/@R<_SN51C`WU[=4Q]K$1C7 M4-1_8,Z+UHNTQ^N1TYMW[//TM1=)S%VTV\OOG]C;3$'CR=P-%HS`#W?X:,1^ M\.@OS([QQ#N]^WEY=W5_F3G062X10?'$7<3.^^PJ(OS][J.^^UF"TF[KF!PO M@C<77D!(8;8PTQ0\.0+-18D\<3%/[+\BF^9%^1<)WM^?&2"]F+(OL/"F!;_$ MX'-$N[S0V4M>L9A45A)K]6I7Y7I9GR4X"SVPT]=IG+=F9:Q:2?`S$IIGQOC9 M(;7>(]`GWYP-0K-;`*Y:H*^AM'2F:KZH3)1&TTK`(O^3AL6Y&)K<)_@AZNM3 MLO!!M'X"]ZJ#E#]4'R< M2^^"83R!1_Y'!`^.$"4820O,+`551!LCN.MK7Z;B!>D`;7:=G9#,S0S3Z8[G MLZYB#SFXGRP0L=Y:AK6]/CUKG9R=M_2I#?FV>/\]@QF?.;_`TGM\_>GVIMFDU#]I1UQ7;M` M/RL"[]'">'36:=LBT/YCMK\R(X6R/)C4M$1JT*"DIWT>Z?1NJ@-`-X&/C@W. M:9W<;(L4UE6X^@B$&0O2F2;K;R`C73-EG'1]Z>6M75^J$25?Z_NG-KES7A)H M*4WW20%K(;]I*#@=WE&]&6X.4L.D"Z:W&R;QW/(1YOHA'6\BQ%A[-2H+J$VQ M11'#&@SZ7B4=K48V&5$8RO#"7*"K,#$:M8=IC?W4-+.@%#\1P2AF$M.6#?)9 M@D6J,BN<>T-+;;:VM$R"E7H\VNE*7<'!;#VR&-0J"%'Z"'#H+WB"3(5.&,8= MIG@0W@!$L"-0)I[`%'>ZD._IMCMI7H_-4#XN2DA7#'@:FAH7I\RY9J]2Z]!X MJ,)D,`0MYPM;^P3<$_1E0I!#G6F2V-O#/JK]E-V'R-AT1#>L#=PF([Q(J"79=IN> M>M&;:D:$4+Y1F^*6 M\//)!P$LA<43X8-'HM6]-B83H1DX$/IL@/)'1%[>2]+9HDI'G"Q43W3)C3?[ M]*EL9'5@)J"6V^S_\I/D58E]06_6PTM3DP$6TML['M?.2Q$;^)KI!$97F["N M@,KI!1-C8/*(=0=HG?A8E`ZGTOL-R/YR"75A,8?H+7FL)Q2#D_*>^UTHV]B9BV81`A8C)^/_&I`$0XPFM, M9B1=)0XFZ($SY8=C`&E"$`1#Q%RO\`S\'=']YA)%*2-?^UO6*<;5^5A^B"9* M/35]5XNT'2R,)&."HPTQ3$U5L3:$]OXUL0-A'!XEOZ%LW5*CD[I;Q>2FS,Z4 M!"!+OFK9C!^,_S$M!S-K=<$-@W8KLOFK>&C@??D7%M;0UQA,UH2F1Q+X*-J: MA`L&H50NNG;S@!WP8-WH%@&(NL#>7.A37C6[O78BK3XFIE:$V;'(Y9DA@W`_ M,IL`IN!3E%!BD:DJ$489R+GT%/`X4\SC94Q-/IV=!J\"51.EH<1*($BJ3#A: M.=Z$]5&>,3JX62$I%):B3IUGJW+5HA<$MN4@V-;\^=:G9$R(GT4/K2=$AS0= ME1HPR5Z7F#@#P_Y`(=J94/F245DXXV7-]V9,TJ`N@,0-*O+6:8DK03+*W0_L M@FZ9?-BXYU'OG?_E%_2,,P)=S7W6,<%&<5*7SEE>B!0(?GUUO%D>J$V_K-EG M)WFMX5%IU&T`DR-&O0!S=-H*G>QF^O\)]#7`<5_Y:-`1S@G8\N>IS[&2]<)C MK8!QW.;HY-3Y#A'N4E\]0;R_&X?#EJ20J\///6 M(R"A+.3U.X#QBNSR9"AC ML(G$O)#!L)J,=4*FTU+5>WY(^GDBEJ#%HQSV/+OD%= MZ5L7>&J&@8WPSMJJN&Y$JQT\,[+!:@.;HZ6C9=T=J"NFNRX?<9<(S>R2<2O+6!.;RX$_:A]YKASM[FS>3ISW>V4 M&E"^(M=[D_=D&K`;LST9K>-&SS[@WU'<4=Q1?+?Q[RC>T)/4I;.<*O6V3`XR M=?;@\=J;??6*!6H=GC9Z+Z]>=*X7-'4,.YN[/U<+JF#_JUKV`'1EABV+3#;D?^GXX,37\IKL: M8Y_M4F6_%E,B&@M$L?`?-]_DV.!&!CV![QZV3V2P6<9L:./C[2?$UAR>9Y0M M3<&L3KHKKWUJI39=[E+_`Q$G5'53I,V1`?M"S;&0'E4L7-#:,7JMZO`V`<8= M%3IM%%<3.;2@NR9SG9>2N1W9&2OET)V=OZG&S6/6PXM#=IM$@GT1/02VQ3Y_ MOF('+(200@;@*0>#%*)O7AQVA6)'VMN#+X.0C6'8$%YE$IE%@.,'(Y-;#'[? MWPG>KH4E"Z[09TR?`>>QTSY\@ZP7)\J6A!XKZ;.CDW4OC=0B,BJ#]?*[W&;J M\\U@I'-1Y06/.E#(,T:[H M=K*OX8,8H;_YWKB;*4#5NIU?^"-[GL]9!V;;*5$[?M^H]B2.#S:T^CH7]W,> M81-GK).H;E]Q[<.,^T[Q'?0(KX6G/<+CT\VZA+\G@;"3.*=PRZOO'#NGT/&! MW_')E.L'XQU?T!PG#>2JG9*I4^?Y.3:H/QLX[Z^),]9)7+>OO/9AQGVG M^.:]OPVG9"[P#4L)ML:#6^PEKNX=FKLMYK[+JOYA;6XVK)I873_0-E,)XJAU M?%)UH9MM$[EN\#BFVRFFJ[WO^R.,N=]`!V&GW*.CH^,UN'RG4+'GC'!68RFB*MR&>EV1<)Y$$=JW%R<;*-18$5N^<_Q7(]!J M>;-G=YW8>2NLI(+;Y0A@B%DO$8SW8Z%8&`CV*+A:4^(ZC9"W_2PEN)8;M5%N MK+)LI6,_QWXU*"`UK]R3+1#UX^;FYL-5.!J9JE)W@>)\H;\@C M42@0=1E]Z^>*0K$DD/H'*E@5O6(]XFJ M`;"S-("GSP70XAR>5`*^OQ;ZOW?!I>>I1/2^L",:L"M@R,!Z='*X*Y'__\K.K?/D!_PT?_Q]02P,$ M%`````@`7(IZ1/[BJYC_!P``'4X``!4`'`!T965E+3(P,30P,C(X7V-A;"YX M;6Q55`D``S]$,U,_1#-3=7@+``$$)0X```0Y`0``[5QM<^*V%O[>F?L?5#J= M;C\X&$BWNW1S.P2_GV/S,O:X!<9XMB=N?E` M@M$Y>LYYSI&.A)0/OSXM`_1`A*2<731:9W8#$>9QG[+;B\;US.K-^J[;0%)A MYN.`,W+18+SQZW__\PV"GP_?6A:ZHB3PNVC`/_ MH#]PL-)/^)^7TR&\77?71>=G-D:69:#L#\)\+JZG[D[9G5+WW6;S\?'QC/$' M_,C%%WGF<3-U,[X2'MGI4H20SRT;_>_L:0%P!UC!P[;=.O^^/;`[\-)^.V^W MNJWS;OMGPPX45BNYZ\!^>F?;'1M^UN(?`LJ^=/7+#98$`0=,=I\DO6A$S'KL MG'%QVVS;=JOYYZ?AS+LC2VQ1IKGP2&,KI;4DR;7>OW_?##_=-CUH^70C@FT? MG>86SDXS?$HSVD>02-J5(;PA][`*0RFW&Y3:0K^SMLTL_K)A2"8=G4'S2!G-62,-5COL,45<^:*;$,@0+X4-.= M((N+AI:S-/%VN_U.=_>=B:QZOH>TD'1Y'X`SFD<@O,2!]N3LCA`E\R`E-GYA M#!,LP.@[HJB'@T*`$B5/1Z<3BF@BY'@QOM<#"Q"0ZZILJ1=$-5[,%/>^W/'` MA\'-^7L%D6(,+DOX93W7Q_+N*N"/A1QW('0ZIA&,CH)$.8'\NL220G<3021T M;)2=1?6A.0$5<$$NX9WVAEV6!RQ%XB MSK[&\(`LJ$>AD#!(@BRITU%-20"1[,.HI)[G`C.)/:.1(T_N)7A<+JD*!^3($\*EMK$W^K11IRPK(+'6MY>_[20A;92 MT3\Q\]%:!8KI*`5V\O(IAK,-X'85,/P-6>\3)HFO_Y(P/_F:"[31A-:JT)MK MAE<^A4]^W*Y2M]`#[L7@!GJ9S$6<]`W:<"V\P/(F7!"OI'6+\3TLC%N=)@F4 MW#[1X=&Q[-9F7?S=YO'GGI0`IK\2>AFV[2#`-R0(N_V\:;?7K%D=8+V\T%4, M_-)+GP<L)#7,`@<-%HV?:V)RR\6!`= M;E-L6C3E:KD.6`NX7V[E%X(OLSR^\2X_QI@H,X"B@1X)O;U3@+]2)F$.O\?4 M=Y[N=;+DAF!*2Z1B8VK M'YZ-"0L!)6W4CEH67T*9WSQQ'/`US24>CXLP<%N'$R@/G=9']]3A8,(_HS*Q4"V M^IPWYLS<%;5C<:JWM1CQ'2P8K'LE5%JKY2K<`MOLU*6S:")KQF*G#BR:NZ)V M+$9F)ZB6BPSR^9+5CYVFUNWQF?==?QY_E18910Q-JDTR+?S03-KG+7T/./G$ M2FQ#N'/JAC!Z$^OEQY+VMG/.N\1L.C>SZ:M*Q!?HJ]*:;'=O`+';S4YBO!7U)&I5I_B[-!F&&+D73U8V0J/7MC11%OU&Z:VQGI M,LA$,N32)`JCC6M$U*$-^U2E4GK(BU7UFI[QN%VYB94A4J$A+E-$$*ERX1\T MK#ZRLQH0DH0[+IAZ>+8U:]/:9*U3I1J+0F52K$IL8T$?R!@HLN MGZ_!`I?MLJSG09V3L_E?1,?_1\5CAH^"%.V/+8GC3]UJU3#C72E7Q!^L!-@U M(8)R/]S373^^XF)&Q`/ULH*QH)I:S`ZGT7N4X^I7M$"("H(E&9#U;Y?%3[)D ME99YDM5OJI[,LJE[:I?7A\!-CBL48=M,GUD,G/^[8J"(*VL7&2G^N*(,,^^T MVB-11Z4'$+E'B"^O(";,OL]/EZAM19)!W,$9Q6QWU"Y4HX"C!]X'Y";S'&F6 M5&U+C^-X3'-+[;A,/LJ\+IKV1]B,,Q.%M%2?L\=8?;B.*#I_U71'ICQG9.5. M379P"E]-CFU[_*ROQU#I!5R"%G@SZLVOIPX:7Z'QQ)GVYNYX-$.]T0!=]F;N M3#^?3)V9,YJ''Y6T;Y-XH3F&^]T^[H]C=_01]<>COC,M"U;>U>88PO<'GAW/ MG1F:]/[J70Z=TC:\,F\Y1P&V['V`L_FX__MOX^'`F?XP0P/GRNV[\Y*`YEY[ MCD%M[4.=.L/>W!F`-Z?SO]!\VAO->OTP5DNC/O\F=`QR>Q]R?_SIDSO_!)FS MSB<(U3F$K#/JNTY9J(^^"ATSI7/:&('>;-67MY4Q_#^9)2A9>,^^39US*:WIP;3IANTZZYEQ$;X%7'FN#A[5GU%%QO;A="HVI;%^ MT?]W"Y[\`U!+`P04````"`!5?2`L``00E#@``!#D!``#56VUS MVD80_MZ9_HGHZINP1/S'OIW]LLG+FQFSNF61EBQ-"[E0%_7.\F`+<'N;0V%34D]^;/:4% M7\T/1E-MJR?MYL>2'7#,Y_ZJ`V7Q25%:"GR6ZE\2/FUE/KF'GWSL3`[>1J(;DHN) MYT1]M.0(SLHRO+7X2B$N?"HO7\9%[1S3,="^W?8#3_K,Q#S(ND)$*%-"_)(B M,4DT26I3:JG'"]]J1#P%P?:80T9DBL2_D$>K7@7WD#>N+%[(P./<)91WJ*51 M;O-G0:KG!D`!?&!IYI'I>4/H22)'E&;SD^CN71E=_OP`(\BWW0<'@B&_`N$% M=D0DQS-"N%\$*55XQQANL`=.SPBW3>Q4`I2JN3TZ,?:((,(?3HTP#**0> MB7,"X^L"^S9T=^,1'SHN-3JKVMD>^16#2;3+(-V]0G1ILMLC`(,PM7-[XI`! MXP0&W#.>"&/Y8`K4=I%G+SG<(U/;M&'-46(0Y&EMCVI$',AD"ZH2?S8\3'UL MEJH<17J[X-%U;1Z,,4A:H(=#MH#S-BD$5T)U?V/TACEV&="OM;<#3V+Y;HBO M8JR9&G6-DW*XRNCNC_D>X=AV_`'VA-AC80G:UNYNJW=5]&5T=YNK82]5DG5- MI18\Y?DNH5O'>.(E`U>L6=_\4S665>WD(<>>&8%/$XX#R=BC15M%L3D[#?#- MP(1GSB=$LFR8F/Q@T15V%(_.RHI-N0RBJ,\EB+K8K@M[4W@/B MH"?))>Z$>!7A)E7KQXH=IQK"0*%^7)3Q3E5HD?"=QDP0FUB!4A%P:W.%6!9J&O+#\JDE"D%7_$U$)+$RAAHP[4Z8?2BTG$INC%:/T/$3(IAYS"^,9QH[E>A`/,`!I(.9!:ITW M5.4%B\,@)V%EZLU37#X$2\NT[S+W@='@)&1AE\FU=+6=RR&DJ_WMV[M04'W9%4+1T MW;86;LM@X&06B:W#DBC.@1D-5@/7X9XNB\`-T;N=GA^&DPNH[%7(F&8?E8H8]XNN^ M/W_9`*>P$)-Z^_%?!YLYNQ\T\@/"=6HRE_29G[.Q28B]^=AOHLT*_DGLA$9. M.:*I^2AJ\])+XM3FPVM.HH1-%!BM_R2J\LV8A'L?Q?&L[8M-/UB!'X..<3O2 MT/`2#6^T4B_6:DC;6!$;RJQZ74ZS0)V)_685\-]<$5 MZ@X'76U4$ZJB>S4)@&<;<1T:VAC=='YT+OI:76>2N3=LXOA491W?V!AV__YK MV.]IH_=CU-,N]:YNU(.S\,9-`JFZCG2D]3N&UH-8CHP?R!AU!N-.-\C3NG@O MOH.30-Q<1]P=7E_KQC4,FN50@C0U(%VU05?7:@+]ZCLX"4]:VU4'=!29KZOV M9=_>2?AQDCL:T=%2M[8_%92XRI.`>UIJ<-8,>^L[/`F7/FR;26$W:-5/36Z7 MNOR3<&UC"DW,1?M#GG<[*`%X8_)<&PVA\OY@%@0X?R[=7X!+W"**XVZ6FV/K MCG?E^T0)'RK,OME$A,MZ\27^HP>T_`=02P,$%`````@`7(IZ1%YNB+]*'``` MTHX!`!4`'`!T965E+3(P,30P,C(X7VQA8BYX;6Q55`D``S]$,U,_1#-3=7@+ M``$$)0X```0Y`0``[5W[<]M&DO[]JNY_F-/>5IPJO27G;"79%"51/FYD22?1 MR:926RX(&$DX@P`#@+)T?_W-`P#QF!?XF&DIFZK8--D]^'KP3<^[^X>?GB81 M>L1I%B;QCQM[V[L;",=^$H3Q_8\;GVZV!CI-^C7[QH1K]) M_G%\?4[^R1]WA`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`*QUN?;C;^QN40$_QA M9UZ2.W[0\0F>X#@?_C$+\V<"<$K&=G&>#9["3&*M1L0U4U),)FR36VK`=5*))<&P M20FO0R/?GTUF$1V&H5-\%_IAOBQ_Z.R=LN)P=W__'>/$>#@=`(?<(Y$/;4=$OOK,45SC^Y`BCW.Z&-2R6BYF@U(ZD)1! M,AGGA-$`ZXR,."7FLFQMSATM3@A74R\:D:GDT\_X66I<1\XN,20PF\QH"0&B MAAB9A!N%,&+2B(B[8$?IQ\:D6(%9S9]M<4$$JJ1`_3<0;UX`2-I94!F7;[E: M9*6[#`I;6G*VW[L09IL`#2%03!`ADU*""Y,A1,"V?ERP8T"`!!3,6>3="^QJ M_6Z+#4)8)0L:/X)X^R)$G0E(*8.HD(MW?3)+4XHQS'PO^@U[J=P9R$5M,4`' MMB2#3`X$+S3@.LNU7!QQ>405G#H'/ECY%4?1SW'R-;[!7I:0^?8HRV:=%0X# M>;O#20WLYK!2(@R"1"8(VTP:9>7$U$-4<^L+546E+N+*/[DCU2])-(MS+WT^ M"R.XVF2YF%\ST^VR*=? M$G'+&2K'PP453*.G0O\RWTFP>/5,GE+&>'#0EMY2U"J639U1@8 MT'(X"@U`9#*`*5M5JQUWV$1<&=6T72Z_\#$]G_&?D>]$/9E"UO8RC!1N>RFF M(PB"23ITTB698NI5K,PP%?>LH1-!,\[4)-TPI@-5S)=*#"!;VMAT7&'3])4S M905'K"[OSL+8B_V0M(`D"Q7[S_U4G1RX,C!&>.Y*H>><>PN`;9.Q4D7)':J4 M4:F-?B_UH9S+RC*<9QH:MH6LGKP2`FP4-?J2?0^YC1.IYLH@J%='[0=&A(E1&9PR*-#RQB;=VV-]I^SFK MO,AK-];TU28A!;OVAOQ&%P>)&$K37%!!S@&(+U_YUB&][?/0NPTC,EO#&>D@ MV=KE0Q(%.,WX#1O-R-AZ5K(2N9E,WE8(C2AI,XN32$&G7;SH7S16!S.D&OI_,R(#^RGOV;B-,6A'Y M)IWAH&NCS.GW*<%JW]G?M$8':ZX.AIC],0LN:[$2T)07P?RBQPL!-HJ_2')< M6JJFJ%#2)A454.N4$XB!H98<6YM"3++DSV8USF<'4U9[1VN5?:FQJW?==YKU MF;`F!L;NISDUK'67,&A3;P0&[<2=D]%Y%Y!NQ<2?P.!!C<]ZQCMS&!I/`=9% M*'T#.)_0>]T`RDI!O[6!%[`:T'O^WYSO!]5\'\C`-!G=T M.U,+;FC!VDM<9`\1%N<,T6JGHFPT!YN1M;'`E9=>INS\NAJ^&(61!0, MJ]3X.@$WF#2:7P"$=M7O45!@,J70(.Z$4 M"C$@NT^7^0-.>4:OB!XD"R9AS*+JTAV*`JO,HX=F9$#@[4R)H,G7@I+2FE@9T0K*WB??9YD M6LK4)9V0I@M52)NY&%#B=`!VKE^0GQ"MA)(^20R$-A=)G#3-*%J!9B!EH&?W M1*"A&5RJ[--@$$3*^KZM!(@OZN6#8'5U.IB2L9+0_0`A M%\ZU(Z66C%42B>`UB%,7`$86`;3.47>C]]7;058_E`VW452;#V/%7;2VD)/PD6/9?;2F!!C2"6')@S_^ MSL2`;/Q4L,[#&(_(1VUBYYJ@$W9T@`H94DG!8TD;FH(I5!0Q625=UEKM"QX4 MWK=:\5,6`YK47)JK1M0*G.VW<(SOPY@.E]"Q1W[P\28:3&B@`R#M5G]0R=WI M)-V1)&?GD$QIHC^')*`'UW+43GO.<^VV3N62K!#7(M-CI`*$X%1>]CZ[>1?AT-:[W*4YBU=,HKV=1\E5W3$BMXB@VO12\)"9] M1QZ,[S0`J8Q!SX+U,BUP!]*(PZ?HKM+D,0QPY8"AL0+0Q>&GKYC;*X?$2#NU*N*`+)E.PC^=Y;EM!EF MX^0:4YJ$$6X,A<;):OB_GD?9O8J_OLIJ7MY?_7/`M+(U&M<-$%`]"N4)2LN' MH;C<22#?TL\L1/R,/`6%<;>U@FFL;,#,QVVGLY0@Y`FGV"4Y_O59DM[@]#'T MI<<+>Y9A_2IX7_,ZTQ[3`J"=ZU@$?/>Z2/R(TSRDP2]C%GJL"-AREZ0H*W1) M.XC)E`O*;@!I]BGV,GR*^=^UAEY$`M%?*#$NP/(=DYZ&M:Z=&&J#\>R](7?H M^T#^14G;<,(LZCK;Q8(7@KAK31W`I!0";5/Q3:GW M+0H*34K+*866%N&=O'8#6/34H"S.X>\`5W`RNB>R\HEK;Q MM'WI>3_4!9GE%F+`G37LAUNT0Z.>T(&)ORJQMM.+`N&=1J`W8QW M7)PSBRX=T+T_NC\3PXMC7K?M&K,0C%=>FC^?XEMY'D65BBN6R<#+F-:6!\DV M"4@UXU*N1.,3Y\]LSG-[1BFILGY%N$^-K#9.GR%9K`^+Q@L@%Q$Y+)E6D/$7Z.M\FP-./_8#W>9<84&RXF]ET M&K%C7EY4G@P;Q61H-V$Q,W2G]DRUK6Y3]S.IL4%MI@IF1-\/;^>$7TT;!6'F M1TDV2]E\TB]7,4C/4A4'9-FB#)U`LU%(E]WK(B[B5]3!B8)7T-_!T$@`2AJO M@FZO0>$!/8\T]I[HLHF""BTI^V$L.Q"[X2LK$4"<$.&2A*O,J=A*J)%CC.D+ M/]S=WW_'7O=X.!SR5'[CI)CQ>5%U.%FV\&ZL98,./4V@]#!4<4Z7?CC%Z1?S M!%6J\\BG0.;BQ[,LC'&6G>+,3\,IZU;C@%X+SR[OKD@UTNZ3?CO&3_EQ),]; MM4A!-GW5XH;6W5G_4IQ3>&GH'59?CH=H;QM=#,:?KH?H\@Q=7@VO!^/1Y<4- M&ERB&?G]U/;P97HS93S#H?AZ2J4H0YL^GU7A01VRUBMV<,GKPS7PR M@Y988EFKC%+!;5!) M)`B'0PIT0O(<$.]%_KY!5X/?!L?G0QCDZ5Y(I0,(JKQ!)E M,&3LBUA(T,-M=#.^//GYOR_/3X?7-]^@T^'9Z&0TO#CY#097ZQNLX]2+,[K) ME,29.5M[E6`WW61OTYIY)XW5P7"V/V8A:]]NH^OA^6`\/"6.]7K\&QI?#RYN M!B=L:`B#MS2C2:8C#:)`QX-EZ:R9!5(,!>[2B*:"5&Y#&2D M9FT=J(<1U4*0@8YSFO4$VB&6E].]A\L[=%D%;$>$IX@52;^O%XK*4F$XS5'\ MB/E%UF,O_D*:U1G&&8,H2\:JU+"[1*V%WERNEHH[9Z`YQC;Y/N+T'J?H:Y@_ MH+-9AM%''(0^S5ER?GZR)F?&=E3"B6#15-2P5-+67)<>G!-\=@J`*C$8I#CSPI2=N[N\J_KA44SF%3/6 M#RM'W(:Z-BG4RYPZLXP4P1"N#]HV#ZDNSS)/Z3@??-7T85#S`G\MKG;3T#!I M$I.//JX9:-91]B_&[O63Q8QL7D+I5P88&B\(O,WH:^S3H(KSHE"SK'6>H"JN M%[*P\OJ34Q)INR>FE)";)Z6$HL[I8X9/?#*JT$!%3?$<7=F/B2+5> MRDS/FK_J8T;EN4R4G#.J+])N+.&Y*N*Z.5"G5N:[PL%),J%A=-C:"S/@DIT) MS(K;IMQRW>,%NG.*R%2%VFHN6ZKP)K-R4[FVVOGN+<"Z/LPDMYUO:>^ZQR=9?[K3JC5/NN,EWG!%T0\)+[ ML$7IJ"I^3=0\86G4>`S6V(]F]`9ETCUT4F18%K(EF'Q(:#)6^PK27ZS/3LT:R/F94'#-1 M@D&Q'DC;#&.JJ-#MY[W6NJ[6*R>3I=ORYK&QQ?"`I6:R%J[14FB*7J^G+W8G M01LE3OG7)/TRCU$]GWJ*7(-W"CYNN:'?$G2QI2T`+U[1;LC`8H@>H7M4N=-;(C^))>S+T\]^M,J`-J_'* MRQ_AO.,6(M%+K<)0T[O<[0.4:`LE:7@?QKR_N/3SA";'WGNWB>ARW/D^+@>W2+/9IX8R[CY>A@>_>OWZ,)G;6RSBA'@VD: M1FCO+2O],=GWTGI$U:AUH M*NW`#;4.5-2R&\K+A%K2^4A/:IUBGU-K_[OU<.OOLQB7A:^3766G?:CKU0\= M#8T.E8.A0S@,:T-24JS)IK_/HF=TL%LRZ8^9EQ)ND._Z\VC_;8=(I)S]]ZSL MM^MW4V\U#?"M&S?U5N6FWL(A40M1#PX-9OH7B3GG)\&X-I4'=,0N*Z6]VKP3F9I2C@O7,?KB@% MQUEVA`JIHOVN<3&.9W8_G>'!'7$>ES'^C3@3D6>3"%KK")1`JQY!*.6\Z6FA M=3*I,ED4S##RJ#1*R$CRF'RW5[B$9:SCG5&ZK1^?(5;2^NZ("Y\+#P@`RG MXGMV[^OX>2YRQ9=L!E^]-"B.SEW.\BSW6.*(BQE=A)8TRS4\Q^KQ\W554^,T M^JH?`C$5S;J,;#>]8R_B20CG\K6UPX,]OC*YB2Z2;7IXF#WSE;3)#T0PST8Q MS^#T(:V=W5OQRQ`^Z26U2T55K;)E"A[CO'-;OVV=,ZY4$@WK=O73>D1C1YM#C!S'$W&762&U>02 M79^1AM/Q,WR;SNCM\N(PS^$K]>ILI$B7D]>Z2"9XSLORZ))J6JT_;SWD%7ES ML662>0O;0/_3-,&:I_H5A_,2I=X_+:=Q5&OJR$WO6GOZ2FFO/*EU3 MYZIZ]"M?_S8P?=%5\;)H5)2-RL(1*_V%^(2LU]+E.OS"*A&`\@VKK]I>_F%U MCW\YW?_*;9:NS_\Y6G]IE%,'T!/$B_(!"U7P2MU`+P2OQQ,L8K9B=^//X0X$ M2]`N'$)O&"_*)2Q8R2MU"CTQO!ZWL)CAB@V8/X=C$*R2NQDI](3QHAS#@I6\ MXM%"+PROQS$L9KATCV@)M_"OY:YEUGQ>]PZ3D>F+[SN]CL[,?(_`P3*X\=-! M=5VKK=(U[66]CHYJI?;VW_=:LPN0706B)M_J:^6VMXN\QA,OC'E,6G9-9>9% M-&*",'R3$QCVKBFYJ^3YI2?[&)PW?<>&KW`X4#T*U9Z%Z,,`#0V6J&2Y?&BG/=BJ\'?3=+,`R.Q"U=JLWN94554.]#EBS2>>M8K1V"G<@JE%A&.Y@` MW7E^$0X*D2$ANDV2+U\PGM(Y6(;3Q]"'9_C^(B,M6-%WEI M+0E4JR8-].S&MC,THQGA3J,$AK>F2&51QIB8,@/1OQ;"5[L>'"2^->:09[&$ MYLPL*`OBO`(ZF2UG69Y,$([88[==,)(%Y@LG9V'LQ7[H13>DWOBQE0YQY**P MWJ\6IS`*9CA!E0::J[AX)\OGB@/U/C0H`38*\ZPVH"I:@`QVY6IRG4&MW#U) MY;*<'*6,XZK5)/J"6K7[!E6[[ZIJ31,1@:O<-C1Q7/R+Z<0XN2K2UW=JW4@+UNOH M`[DS.&&Z**/**"RU4<+5:3*^:5&`[7=8KCP,L@SGF2*14$,`4)H),:Z.0V)2 MFV7>(*>5+*]=<-6JJ4_T.YGS>+,H1VR[[I^.JK46E%]!X*X4H.I6@.LDP)J+ MNN9S#8JFQF%6M4D=N[I65`OQ/_QC%HKW:[I2G]UG"S4`ITIH\`WBPFB0YVEX M.\O+?+57'@RJ#^+`[.WH=&`V"C5414MA.V!N]DD2EJ.LZ)X/B9(+/):'N!6(0ZUV`3E[S7!B]H>+?.DL#&B=-\(ID M<5)A0*]"C[$["9YK5.^D4'+U6GB,0QX.7MAQUW[_[/XZC1)6I[-F0IN(B[D< M'W7#[;,S=_SKLR2]*8Y@2(=.I@4`:A^+X18.N(HWB'@YB!>TR<\MEJ^7'7:Y M,3C*LDX?A_,3+WNX2I/',,#!\?.GC.9=JQSQP,_#1^DLQ%P;4$-<`'3'+>(< MT3)060BZ?49O:#DHC+]%\VYL7A:L]UML6B_X?@7:@%KQ`J![OM^J*/?OEZ(D MLPKZ%YT>/'H1/7_`W4W[Q)/H#??1!_2.%X+=63FF;YA.K-B'6CF;A;]&95'H M35F8TT'/RPN@#\?KK\\VX1ANBYT#0_5GH=K#J#^IRQ4/1.R)FZAX)ODP?^HF MXL]]^02$&HOG59+5R&)K%`8<9^HU7":#TT%;,'*=I*T]?M/@VEG]JW/RB7Q= M?D7^H(\BW_P_4$L#!!0````(`%R*>D1V/P81OQ(``)L<`0`5`!P`=&5E92TR M,#$T,#(R.%]P&UL550)``,_1#-3/T0S4W5X"P`!!"4.```$.0$``.U= MW7/;N!%_[TS_!]8WG4L?%$NRDTM\23NR)*>:#+Y-&9](=#`XL/["]F>TRCWP\\-C!/_[^YS]9XM^'OS0:UADE[NS$ MZC&G,?"NV*_6T%Z0$^L3\0BW`\9_M7ZWW5!^POXX'9^+_\:/.[&.7S=MJ]$` M=/8[\6:,?QD/'CJ[#H+ER>'A[>WM:X_=V+>,__!?.PS6W82%W"$/?06$D.^M MIO6OUW=7@MV>'8@/V\W6\5_;O>:1^-%^.VVW3EK')^U?@`\(["#T'Q[0O'O7 M;!XUQ;^8_(-+O1\G\L>E[1-+8.#Y)W<^_7B0$.OVZ#7C\\-VL]DZ_./S^<2Y M)@N[03V)A4,.UE2RES2ZUOOW[P^C;]=-=UK>77)W_8RCPS4[#SV+;ZFB?8(3 MGY[X$7OGS+&#R)1R'V-EMI#_:ZR;->1'C5:[<=1Z?>?/#M;*CS3(F4O&Y,J2 MOX5Q/#Q5`BJ,87$HOS@4X(0+X@4=;];W`AK<2Z3X(F)4,!_U=,W)U<<#2=>0 MP#?;[7?R<3]!:(/[I7`+GRZ6KE#&80$.3VU7:G)R34C@Y[&4VKAB'BYL+H2^ M)@%U;%>+H53*\MQ)AR(2"']T-5K*@44`D*LJ-56%7(VN)@%S?EPS=R8&M_Y_ M0F$I8.94Q-5JKFO[UV9Z&8G3D)(F)\*]3VZ?B<1><^.+!(._4 M[:<\YY^8>#-VF3!WGLM=6MOR'(@.Q?LZH)[MR]E9VIF1CPF@% M/(&P%B$\);G,`4B?SDY0U#9?JL=O76YA]!6:ZNKI^@8ZQ9)+?S`\0;0UN%/`5!Q^93U MO7]T=:G;CXKS9<+7SL4'&R3D+A!S;3);=R2E*#&O$A]+^F;\KV4UK#55\D_; MFUEQ%U:RCQ77:[Y=YFRPZLK))N-YJIOV^_WO*EX[EW[`A3[7';GV)7&C[K]+ M6ACI81%F5VJ-IK\^<5[/V-9FLU^?U)?/0]YF%,YE0^ MV@MDPB&%<]$TO>4VHTEKZ'#'8ESX@T!LW:?-G0T;V)VOKUH<+J.I7\.YINZ# M^5QQMM!5Y4IM+$>0I'8%"T\.05<(PFUW(+SE[C=RK\)@IRD0A)9Y*&1(C0'# M6HZIZ#9=^YLM@$IOFZ3T-!DQ=7U!.&5"@IE,DJJ5OM44J/TC$[6?*C4&#!W! MS4QR=.;:\W3U;S4!JOW8)+6G2HFA[F[(I8AGU'=L]QNQN=+PLUL#07AC$@AY MLN.]>+\2U_W-8[?>A-@^\\ALX/LAX:H7<"8)$)FW)B$#T@(>/+\S-Q0:Y/=G MU!4S*Q4L.TV!E`":7`O)_5$81#4.PDB4+J*D M`\_JS,,'HA#,>4<>0"("DE-@.4#7&`XQMB M5KD`"*D2)I0O>+\BXLO9>2QU)H<1>P$+;#=J:0!L>7@A9I[U7T#/!9IS:E]2 M5\0_1-8W[9;VY@<3\![0TM?E@S]=-9DQ7":X!L>&*AJTA'=1%#)!-#I^[#@. M"[U@78TF1!6?\%`,+#L"*,94G4[0DN9P9%AQZ4S"-EEFF(MA:F.TM'I1K!0B MFX&)CEN5\)X:,NE%(0%YR5[&,VG;1=2.A9ELK^:]EKU%QB#/`KD49J*]\ACC MN;A4D4E!!=.`5FWS\1+S@'V)_!,KI'G9QIV64'QJFX9K.UV6M&9@T9G-(M,2 M1F;3V<#KVDLJ'#O!M"**!]!"\:IQ7JV)%UPC9B`XEOM6/#+KV]RCWMP7>$)X\L!D?F2528#H7BNM>O-551J@ MXEA!@EQ\G(/(EE/EBF[&`#@2\R0>'Y_JRF7XV8)ZTL*L$#4V'%] M/A2L@%1&H;@MH89_X8?LVOAD2;OOJ;$'P>*AYISY$""3C;$C^8)CY*Z\^P[E MD'EL4[J5L>:_`0&DV),!/9C!NC!C,!UX`1'Z#'+??CL-L2-_N**96I"B/O@^ M]D&/S&6(;;`7%O`^_`+HHO#F:F'O!UL20-Z86\VPRZ$U!]$T&?<=N/7Z\SK1 M*@]H=43(W:-N&*C29+F$V"71>N`"]6#&^_$KH?-KP57G1HPI$CZXB MQA.9(S"61?O#KJ36@[BJL@&((.%777F^WR_/"'?NM>^FV0*G-ID3)>G\3`!&.2P;B3T5DD];6,&`V MS"H+@03[#TDG0U"(3:G+%DOFR46#SAV%`)).MH_8I$N2R-UBQI&;O/78PJ:> M(GI,;VX8*BJ+VXX?TP5*I(',6&/]3&34`UI873?%7CPH`D>FQ&8$\!GUVWG@ MY)!AKR(4`0JD"3-`VR[9SD,KJSWV"D$1F-2RFX'/$Y6HU^\^.^%F_97IR^BL M0<$!#_!S4K`ZK4+%6?4[52YXZDJL/8:MUAQP_7L9\X#+2__N[`^5,1TGH#?Q]K#\PI$"?9ESH&LF MFKMOPH(:,^-U66N@4EL:I(36]R:0ZR`7#\>'ZT1ZS^.,SQB>$WU!'5;JKV0WVI+16 M7%/BB3^G5#=*I,)VC8"[@-[MOR$%J6O6C.&FEV^-\^% MUC&$;4KL:7H!3/)`35>.J5!"CLW4`1C6'_;TO@;8=11IAC'`X^\JYH?XQ;%/ M.-3KJW;?RVXS)%X=>E%)TD'9%W9Q;G59!X#*S!@_!.,.(3/_3.@"=LAJ-@5V MX6T)++:OS%`KQ3SHQB0ZI.W"YL%]CUPJ;S114:&?>5P+AEG:,0-'N,A5C+8& MG(M<&<;ZFMOW-W3ZC4MQ5F,[G%64TVGU@GYVPA@TUOB?Y-3O2LWAF15PA,NE&ZG)=M=J4MPVF[+&`.W`@&/& MM0U"4SMFA(WKS?FR0EF5W$NVPC]37%/3Z><1)$4V!0R9?9K:=W*NJ,9CJR'^ M(>$E(4D5''E?ZM`.0DZ21\*)\5YNH?5'5Q>)9Z071/UB-:P>]1V7^:(7\9]A M9_IEW+=&9];HHC_N3`>CX<3J#'O6:6A3C_A^C_@.I\O(T%(1F@K4 M3UWE90I%^L(J;X)"D^IKQ96&[(Z?F%R389Y#>(;+O=MVN4^CP?"3U1T-N_WQ MBT>!CL\7H>R,!O>/:@3XCIIJ+[T$H@AD?Q"N<$-X0"]=DII>WG"-]SMOH]&T M/[$N.M\ZI^?]%]<`N`;SYE/"%S+U"_&)].;[Z0PJT=$/#WG<-!'?+D,\)_W4 MD%9SVPDFTU'WMW^.SGO]\<\3J]<_&W0'TQ=G*+(K1S*L]=+0Z&(OG49;1FG+;\X5HF<=@MUK;KC3NGW>F_9YXHXRGWZSIN#.<=+K1'.?%GR#[K].5 MK^516IWLI4\54!-ZD+98T+C22":+F2=K?L0;*KF:N.%8[6W'ZHX^?QY,/_>' MTSA;(&8S4S&KZ0^[@_Z+;P%/",F`0,N]=/O92P\KIJP]2=1=,)=F>]Y1N82= M]6K=?;$-C!E>J1`CQRU!E*C9[AL2%V&>VMX/869G1$QB)8>*+=Y*(DR/T\!I M)_F=JX>RRQ,9MA6MA-!%RBB185(J`K0]A`6UGR>/20M#CUNHUX+=@UY8*BJT MO7SEO`6B"C-`VSYV%XQ;+B':WKMRT`$58@9Z7WP14/3]@"[$D*"HF=QNA[:+ MK1PVZ>*:`<6937E439.X.7/@"7'":*C."QF`Y&C[S\H!IZ4<,_`T[6;E4"ZJ,NR)66)=*CH&-F/J=:QQ;25SJMV M68-D.3((,#/QSC69A:YP?[DZD_!\2`H>0(N>Q5!BM)US!RO#R%4KE8N\`:U= MU>(J*F9SG`9&:H3[K*_&(#-Y:BCQ_`CD2(#1,DXJQ1M!8O:UW*MXWYCNIX-[ MIB.652OV&PR86NS)0V1=?VCS^"+'="=^6S;%N'J,]?"Z@R ME94X%'O@.6XH;SM9V=>47838B56>F2RLR%A*Z^U(JXML;7J7R.SM4-1I5'+!ZV>TU+P\MC$ ME.13AAZ3)ILF6TUC0^)1[7PU:FRO-DR/:7NG:]+C4;X>CY`CF^)Z/'H"/:XY M.P:,,Z(5[])OLDWR3?(K_?B)OFF*CU6N[<'=G99>FO4]6,-))1" MF`1*DK-NR*4*%!/4M,:HB[WZD"@$QIQI9@Q5G85DB@!.QMQH:-MF! MIDHR!#;C';+%7'+_$!B932+3YE(%84K3A!F0]/*HN7):NY6&H[W],RU2HWHS`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`14IIU:_3(?FW0FUVL#C MGPFW2LKPE0;7L/U-I3M&K8$N;QZP2Z5T]6S&RVK@.9R(X:]'XM\#;[5/:&*[ M-E>>\04@12UQKAQXL*ZT]E2MOI$_Y'M(?/(_4$L#!!0````(`%R*>D3QBW!1 M^`<``*,^```1`!P`=&5E92TR,#$T,#(R."YX7V.='1D3LY_F_D>>B0B MH)Q=E(RC:@D1YG"7LO%%Z?V@W!JTN]T2^NW7?W^'X._\^W(975'BN4W4X4ZY MRT;\%]3#/FFB:\*(P)*+7]"?V`O5"+^_[-_`UUA^$S6.JAB5RP6$_4F8R\7[ M?G`B.'%Y,W("'PB$+69(0\LFHHC^.9B,PMX,E M#-:J1N.'6J=:AX_:B5TSFD:C67M;4('$,@P6"JJSTVJU7H6_8NRW-'`6S#]_ MYL?!VUF?WH\M=AK^/KSO!A;^^9V%+7?^U^7\A#S,@FOC/R/7?]>9C_GU???S M<'[;.!7C#]4_3#-6>1XX$^)C!`%FP44I`]]3_8B+<:56K1J5^]N;0417B@F; M,X^RASQRX^SLK!+-IJ0;E+.A\%+1]8J:'N*`+"3#+-704Q9(S)P5>EQ*0T)0V#\ACCZ8)VA(-A1)M,`(]1+U>-5HB+G4U(!HC)0$4&=!=^7F589P`8UG&]=-)-CG6V:YH)![0;8 M2;ZB:U1KM5/(`1[Q"9-77/@=,L*A!W'X'&*/CBAQ2TAB,292+=U@BAVBD92N M?+I:FPM,%BI!Y@[V_*51,5V#RALJ[%7)-) M*N=J)PD_DEY"U+TH:2F4/M`>:73)B#(:F56-_PQ41BE[]A$S%\6R4$;8>65= M3$9X&!#78K]&SU-!`A`3,=W`0,*8D&QAB1"2*9:(W[QD.70HS M/QTVX'=8@$\3(BE8FH/^ZKP^%/67A@*]65%W>*%9H!=8(VNJ:A_0E&R*+7/Z MD#2*A60I&_$16DH_Z'VR`,4:#21W'B;<[*.$HDG[0H>C!=460;&Z"6ND2 M!Q3PO\OX&$>G,+4^8&]5004W'8\'(`Z^]%KV^[Z)K"MDW9G]EMVU>@/4ZG70 M96O0':CQN[XY,'MV-'5P0;KF<`V'M>P0D01B940/]NDZV-=6MW>-VE:O;?8/ M#TL`[9$(28<>Z7%)H%2:8WB.8=TVJ4?X;&,Y6[8Y0'>MCZW+&_/@$,X>=W!I MI`XES%D==M=^^!P[A-/G6M0?,NY M+3`+L),I/+?.ZK$VUK'NFS%SM_#!;]HGND0B:D7]+!09(]DMRRUP:T/VLE+LU6B#RT4'EY@ ML[>L_.!I*?0!VK@$K]S+ON&_=FPD<&R>&^F$'NV-6_#:P9%(^89Q3H+24>A1 MU]^,OZWQW)-;KBQUS;P6^UJQ6_,!K_QM-^3\75"86A^5'>[7_]_;0WVHKI`^ M&:&HFZ2I>A0N2@'UI^IU7#PV$61T45)Q*Z>M!)_`M:.9[Z4D2K2FFR0*]3H: MB>)4!!;.AI2-;A<0PJ?JY2`)*JGQJ0!)I6+/EFM(Z8$]7'D-EST\W-5E8"'> M5_3U1LE_52=A]>WJY-J"_4JNMI=:7M5AV#J[.KRZV[Z2OYV%DJR[2;-.9=FM MDWQ?[^@Y!\>YD(AMM`7I>KWB+K4;[D2B-"SJ6SGE*ZNALE$KUXVC6>`N+=W% MB"4,NQF1\CW#B/PFMH+J4P:E]W@GC0%QCL;\$98176D&VZ(XET<]E)?,1?5K M^^MT^G,9*\2303KR0FLV>^.>;TXDZQGV%&@+++(XLIR]F%$MDC.U.(V3%QKS M/$.^9$7281C56*H;\9.N9Z\U#*2`PJL46:WO[UO2XN0)\J\(89[H4A^]8YS>4P!4N"VWY7$5U0`1`B"J0P5Y;7@X30EI$"B M+4.Z=>YI7[.O^%2+=.P>[3((R/R*'Z7Q1K&EVZ;7X7"F<2U6RQJT6)O^A47%G*-9\F&#!\!9]T M[XO7HU>,=N_"]H&+!V4XGE*)O6P#2.R69KYX<.*I8=R3?%%R!''I6LQ@.0!H M8O[*R3*)A"Y;;I#L78R4M8FQ1M:#S-@^QR(QLY9C>NU_P_1ZCNGU/3<]7=Z- MO#7?V'/C$S./R$I#6"@M)BY"/!(O5AV^2SG7')\._-HEO/ MOF*T>Y=7\TO++4=&0>+]IQZQ0JN6G*K0/A(XGDKBM1R+PF/2)CRF+JY[(YQ![-A'^(EO^,ZJ?"7@Z M^@J0+W\Q*OHSU,:;DA=(^`=7X'DE?ML$C_\%4$L!`AX#%`````@`7(IZ1`T= M53_,/@``6+("`!$`&````````0```*2!`````'1E964M,C`Q-#`R,C@N>&UL M550%``,_1#-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`7(IZ1/[BJYC_ M!P``'4X``!4`&````````0```*2!%S\``'1E964M,C`Q-#`R,CA?8V%L+GAM M;%54!0`#/T0S4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%R*>D1=Y5]) MR08``+DT```5`!@```````$```"D@65'``!T965E+3(P,30P,C(X7V1E9BYX M;6Q55`4``S]$,U-U>`L``00E#@``!#D!``!02P$"'@,4````"`!&UL550%``,_1#-3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`7(IZ1'8_ M!A&_$@``FQP!`!4`&````````0```*2!%FL``'1E964M,C`Q-#`R,CA?<')E M+GAM;%54!0`#/T0S4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%R*>D3Q MBW!1^`<``*,^```1`!@```````$```"D@21^``!T965E+3(P,30P,C(X+GAS M9%54!0`#/T0S4W5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!GA@`` "```` ` end XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 3. NOTES PAYABLE

On October 18, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due April 15, 2014 in exchange for cash proceeds of $39,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

 

On November 4, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due May 5, 2014 in exchange for cash proceeds of $24,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

 

On December 26, 2013, the Company issued a six-month promissory note to Fuse Medical, LLC due June 26, 2014 in exchange for cash proceeds of $32,000. The note is unsecured, bears interest at 3.0% and requires payment of principal and interest at maturity.

 

During the three and six months ended February 28, 2014, interest expense of $777 and $1,112, respectively, was recognized on outstanding notes payable. During the three and six months ended February 28, 2013, interest expense of $98 (of which $56 is for related parties) was recognized on outstanding notes payable. As of February 28, 2014, accrued interest payable was $852, which is included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.

 

Notes payable consisted of the following at February 28, 2014 and August 31, 2013, respectively:

 

   

February 28,

2014

   

August 31,

2013

 
Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014   $ 39,000     $ -  
                 
Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014     24,000       -  
                 
Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014     32,000       -  
                 
Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015     6,000       6,000  
                 
Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015     11,250       11,250  
Total     112,250       17,250  
Less: Current maturities     (95,000 )     -  
Amount due after one year   $ 17,250     $ 17,250  
EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A,C(Y-S,X9%\R,V-A7S1D.#E?.30V8U\P,F1F M,3ED9#4V.#@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$537U!!64%"3$4\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E)%3$%4141?4$%25%E?5%)! M3E-!0U1)3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O#I7;W)K#I% M>&-E;%=O#I7 M;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY37T1E M=#PO>#I.86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X- M"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V$R,CDW,SAD7S(S8V%?-&0X.5\Y-#9C M7S`R9&8Q.61D-38X.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A M,C(Y-S,X9%\R,V-A7S1D.#E?.30V8U\P,F1F,3ED9#4V.#@O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0^)T=/3$8@4D]5 M3D13($-/32!)3D,\"!+97D\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M'0^)S$P+5$\ M2!A(%=E;&PM:VYO=VX@ M4V5A'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)UEE2!&:6QE3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O M;7!A;GD\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]A,C(Y-S,X9%\R,V-A7S1D.#E?.30V8U\P,F1F,3ED M9#4V.#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83(R.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ,BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]A,C(Y-S,X9%\R,V-A7S1D.#E?.30V8U\P,F1F,3ED M9#4V.#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83(R.3'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`H56YA=61I=&5D*2`H55-$("0I/&)R/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E M6%B;&4@86YD(&%C8W)U960@97AP M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5S('!A:60\+W1D M/@T*("`@("`@("`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`P M+#`P,"!S:&%R97,@;V8@8V]M;6]N('-T;V-K('1O#0HU,#`L,#`P+#`P,"!S M:&%R97,@;V8@8V]M;6]N('-T;V-K(&%N9"!F'!R97-S;'D-"F%U=&AO2!I;F9O2!T:&%T('1H92!02!);F9O28C,30V.W,@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&9O M;G0@2!P2!C;VUP86YY#0IO<&5R871I;F<@86=R965M96YT+CPO9F]N=#X\ M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O;G0@6QE/3-$)W=I9'1H.B`U)3L@9F]N=#H@,3!P="!4:6UE2<^ M/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@28C M,30X.RDL(&%S(&]F($9E8G)U87)Y(#(X+"`R,#$T+"!A;F0@=&AE#0IU;F%U M9&ET960@8V]N9&5N2`R."P@,C`Q-"!A;F0@,C`Q,RP@=&AE#0IU;F%U9&ET960@8V]N M9&5N2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,-"FAA=F4@8F5E;B!C M;VYD96YS960@;W(@;VUI='1E9"!P=7)S=6%N="!T;R!T:&4@&-H86YG92!# M;VUM:7-S:6]N+B!4:&4-"D-O;7!A;GD@8F5L:65V97,@=&AA="!T:&4@9&ES M8VQO28C,30V.W,@06YN=6%L(%)E<&]R="!O;B!&;W)M(#$P+4L@ M9FEL960@=VET:"!T:&4@4V5C=7)I=&EE65A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&9O;G0@2`R M."P@,C`Q-"!A;F0@,C`Q,R!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O M;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!O M=VYE9`T*2!T6QE/3-$ M)W=I9'1H.B`U)3L@9F]N=#H@,3!P="!4:6UE2<^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!S=&]C:R!M M971H;V0@87-S=6UE2!S=&]C:R!M971H;V0@ M;VYL>2!W:&5N('1H92!A=F5R86=E(&UA&-E961S('1H92!E>&5R M8VES92!P'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)W=I9'1H.B`U)3L@9F]N=#H@,3!P="!4:6UE2<^/&9O;G0@ M'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)W=I9'1H.B`U)3L@9F]N=#H@,3!P="!4:6UE2<^/&9O;G0@ M'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'!E;G-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&9O;G0@6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^/&9O;G0@ M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT M.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@2<^/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!H87,@;F]T(&=E;F5R871E9`T*86YY(')E=F5N=65S(&9R;VT@;W!E M"!M M;VYT:',@96YD960@1F5B2!H M860@82!N970@;&]S2!H860@86X@86-C=6UU;&%T960@9&5F:6-I="!O9B`D,RPT,S4L.#0V(&%N M9"!A('=O2P-"G1H92!#;VUP86YY)B,Q-#8[28C,30V M.W,@86)I;&ET>2!T;R!C;VYT:6YU92!A2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C M;VYC97)N+B!4:&4@0V]M<&%N>28C,30V.W,@97AI2!N;W1E0T*;F]T97,N(%1H97)E(&-A;B!B92!N;R!A M'0M86QI9VXZ(&IU M2!S96-U2!T;R!B92!D:6QU=&5D M+`T*=6YL97-S('-O;64@;V8@;W5R(&-U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&9O;G0@"UM;VYT:"!P6UE;G0@;V8@<')I;F-I<&%L(&%N9"!I;G1E2X\ M+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@ M"UM;VYT:"!P2`U+"`R,#$T(&EN(&5X8VAA;F=E(&9O6UE;G0@;V8@ M<')I;F-I<&%L(&%N9"!I;G1E2X\+V9O;G0^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!I2!N;W1E('1O($9U6UE;G0@;V8@<')I;F-I M<&%L(&%N9"!I;G1E2X\+V9O;G0^/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@"!M;VYT:',@96YD960@1F5BF5D(&]N(&]U='-T86YD:6YG#0IN;W1E M2`R."P@,C`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6%B;&4@=&\@1G5S92!-961I8V%L+"!,3$,@+2!O6UE;G1S(')E<75I6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6UE;G1S(')E<75I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2`S,"P@,C`Q M,SL@<75A6UE;G1S#0H@("`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`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`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`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`U,B4[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2`R."P@,C`Q-#PO9F]N=#X\+W1D/@T*("`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`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU2!E>&5C=71E9"!A(&UO M;G1H+71O+6UO;G1H(&%G28C,30V.W,@97AP96YS M92!F;W(@=&AE2`R."P@,C`Q,RX\+V9O M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@"!M;VYT:',@96YD960@1F5B M2`R."P@,C`Q,RP@=&AE($-O;7!A;GD@86-C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2`R-RP@,C`Q M-"P@32X@4FEC:&%R9"!#=71L97(@86YD($-U=&QE&%S+"`R,#$T+3`S,S4U+"!A9V%I;G-T($9U3L@*'8I("0Q M+#`P,"PP,#`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`F(S$T-SM&=7-E#0I-961I8V%L M+"!);F,N)B,Q-#@[+"`H:6DI('1O(&EN8W)E87-E('1H92!#;VUP86YY)B,Q M-#8[F5D(&-A<&ET86P@F5R;R!S:&%R97,@;V8@<')E M9F5R0T*875T:&]R:7IE('1H92!B;V%R M9"!O9B!D:7)E8W1O"!F;W(-"F5A8V@@2!F:6QE9"!W:71H('1H92!3 M96-U&-H86YG92!#;VUM:7-S:6]N("AT:&4@)B,Q-#<[ M4T5#)B,Q-#@[*2!A('!R96QI;6EN87)Y(&EN9F]R;6%T:6]N('-T871E;65N M=`T*;VX@4V-H961U;&4@4%)%(#$T0R!R96QA=&EN9R!T;R!T:&4@87!P2!);F9O'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE28C,30V.W,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!C;VUM;VX@'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE&5C=71E9"!A="!T:&4@8VQO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@28C,30X.RDL(&%S(&]F($9E8G)U87)Y(#(X+"`R,#$T+"!A;F0@=&AE#0IU M;F%U9&ET960@8V]N9&5N2`R."P@,C`Q-"!A;F0@,C`Q,RP@=&AE#0IU;F%U9&ET960@ M8V]N9&5N2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,-"FAA=F4@8F5E M;B!C;VYD96YS960@;W(@;VUI='1E9"!P=7)S=6%N="!T;R!T:&4@&-H86YG M92!#;VUM:7-S:6]N+B!4:&4-"D-O;7!A;GD@8F5L:65V97,@=&AA="!T:&4@ M9&ES8VQO28C,30V.W,@06YN=6%L(%)E<&]R="!O;B!&;W)M(#$P M+4L@9FEL960@=VET:"!T:&4@4V5C=7)I=&EE65A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&9O;G0@2`R."P@,C`Q-"!A;F0@,C`Q,R!A2<^/&9O;G0@2!O=VYE9"!S=6)S:61I87)I97,@1%!%($%C<75I2X@)B,Q-C`[26X@8V]M<'5T:6YG(&1I;'5T960@96%R;FEN9W,@<&5R M('-H87)E+"!T:&4@=')E87-U'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2`R."P@,C`Q-"!A;F0@ M,C`Q,RP@8V]M;6]N('-T;V-K(&5Q=6EV86QE;G1S(&EN8VQU9&4@;W!T:6]N M'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2!A8V-E<'1E M9"!I;B!T:&4@56YI=&5D#0I3=&%T97,@;V8@06UE'0^)SQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6EN9R!A;6]U;G1S(&]F(&-E'!E;G-E6%B;&4-"F%N M9"!A8V-R=65D(&5X<&5N&EM871E('1H96ER(&9A:7(@=F%L M=65S(&)E8V%U2!T:&4@1D%30B`H:6YC;'5D:6YG(&ET&-H86YG92!#;VUM:7-S:6]N("AT:&4@)B,S-#M3 M14,F(S,T.RD[('-U8V@@<')O;F]U;F-E;65N=',@87)E(&YO="!B96QI979E M9"!B>2!M86YA9V5M96YT('1O(&AA=F4@82!M871E'1087)T7V$R,CDW,SAD7S(S8V%?-&0X.5\Y-#9C7S`R9&8Q M.61D-38X.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]A,C(Y-S,X M9%\R,V-A7S1D.#E?.30V8U\P,F1F,3ED9#4V.#@O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@5&%B;&5S M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2`R."P@,C`Q-"!A;F0@075G M=7-T(#,Q+"`R,#$S+"!R97-P96-T:79E;'DZ/"]F;VYT/CPO<#X-"@T*/'`@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE0T*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`R."P\+V(^/"]F;VYT M/CPO<#X-"B`@("`@("`@/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W9E6%B;&4@=&\@1G5S92!-961I8V%L+"!,3$,@+2!O M6UE;G1S(')E<75I6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H M.B`X)3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H M.B`Q)2<^/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W9E65A6QE/3-$)V)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@28C,30V.W,@2`R."P@,C`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`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F&5R8VES960\+V9O;G0^/"]T9#X- M"B`@("`\=&0^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`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`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)W9E6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^ M/&9O;G0@6QE M/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O M=6)L92<^/&9O;G0@6QE/3-$)W=I9'1H.B`Y)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O;G0@ M6QE/3-$)W=I M9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)3L@ M8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L92<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O M;G0@6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUB;W1T;VTZ(#-P="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q M)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L92<^/&9O;G0@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M&5R8VES86)L92!A="!&96)R=6%R>2`R."P@,C`Q M-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@,W!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V)O M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M.B`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6%B;&4@=&\@1G5S92!-961I8V%L+"!,3$,@+2!O6%B;&4@=&\@1G5S92!-961I8V%L+"!,3$,@+2!O'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO6UE;G1S(')E<75I2!I;G1E2`R.2P@ M,C`Q-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO65A7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!I'0^)S$@>65A&5R8VES M86)L92!A="!&96)R=6%R>2`R."P@,C`Q-"P@5V5I9VAT960@079E'0^)S$@>65A&5R8VES M86)L92!A="!&96)R=6%R>2`R."P@,C`Q-"P@06=G'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!4 M'!E;G-E(&9O3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]A,C(Y-S,X9%\R,V-A7S1D.#E?.30V8U\P,F1F,3ED9#4V.#@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83(R.3&UL M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7V$R,CDW,SAD7S(S =8V%?-&0X.5\Y-#9C7S`R9&8Q.61D-38X."TM#0H` ` end XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 2. GOING CONCERN

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated any revenues from operations since 2001 and has suffered recurring losses from its operations. During the six months ended February 28, 2014, the Company had a net loss of $67,578, used cash in operations of $89,250, and had no revenues from operations. As of February 28, 2014, the Company had an accumulated deficit of $3,435,846 and a working capital deficiency of $89,173. Currently, the Company’s working capital is not sufficient to last for more than 12 months. As a result, the Company’s independent registered public accounting firm, in its report on the Company’s August 31, 2013 consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. These factors among others indicate that the Company may be unable to continue as a going concern. The Company’s existence is dependent upon management’s ability to effect a business combination with a target business and/or obtain additional funding sources. Commencing in December 2012, the Company began financing its working capital requirements through sale of its promissory notes and convertible promissory notes. There can be no assurance that the Merger or the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

In order to continue our operations and to make acquisitions, if any, under our current business model during the next twelve months, we will need to secure additional working capital, by way of debt or equity financing, or otherwise. We will need additional financing for working capital, and, in the case of acquisitions, for payment of seller notes and future earned cash to sellers of acquired companies. There can be no assurance that we will be able to secure sufficient financing or on terms acceptable to us. If adequate funds are not available on acceptable terms, we would need to delay, limit or eliminate some or all of our proposed operations, and we may be unable to successfully promote our products or develop new or enhanced products or prosecute acquisitions, any of which could lower our revenues and net income, if we achieve profitability in the future. If we raise additional funds through the issuance of convertible debt or equity securities, the percentage ownership of our current stockholders is likely to be diluted, unless some of our current stockholders were to invest in subsequent convertible debt or equity financings, and some of the newly issued securities may also have rights superior to those of our common stock. Additionally, if we issue or incur debt to raise funds, we may be subject to limitations on our operations.

XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
Feb. 28, 2014
Aug. 31, 2013
Current assets:    
Cash and cash equivalents $ 6,551 $ 801
Prepaid expenses 18,673 10,700
Total current assets 25,224 11,501
Total assets 25,224 11,501
Current liabilities:    
Accounts payable and accrued expenses 19,397 33,096
Notes payable, current portion 95,000   
Total current liabilities 114,397 33,096
Notes payable 17,250 17,250
Total liabilities 131,647 50,346
Stockholders' deficiency:    
Common stock, $0.01 par value; 12,000,000 shares authorized, 5,848,185 shares issued and outstanding, respectively 58,481 58,481
Additional paid-in capital 3,270,942 3,270,942
Accumulated deficit (3,435,846) (3,368,268)
Total stockholders' deficiency (106,423) (38,845)
Total liabilities and stockholders' deficiency $ 25,224 $ 11,501
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Cash flows from operating activities:    
Net loss $ (67,578) $ (56,642)
Adjustments to reconcile net loss to net cash used in operating activites:    
Convertible notes issued for services rendered    5,250
Changes in operating assets and liabilities:    
(Increase) decrease in prepaid expenses (7,973) 3,750
Increase in accounts payable and accrued expenses (13,699) 37,462
Net cash used in operating activities (89,250) (10,180)
Cash flows from financing activities:    
Proceeds from issuance of notes payable 95,000   
Proceeds from related party for convertible notes    10,000
Net cash provided by financing activities 95,000 10,000
Net increase (decrease) in cash and cash equivalents 5,750 (180)
Cash and cash equivalents - beginning 801 334
Cash and cash equivalents - ending 6,551 154
Supplemental disclosure of cash flow information:    
Interest paid 280   
Income taxes paid      
XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND BASIS OF PRESENTATION
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION

(A) Merger with Fuse Medical, LLC

 

On December 18, 2013, Golf Rounds.com, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Fuse Medical, LLC (“Fuse”), Project Fuse LLC, a wholly owned subsidiary of the Company (“Merger Sub”), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the “Representative”). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the “Merger”). The Merger is expected to be completed during the third fiscal quarter of 2014.

 

Fuse is a physician-partnered company and national distributor that provides diversified healthcare products and supplies, including biologics and bone substitute materials, while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners. Fuse has entered into partnership arrangements with physicians in order to distribute its products.

 

In accordance with the Merger Agreement, on December 18, 2013, the Company obtained approval by written consent from the holders of 3,220,330 shares of its common stock, representing a majority of its outstanding common stock, to amend its certificate of incorporation, effective immediately prior to the consummation of the Merger, (i) to change the name of the Company to “Fuse Medical, Inc.”, (ii) to increase the Company’s authorized capital stock from 12,000,000 shares of common stock to 500,000,000 shares of common stock and from zero shares of preferred stock to 20,000,000 shares of preferred stock, and to expressly authorize the board of directors of the Company to issue shares of the preferred stock, in one or more series, and to fix for each such series the voting powers, designations, preferences, or other special rights thereof and the qualifications, limitations or restrictions thereon, and (iii) to effect a 14.62 to 1 reverse stock split (the “Reverse Stock Split”). On March 4, 2014, the Company filed with the Securities and Exchange Commission (the “SEC”) a preliminary information statement on Schedule PRE 14C relating to the approval and adoption of the amendments (the “Preliminary Information Statement”). On March 13, 2014, the SEC notified the Company that the Preliminary Information Statement would be reviewed. Once the comments on the Preliminary Information Statement have been cleared by the SEC, the Company shall file a definitive information statement on Schedule DEF 14C relating to the adoption of the amendments (the “Definitive Information Statement”). The amendments will become effective no earlier than 20 days after the Definitive Information Statement is mailed to the Company’s stockholders.

 

All of the units reflecting membership interests in Fuse that are issued and outstanding immediately prior to the effective time of the Merger shall be cancelled and converted into the right to receive 3,600,000 shares of the Company’s common stock (on a post-Reverse Stock Split basis), representing 90% of the Company’s issued and outstanding common stock after giving effect to the Merger (the “Merger Consideration”). The Merger Consideration will be allocated among the members of Fuse immediately prior to the effective time of the Merger (the “Holders”) in accordance with Fuse’s limited liability company operating agreement.

 

In order to fund the indemnification obligations of the Holders after the closing of the Merger, of the shares of common stock constituting the Merger Consideration, 180,000 shares (on a post-Reverse Stock Split basis) will be deposited in escrow pursuant to the terms of the Merger Agreement and an escrow agreement, in the form attached to the Merger Agreement, to be executed at the closing.

 

(B) Interim Financial Statements

 

The accompanying unaudited condensed consolidated balance sheet of Golf Rounds.com, Inc. and its wholly owned subsidiaries, DPE Acquisition Corp. and Project Fuse LLC, (collectively, the “Company”), as of February 28, 2014, and the unaudited condensed consolidated statements of operations for the three and six months ended February 28, 2014 and 2013, the unaudited condensed consolidated statement of stockholders’ deficit for the six months ended February 28, 2014, and the unaudited condensed consolidated statements of cash flows for the six months ended February 28, 2014 and 2013 reflect all material adjustments which, in the opinion of management, are ordinary and necessary for a fair presentation of results for the interim periods. Certain information and footnote disclosures required under generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company believes that the disclosures are adequate to make the information presented not misleading. The condensed consolidated balance sheet information as of August 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 15, 2013. These condensed consolidated financial statements should be read in conjunction with the year-end audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2013.

 

The results of operations for the three and six months ended February 28, 2014 and 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or for any other period.

 

(C) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Golf Rounds.com, Inc. and its wholly owned subsidiaries DPE Acquisition Corp. (formed on September 2, 2003) and Project Fuse LLC (formed on December 17, 2013). Intercompany transactions and accounts have been eliminated in consolidation.

 

(D) Loss Per Share

 

Diluted earnings per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. In computing diluted earnings per share, the treasury stock method assumes that our outstanding options are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options.

 

As of February 28, 2014 and 2013, common stock equivalents include options to purchase 330,000 and 360,000 common shares, respectively. These instruments are not considered in the diluted loss per share because the effect would be anti-dilutive.

 

(E) Use of Estimates

 

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the valuation of equity instruments at the date of the condensed consolidated financial statements. Actual results could differ from those estimates.

 

(F) Fair Value of Financial Instruments

 

The carrying amounts of certain financial instruments, including cash and cash equivalents, prepaid expenses, and accounts payable and accrued expenses approximate their fair values because of the short-term maturity of these instruments.

 

(G) Recent Accounting Pronouncements

 

There are recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the "SEC"); such pronouncements are not believed by management to have a material impact on the Company's present or future financial statements.

 

XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)
Feb. 28, 2014
Aug. 31, 2013
Stockholders' deficiency:    
Common Stock Par Value $ 0.01 $ 0.01
Common Stock Shares Authorized 12,000,000 12,000,000
Common Stock Shares Issued 5,848,185 5,848,185
Common Stock Shares Outstanding 5,848,185 5,848,185
XML 21 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN (Details Narrative) (USD $)
3 Months Ended 6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Feb. 28, 2014
Feb. 28, 2013
Aug. 31, 2013
Going Concern Details Narrative          
Net loss $ 19,154 $ 24,470 $ 67,578 $ 56,642  
Net cash used in operating activities     89,250 10,180  
Accumulated deficit (3,435,846)   (3,435,846)   (3,368,268)
Working capital deficiency $ 89,173   $ 89,173    
XML 22 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Feb. 28, 2014
Mar. 25, 2014
Document And Entity Information    
Entity Registrant Name GOLF ROUNDS COM INC  
Entity Central Index Key 0000319016  
Document Type 10-Q  
Document Period End Date Feb. 28, 2014  
Amendment Flag false  
Current Fiscal Year End Date --08-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   5,848,185
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2014  
XML 23 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details) (USD $)
Feb. 28, 2014
Aug. 31, 2013
Notes Payable Details    
Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014 $ 39,000   
Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014 24,000   
Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014 32,000   
Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015 6,000 6,000
Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015 11,250 11,250
Total 112,250 17,250
Less: Current maturities (95,000)   
Amount due after one year $ 17,250 $ 17,250
XML 24 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Feb. 28, 2014
Feb. 28, 2013
Expenses:        
General, administrative and other $ 18,377 $ 24,372 $ 66,466 $ 56,544
Total operating expenses 18,377 24,372 66,466 56,544
Loss from operations (18,377) (24,372) (66,466) (56,544)
Other income (expense):        
Interest expense (777) (98) (1,112) (98)
Total other income (expense) (777) (98) (1,112) (98)
Net loss $ (19,154) $ (24,470) $ (67,578) $ (56,642)
Net loss per common share - basic and diluted $ 0.00 $ (0.01) $ (0.01) $ (0.02)
Weighted average number of common shares outstanding - basic and diluted 5,848,185 3,567,377 5,848,185 3,567,377
XML 25 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 6 - COMMITMENTS AND CONTINGENCIES

Legal Matters

 

On January 27, 2014, M. Richard Cutler and Cutler Law Group, P.C. (the “Plaintiffs”) filed a complaint in the District Court of Harris County, Texas, 2014-03355, against Fuse Medical, LLC, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc. (the “Defendants”). Plaintiff Richard Cutler is the sole principal of Plaintiff Cutler Law Group, which provided legal representation to its client (“Cutler’s Client”) that was interested in merging into a publicly traded corporation and attracting doctors as investors. Plaintiffs allege that a proposed transaction between Cutler’s Client and Fuse Medical, LLC (“Cutler’s Failed Transaction”), failed to materialize notwithstanding the alleged efforts of Mr. Cutler and his law firm to document the transaction. Plaintiffs further allege that, subsequently, the Defendants continued to pursue a similar transaction without Cutler’s Client or the Plaintiffs. The Plaintiffs are claiming that the Defendants are responsible for damages in the amount of: (i) $46,465 plus interest because Plaintiffs were not paid their legal fees by Cutler’s Client nor did they receive equity in the company that Plaintiffs hoped would be issued from Cutler’s Failed Transaction; (ii) $46,465 plus interest due to Defendant being unjustly enriched from Plaintiffs’ legal services to Cutler’s Client; (iii) $1,186,000 plus interest, being the alleged value of shares that Plaintiffs claimed to be entitled from Cutler’s Failed Transaction, which amount should allegedly be tripled as exemplary damages as a result of intentional fraud and/or negligent representations that some or all of the Defendants allegedly committed and that such conduct allegedly constitutes conspiracy to commit fraud; (iv) $1,186,000, allegedly arising from a breach of a Non-Competition and Non-Disclosure Agreement to which Plaintiffs were not a party; (v) $1,000,000 for breach of fiduciary duty by the Defendants because they would have been directors and officers of the surviving corporation in Cutler’s Failed Transaction had it not failed and Defendants’ moving on to another transaction without Plaintiffs; and (vi) Plaintiffs’ attorneys fees and costs for bringing this action. Defendants believe the lawsuit to be without merit and have retained counsel to vigorously defend the action. In addition, Defendant Robert H. Donehew is covered by Directors and Officers Insurance policies.

XML 26 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 5. RELATED PARTY TRANSACTIONS

On March 1, 2000, the Company executed a month-to-month agreement to sub-lease office space and share office equipment and a bookkeeper’s time for $900 a month from R. D. Garwood, Inc. (“Garwood”). The Company’s President/Treasurer/Secretary is the Chief Financial Officer of Garwood. Effective June 1, 2013, due to the financial status of the Company, R.D. Garwood, Inc. began providing the aforementioned services at no charge to the Company. The Company’s expense for these shared facilities and bookkeeping services was $2,700 and $5,400 for the three and six months ended February 28, 2013.

 

During the three and six months ended February 28, 2014, the Company’s President provided services at no charge to the Company. During the three and six months ended February 28, 2013, the Company accrued salary for its President in the amount of $7,500 and $15,000, respectively, which is included in general and administrative expenses in the accompanying consolidated statements of operations.

XML 27 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Details Narrative) (USD $)
3 Months Ended 6 Months Ended
Feb. 28, 2014
Feb. 28, 2013
Feb. 28, 2014
Feb. 28, 2013
Notes Payable Details Narrative        
Interest expense $ 777 $ 98 $ 1,112 $ 98
Interest expense for related parties   56    
Accrued interest payable $ 852   $ 852  
XML 28 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDER'S DEFICIT (Tables)
6 Months Ended
Feb. 28, 2014
Stockholders Deficit Tables  
Summary of the Company stock option activity

A summary of the Company’s stock option activity during the six months ended February 28, 2014 is presented below:

 

                Weighted        
          Weighted     Average        
          Average     Remaining     Aggregate  
    No. of     Exercise     Contractual     Intrinsic  
    Shares     Price     Term     Value  
Balance outstanding at August 31, 2013     330,000     $ 0.68              
Granted     -                      
Exercised     -                      
Forfeited     -                      
Expired     -                      
Balance outstanding at February 28, 2014     330,000     $ 0.68       1.7     $ -  
                                 
Exercisable at February 28, 2014     330,000     $ 0.68       1.7     $ -  
                                 
XML 29 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Policies)
6 Months Ended
Feb. 28, 2014
Nature Of Operations And Basis Of Presentation Policies  
Merger with Fuse Medical, LLC

On December 18, 2013, Golf Rounds.com, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Fuse Medical, LLC (“Fuse”), Project Fuse LLC, a wholly owned subsidiary of the Company (“Merger Sub”), and D. Alan Meeker, solely in his capacity as the representative of the Fuse members (the “Representative”). Upon consummation of the transactions contemplated by the Merger Agreement, Merger Sub will merge with and into Fuse, with Fuse surviving as a wholly owned subsidiary of the Company (the “Merger”). The Merger is expected to be completed during the third fiscal quarter of 2014.

 

Fuse is a physician-partnered company and national distributor that provides diversified healthcare products and supplies, including biologics and bone substitute materials, while striving to document cost savings and clinical outcomes to its manufacturers, physicians, health insurers and medical facility partners. Fuse has entered into partnership arrangements with physicians in order to distribute its products.

 

In accordance with the Merger Agreement, on December 18, 2013, the Company obtained approval by written consent from the holders of 3,220,330 shares of its common stock, representing a majority of its outstanding common stock, to amend its certificate of incorporation, effective immediately prior to the consummation of the Merger, (i) to change the name of the Company to “Fuse Medical, Inc.”, (ii) to increase the Company’s authorized capital stock from 12,000,000 shares of common stock to 500,000,000 shares of common stock and from zero shares of preferred stock to 20,000,000 shares of preferred stock, and to expressly authorize the board of directors of the Company to issue shares of the preferred stock, in one or more series, and to fix for each such series the voting powers, designations, preferences, or other special rights thereof and the qualifications, limitations or restrictions thereon, and (iii) to effect a 14.62 to 1 reverse stock split (the “Reverse Stock Split”). On March 4, 2014, the Company filed with the Securities and Exchange Commission (the “SEC”) a preliminary information statement on Schedule PRE 14C relating to the approval and adoption of the amendments (the “Preliminary Information Statement”). On March 13, 2014, the SEC notified the Company that the Preliminary Information Statement would be reviewed. Once the comments on the Preliminary Information Statement have been cleared by the SEC, the Company shall file a definitive information statement on Schedule DEF 14C relating to the adoption of the amendments (the “Definitive Information Statement”). The amendments will become effective no earlier than 20 days after the Definitive Information Statement is mailed to the Company’s stockholders.

 

All of the units reflecting membership interests in Fuse that are issued and outstanding immediately prior to the effective time of the Merger shall be cancelled and converted into the right to receive 3,600,000 shares of the Company’s common stock (on a post-Reverse Stock Split basis), representing 90% of the Company’s issued and outstanding common stock after giving effect to the Merger (the “Merger Consideration”). The Merger Consideration will be allocated among the members of Fuse immediately prior to the effective time of the Merger (the “Holders”) in accordance with Fuse’s limited liability company operating agreement.

 

In order to fund the indemnification obligations of the Holders after the closing of the Merger, of the shares of common stock constituting the Merger Consideration, 180,000 shares (on a post-Reverse Stock Split basis) will be deposited in escrow pursuant to the terms of the Merger Agreement and an escrow agreement, in the form attached to the Merger Agreement, to be executed at the closing.

Interim Financial Statements

The accompanying unaudited condensed consolidated balance sheet of Golf Rounds.com, Inc. and its wholly owned subsidiaries, DPE Acquisition Corp. and Project Fuse LLC, (collectively, the “Company”), as of February 28, 2014, and the unaudited condensed consolidated statements of operations for the three and six months ended February 28, 2014 and 2013, the unaudited condensed consolidated statement of stockholders’ deficit for the six months ended February 28, 2014, and the unaudited condensed consolidated statements of cash flows for the six months ended February 28, 2014 and 2013 reflect all material adjustments which, in the opinion of management, are ordinary and necessary for a fair presentation of results for the interim periods. Certain information and footnote disclosures required under generally accepted accounting principles have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company believes that the disclosures are adequate to make the information presented not misleading. The condensed consolidated balance sheet information as of August 31, 2013 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 15, 2013. These condensed consolidated financial statements should be read in conjunction with the year-end audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2013.

 

The results of operations for the three and six months ended February 28, 2014 and 2013 are not necessarily indicative of the results to be expected for the entire fiscal year or for any other period.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Golf Rounds.com, Inc. and its wholly owned subsidiaries DPE Acquisition Corp. (formed on September 2, 2003) and Project Fuse LLC (formed on December 17, 2013). Intercompany transactions and accounts have been eliminated in consolidation.

Loss Per Share

Diluted earnings per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company.  In computing diluted earnings per share, the treasury stock method assumes that our outstanding options are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options will have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options.

 

As of February 28, 2014 and 2013, common stock equivalents include options to purchase 330,000 and 360,000 common shares, respectively. These instruments are not considered in the diluted loss per share because the effect would be anti-dilutive.

Use of Estimates

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the valuation of equity instruments at the date of the condensed consolidated financial statements. Actual results could differ from those estimates.

Fair Value of Financial Instruments

The carrying amounts of certain financial instruments, including cash and cash equivalents, prepaid expenses, and accounts payable and accrued expenses approximate their fair values because of the short-term maturity of these instruments.

Recent Accounting Pronouncements

There are recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the Securities Exchange Commission (the "SEC"); such pronouncements are not believed by management to have a material impact on the Company's present or future financial statements.

XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTES PAYABLE (Tables)
6 Months Ended
Feb. 28, 2014
Notes Payable Tables  
Schedule of notes payable

Notes payable consisted of the following at February 28, 2014 and August 31, 2013, respectively:

 

   

February 28,

2014

   

August 31,

2013

 
Note payable to Fuse Medical, LLC - originating October 18, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at April 15, 2014   $ 39,000     $ -  
                 
Note payable to Fuse Medical, LLC - originating November 4, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at May 5, 2014     24,000       -  
                 
Note payable to Fuse Medical, LLC - originating December 26, 2013; no periodic interest payments required; bearing interest at 3.0%; maturing at June 26, 2014     32,000       -  
                 
Note payable - originating July 30, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at July 29, 2015     6,000       6,000  
                 
Note payable - originating August 29, 2013; quarterly interest payments required; bearing interest at 3.25%; maturing at August 28, 2015     11,250       11,250  
Total     112,250       17,250  
Less: Current maturities     (95,000 )     -  
Amount due after one year   $ 17,250     $ 17,250  
XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative)
Feb. 28, 2014
Feb. 28, 2013
Nature Of Operations And Basis Of Presentation Details Narrative    
Common stock including options to purchase 330,000 360,000
XML 32 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)
3 Months Ended 6 Months Ended
Feb. 28, 2013
Feb. 28, 2013
Related Party Transactions Details Narrative    
Expense for shared facilities and bookkeeping services $ 2,700 $ 5,400
Accrued Salary $ 7,500 $ 15,000
XML 33 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (USD $)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Amount at Aug. 31, 2013 $ 58,481 $ 3,270,942 $ (3,368,268) $ (38,845)
Beginning Balance, Shares at Aug. 31, 2013 5,848,185      
Net loss       (67,578) (67,578)
Ending Balance, Amount at Feb. 28, 2014 $ 58,481 $ 3,270,942 $ (3,435,846) $ (106,423)
Ending Balance, Shares at Feb. 28, 2014 5,848,185      
XML 34 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDER'S DEFICIT
6 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
NOTE 4. STOCKHOLDERS' DEFICIENCY

Stock Options

 

A summary of the Company’s stock option activity during the six months ended February 28, 2014 is presented below:

 

                Weighted        
          Weighted     Average        
          Average     Remaining     Aggregate  
    No. of     Exercise     Contractual     Intrinsic  
    Shares     Price     Term     Value  
Balance outstanding at August 31, 2013     330,000     $ 0.68              
Granted     -                      
Exercised     -                      
Forfeited     -                      
Expired     -                      
Balance outstanding at February 28, 2014     330,000     $ 0.68       1.7     $ -  
                                 
Exercisable at February 28, 2014     330,000     $ 0.68       1.7     $ -  
                                 
XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 18 91 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://teee.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://teee.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://teee.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://teee.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Stockholders' Equity (Unaudited) Sheet http://teee.com/role/StatementOfStockholdersEquity Condensed Consolidated Statement of Stockholders' Equity (Unaudited) false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://teee.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION Sheet http://teee.com/role/NatureOfOperationsAndBasisOfPresentation NATURE OF OPERATIONS AND BASIS OF PRESENTATION false false R8.htm 00000008 - Disclosure - GOING CONCERN Sheet http://teee.com/role/GoingConcern GOING CONCERN false false R9.htm 00000009 - Disclosure - NOTES PAYABLE Notes http://teee.com/role/ConvertibleNotesPayable NOTES PAYABLE false false R10.htm 00000010 - Disclosure - STOCKHOLDER'S DEFICIT Sheet http://teee.com/role/StockholdersDeficiency STOCKHOLDER'S DEFICIT false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://teee.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://teee.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R13.htm 00000013 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Policies) Sheet http://teee.com/role/NatureOfOperationsAndBasisOfPresentationPolicies NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Policies) false false R14.htm 00000014 - Disclosure - NOTES PAYABLE (Tables) Notes http://teee.com/role/NotesPayableTables NOTES PAYABLE (Tables) false false R15.htm 00000015 - Disclosure - STOCKHOLDER'S DEFICIT (Tables) Sheet http://teee.com/role/StockholdersDeficiencyTables STOCKHOLDER'S DEFICIT (Tables) false false R16.htm 00000016 - Disclosure - NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) Sheet http://teee.com/role/NatureOfOperationsAndBasisOfPresentationDetailsNarrative NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) false false R17.htm 00000017 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://teee.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) false false R18.htm 00000018 - Disclosure - NOTES PAYABLE (Details) Notes http://teee.com/role/NotesPayableDetails NOTES PAYABLE (Details) false false R19.htm 00000019 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://teee.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) false false R20.htm 00000020 - Disclosure - STOCKHOLDER'S DEFICIT (Details) Sheet http://teee.com/role/StockholdersDeficitDetails STOCKHOLDER'S DEFICIT (Details) false false R21.htm 00000021 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://teee.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Feb. 28, 2013' Process Flow-Through: Removing column 'Aug. 31, 2012' Process Flow-Through: 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) teee-20140228.xml teee-20140228.xsd teee-20140228_cal.xml teee-20140228_def.xml teee-20140228_lab.xml teee-20140228_pre.xml true true XML 36 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDER'S DEFICIT (Details) (USD $)
6 Months Ended
Feb. 28, 2014
Stockholders Deficit Details  
Balance outstanding at August 31, 2013, No. Of Shares 330,000
Granted, No. Of Shares   
Exercised, No. Of Shares   
Forfeited, No. Of Shares   
Expired, No. Of Shares   
Balance outstanding at February 28, 2014, No. Of Shares 330,000
Exercisable at February 28, 2014, No. Of Shares 330,000
Balance outstanding at August 31, 2013, Weighted Average Exercise Price $ 0.68
Expired, Weighted Average Exercise Price $ 0.68
Balance outstanding at February 28, 2014, Weighted Average Exercise Price $ 0.68
Exercisable at February 28, 2014, Weighted Average Exercise Price $ 0.68
Balance outstanding at February 28, 2014, Weighted Average Remaining Contractual Term 1 year 8 months 12 days
Exercisable at February 28, 2014, Weighted Average Remaining Contractual Term 1 year 8 months 12 days
Exercisable at February 28, 2014, Aggregate Intrinsic Value   
Exercisable at February 28, 2014, Aggregate Intrinsic Value